0001689657-22-000019.txt : 20220509 0001689657-22-000019.hdr.sgml : 20220509 20220509161336 ACCESSION NUMBER: 0001689657-22-000019 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220509 DATE AS OF CHANGE: 20220509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Berkeley Lights, Inc. CENTRAL INDEX KEY: 0001689657 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 352415390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39388 FILM NUMBER: 22905093 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET STREET 2: SUITE 320 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-858-2855 MAIL ADDRESS: STREET 1: 5858 HORTON STREET STREET 2: SUITE 320 CITY: EMERYVILLE STATE: CA ZIP: 94608 10-Q 1 bli-20220331.htm 10-Q bli-20220331
000168965712/312022Q1falsehttp://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent00016896572022-01-012022-03-3100016896572022-04-30xbrli:shares00016896572022-03-31iso4217:USD00016896572021-12-31iso4217:USDxbrli:shares0001689657us-gaap:ProductMember2022-01-012022-03-310001689657us-gaap:ProductMember2021-01-012021-03-310001689657us-gaap:ServiceMember2022-01-012022-03-310001689657us-gaap:ServiceMember2021-01-012021-03-3100016896572021-01-012021-03-310001689657us-gaap:CommonStockMember2021-12-310001689657us-gaap:AdditionalPaidInCapitalMember2021-12-310001689657us-gaap:RetainedEarningsMember2021-12-310001689657us-gaap:CommonStockMember2022-01-012022-03-310001689657us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001689657us-gaap:RetainedEarningsMember2022-01-012022-03-310001689657us-gaap:CommonStockMember2022-03-310001689657us-gaap:AdditionalPaidInCapitalMember2022-03-310001689657us-gaap:RetainedEarningsMember2022-03-310001689657us-gaap:CommonStockMember2020-12-310001689657us-gaap:AdditionalPaidInCapitalMember2020-12-310001689657us-gaap:RetainedEarningsMember2020-12-3100016896572020-12-310001689657us-gaap:CommonStockMember2021-01-012021-03-310001689657us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001689657us-gaap:RetainedEarningsMember2021-01-012021-03-310001689657us-gaap:CommonStockMember2021-03-310001689657us-gaap:AdditionalPaidInCapitalMember2021-03-310001689657us-gaap:RetainedEarningsMember2021-03-3100016896572021-03-310001689657us-gaap:RevenueFromContractWithCustomerMemberbli:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-31xbrli:pure0001689657bli:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657us-gaap:RevenueFromContractWithCustomerMemberbli:CustomerThreeMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657us-gaap:RevenueFromContractWithCustomerMemberbli:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-03-310001689657bli:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-03-310001689657us-gaap:AccountsReceivableMemberbli:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657bli:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657us-gaap:AccountsReceivableMemberbli:CustomerThreeMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657bli:CustomerFourMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001689657us-gaap:AccountsReceivableMemberbli:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001689657bli:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001689657us-gaap:AccountsReceivableMemberbli:CustomerThreeMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001689657us-gaap:SalesChannelDirectlyToConsumerMember2022-01-012022-03-310001689657us-gaap:SalesChannelDirectlyToConsumerMember2021-01-012021-03-310001689657us-gaap:SalesChannelThroughIntermediaryMember2022-01-012022-03-310001689657us-gaap:SalesChannelThroughIntermediaryMember2021-01-012021-03-310001689657bli:AntibodyTherapeuticsMember2022-01-012022-03-310001689657bli:AntibodyTherapeuticsMember2021-01-012021-03-310001689657bli:SyntheticBiologyMember2022-01-012022-03-310001689657bli:SyntheticBiologyMember2021-01-012021-03-310001689657bli:AgriculturalBiologyMember2022-01-012022-03-310001689657bli:AgriculturalBiologyMember2021-01-012021-03-310001689657bli:GeneTherapyMember2022-01-012022-03-310001689657bli:GeneTherapyMember2021-01-012021-03-310001689657bli:CellTherapyMember2022-01-012022-03-310001689657bli:CellTherapyMember2021-01-012021-03-310001689657us-gaap:TransferredAtPointInTimeMember2022-01-012022-03-310001689657us-gaap:TransferredAtPointInTimeMember2021-01-012021-03-310001689657us-gaap:TransferredOverTimeMember2022-01-012022-03-310001689657us-gaap:TransferredOverTimeMember2021-01-012021-03-3100016896572022-04-012022-03-310001689657us-gaap:FairValueInputsLevel1Member2022-03-310001689657us-gaap:FairValueInputsLevel2Member2022-03-310001689657us-gaap:FairValueInputsLevel3Member2022-03-310001689657us-gaap:FairValueInputsLevel1Member2021-12-310001689657us-gaap:FairValueInputsLevel2Member2021-12-310001689657us-gaap:FairValueInputsLevel3Member2021-12-310001689657us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2022-03-310001689657us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2022-03-310001689657us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-12-310001689657us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-12-310001689657bli:EquipmentToolingAndMoldsMember2022-03-310001689657bli:EquipmentToolingAndMoldsMember2021-12-310001689657us-gaap:ComputerEquipmentMember2022-03-310001689657us-gaap:ComputerEquipmentMember2021-12-310001689657us-gaap:FurnitureAndFixturesMember2022-03-310001689657us-gaap:FurnitureAndFixturesMember2021-12-310001689657us-gaap:LeaseholdImprovementsMember2022-03-310001689657us-gaap:LeaseholdImprovementsMember2021-12-310001689657us-gaap:ConstructionInProgressMember2022-03-310001689657us-gaap:ConstructionInProgressMember2021-12-310001689657us-gaap:BuildingMember2021-09-30bli:facility0001689657us-gaap:NotesPayableToBanksMemberbli:EWBLoanMember2018-05-230001689657bli:TermLoanMemberus-gaap:NotesPayableToBanksMember2021-06-300001689657bli:TermLoanMemberus-gaap:NotesPayableToBanksMember2021-06-302021-06-300001689657us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-06-300001689657us-gaap:LineOfCreditMemberus-gaap:PrimeRateMemberus-gaap:RevolvingCreditFacilityMember2021-06-302021-06-300001689657us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-03-310001689657bli:TermLoanMemberus-gaap:NotesPayableToBanksMember2022-03-310001689657us-gaap:CostOfSalesMember2022-01-012022-03-310001689657us-gaap:CostOfSalesMember2021-01-012021-03-310001689657us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001689657us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-03-310001689657us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001689657us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-03-310001689657us-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001689657us-gaap:SellingAndMarketingExpenseMember2021-01-012021-03-310001689657us-gaap:RestrictedStockUnitsRSUMembersrt:ChiefExecutiveOfficerMember2022-03-102022-03-100001689657srt:ChiefExecutiveOfficerMember2022-03-102022-03-100001689657us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2022-03-102022-03-100001689657us-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMember2022-03-102022-03-100001689657srt:MinimumMemberus-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2022-03-100001689657srt:MaximumMemberus-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2022-03-100001689657us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2022-01-012022-03-310001689657bli:AbCelleraAndUBCMember2021-07-012021-07-01bli:patentbli:claim0001689657bli:AbCelleraUnfairCompetitionMember2020-08-012020-08-310001689657bli:AbCelleraNonInfringementMember2020-08-012020-08-3100016896572020-10-012020-10-310001689657us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001689657us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001689657us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001689657us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-31bli:segment0001689657srt:NorthAmericaMember2022-01-012022-03-310001689657srt:NorthAmericaMember2021-01-012021-03-310001689657srt:AsiaPacificMember2022-01-012022-03-310001689657srt:AsiaPacificMember2021-01-012021-03-310001689657srt:EuropeMember2022-01-012022-03-310001689657srt:EuropeMember2021-01-012021-03-31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark one)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022

or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from___ to___
Commission file number: 001-39388
bli-20220331_g1.jpg
Berkeley Lights, Inc.
(Exact name of registrant as specified in its charter)
Delaware35-2415390
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
5858 Horton Street, Suite 320
Emeryville, California 94608
(Address of principal executive offices)( Zip code)
(510) 858-2855
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, $0.00005 par valueBLIThe Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer☐Non-accelerated filer☐
Smaller reporting company☐Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of April 30, 2022, 67,826,564 shares of the registrant’s common stock, $0.00005 par value per share, were outstanding.

BERKELEY LIGHTS, INC.
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022
Table of Contents
Page(s)
Item 1.
Item 3.
Item 4.

PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements (Unaudited).
Berkeley Lights, Inc.
Condensed Consolidated Balance Sheets
March 31,
2022		December 31,
2021
(In thousands, except share and per share data)(unaudited)
Assets
Current assets:
Cash and cash equivalents$164,674 $178,096 
Trade accounts receivable17,721 25,942 
Inventory15,665 14,547 
Prepaid expenses and other current assets10,304 11,985 
Total current assets208,364 230,570 
Restricted cash270 270 
Property and equipment, net29,913 27,992 
Operating lease right-of-use assets25,325 26,060 
Other assets1,985 2,361 
Total assets$265,857 $287,253 
Liabilities and Stockholders’ Equity
Current liabilities:
Trade accounts payable$8,015 $8,198 
Accrued expenses and other current liabilities9,916 12,425 
Deferred revenue9,780 12,128 
Total current liabilities27,711 32,751 
Notes payable19,778 19,762 
Deferred revenue, net of current portion1,600 2,187 
Lease liability, long-term23,567 24,337 
Total liabilities72,656 79,037 
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock, $0.00005 par value. Authorized 300,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding 67,820,115 and 67,595,535 shares at March 31, 2022 and December 31, 2021, respectively
4 4 
Additional paid-in capital478,231 471,820 
Accumulated deficit(285,034)(263,608)
Total stockholders’ equity193,201 208,216 
Total liabilities and stockholders’ equity$265,857 $287,253 
See accompanying notes to these condensed consolidated financial statements.
1
Berkeley Lights, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

Three months ended March 31,
20222021
(In thousands, except share and per share data)
Revenue:
Product revenue$9,774 $13,533 
Service revenue10,432 5,095 
Total revenue20,206 18,628 
Cost of sales:
Product cost of sales2,695 3,703 
Service cost of sales3,684 2,474 
Total cost of sales6,379 6,177 
Gross profit13,827 12,451 
Operating expenses:
Research and development17,573 13,027 
General and administrative11,716 8,967 
Sales and marketing5,811 5,606 
Total operating expenses35,100 27,600 
Loss from operations(21,273)(15,149)
Other income (expense):
Interest expense(224)(354)
Interest income34 66 
Other income, net57 19 
Loss before income taxes(21,406)(15,418)
Provision for income taxes20 17 
Net loss and comprehensive loss$(21,426)$(15,435)
Net loss attributable to common stockholders per share, basic and diluted$(0.32)$(0.24)
Weighted-average shares used in calculating net loss per share, basic and diluted67,697,488 65,259,398 

See accompanying notes to these condensed consolidated financial statements.
2
Berkeley Lights, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)


Three Months Ended March 31, 2022
Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Total
Stockholders'
Equity
(In thousands, except per share data)SharesAmount
Balances at December 31, 202167,595,535 $4 $471,820 $(263,608)$208,216 
Shares issued in connection with:
Exercise of stock options81,654 — 412 — 412 
Vesting of restricted stock units27,580 — — — — 
Employee stock purchase plan115,346 — 610 — 610 
Stock-based compensation— — 5,389 — 5,389 
Net loss— — — (21,426)(21,426)
Balances at March 31, 202267,820,115 $4 $478,231 $(285,034)$193,201 
Three Months Ended March 31, 2021
Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Total
Stockholders'
Equity
(In thousands, except per share data)SharesAmount
Balances at December 31, 202064,486,246 $3 $436,662 $(191,884)$244,781 
Shares issued in connection with:
Exercise of stock options1,778,130 1 6,361 — 6,362 
Vesting of restricted stock units5,000 — — — — 
     Employee stock purchase plan115,360 — 2,157 — 2,157 
Stock-based compensation— — 4,501 — 4,501 
Net loss— — — (15,435)(15,435)
Balances at March 31, 202166,384,736 $4 $449,681 $(207,319)$242,366 

See accompanying notes to these condensed consolidated financial statements.
3
Berkeley Lights, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)

Three months ended March 31,
(In thousands)20222021
Cash flows from operating activities:
Net loss$(21,426)$(15,435)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation1,944 1,345 
Stock-based compensation5,393 4,494 
Amortization of operating lease right-of-use assets735 495 
Non-cash interest and other expense related to debt and note receivable agreements16 18 
Provision for excess and obsolete inventory195 44 
Loss on disposal and impairment of property and equipment28 13 
Changes in operating assets and liabilities:
Trade accounts receivable8,221 (3,493)
Inventory(1,317)(2,744)
Prepaid expenses, other current assets and other assets2,057 (1,036)
Trade accounts payable298 2,690 
Deferred revenue(2,935)3,039 
Accrued expenses and other current liabilities(2,552)(429)
Operating lease liabilities(726)(361)
Net cash used in operating activities(10,069)(11,360)
Cash flows from investing activities:
Purchase of property and equipment(4,375)(402)
Net cash used in investing activities(4,375)(402)
Cash flows from financing activities:
Proceeds from issuance of common stock upon exercise of stock options412 6,362 
Proceeds from issuance of common stock under employee stock purchase plan610 2,157 
Net cash provided by financing activities1,022 8,519 
Net decrease in cash and cash equivalents and restricted cash(13,422)(3,243)
Cash and cash equivalents and restricted cash at beginning of period178,366 233,678 
Cash and cash equivalents and restricted cash at end of period$164,944 $230,435 

See accompanying notes to these condensed consolidated financial statements.
4
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

(1)The Company and Basis of Presentation
Description of Business
Berkeley Lights, Inc. (the “Company” or “Berkeley Lights”) is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights’ platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including the Company’s OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software.
Berkeley Lights and its consolidated subsidiaries are hereinafter referred to as the “Company”. The Company’s headquarters are in Emeryville, California.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.
Liquidity
The Company has experienced losses from its operations since its inception and has relied primarily on equity and debt financing to fund its operations to date. For the three months ended March 31, 2022, the Company had a consolidated net loss of $21.4 million and as of March 31, 2022 had an accumulated deficit of $285.0 million and unrestricted cash and cash equivalents of $164.7 million. Management expects to continue to incur significant expenses for the foreseeable future and to incur operating losses in the near term while the Company makes investments to support its anticipated growth. The Company believes that its cash and cash equivalents balance as of March 31, 2022 provides sufficient capital resources to continue its operations for at least 12 months from the issuance date of the accompanying consolidated financial statements.
(2)Summary of Significant Accounting Policies
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission and have not materially changed during the three months ended March 31, 2022, with the exception of the Company’s accounting policy for stock-based compensation, as the Company granted awards with market conditions for the first time during the three months ended March 31 2022, as described further below.
Stock-Based Compensation
The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants.
Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant.
The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value.
The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur.
5
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis.
For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.
The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.
(3)Significant Risks and Uncertainties Including Business and Credit Concentrations
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and trade receivables. The Company’s cash and cash equivalents are held by large, credit worthy financial institutions. The Company invests its excess cash in money market funds. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. Deposits in these banks may exceed the amounts of insurance provided on such deposits. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.
The Company controls credit risk through credit approvals and monitoring procedures. The Company performs periodic credit evaluations of its customers and generally does not require collateral. Accounts receivable are recorded net of an allowance for doubtful accounts. The allowance for doubtful accounts is based on management’s assessment of the collectability of specific customer accounts and the aging of the related invoices and represents the Company’s best estimate of expected credit losses in its existing trade accounts receivable. At each of March 31, 2022 and December 31, 2021, the Company had not recorded any material allowance for doubtful accounts.
Most of the Company’s customers are located in the United States and Asia Pacific. For the three months ended March 31, 2022, three customers accounted for 18%, 13% and 10% of revenue. For the three months ended March 31, 2021, two customers accounted for 11% and 10% of revenue.
As of March 31, 2022, four customers comprised 22%, 14%, 11% and 10% of accounts receivable. As of December 31, 2021, three customers accounted for 15%, 11% and 11% of accounts receivable.
6
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(4)Revenue From Contracts With Customers
Disaggregation of Revenue
The following table depicts the disaggregation of revenue by type of customer or sales channel, market segment as defined by nature of workflows and activities of the end customer and timing of revenue recognition (in thousands):
Three months ended March 31,
20222021
Type of Sales Channel
Direct sales channel$15,486 $10,439 
Distributor channel4,720 8,189 
Net revenues$20,206 $18,628 
Market
Antibody therapeutics$14,225 $15,114 
Synthetic biology2,472 1,984 
Agricultural biology1,491 — 
Gene therapy1,774 1,225 
Cell therapy244 305 
Net revenues$20,206 $18,628 
Timing of Revenue Recognition
Goods and services transferred at a point in time$9,836 $13,064 
Goods and services transferred over time10,370 5,564 
Net revenues$20,206 $18,628 
Revenues by market are determined by the revenue associated with workflows that the Company’s customers are utilizing, primarily on the Company’s Beacon platform, or by the nature of the workflows that the Company is developing under strategic partnerships and services agreements. Revenues by geographical markets are presented in Note 15 to these condensed consolidated financial statements.
Performance Obligations
A significant number of the Company’s product and service sales, as well as its feasibility study arrangements, are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14 exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
As of March 31, 2022, the aggregate amount of remaining performance obligations that are unsatisfied or partially unsatisfied related to customer contracts in excess of one year was $6.9 million, which is included in deferred revenue on the Company’s condensed consolidated balance sheets, of which approximately 35% is expected to be recognized as revenue in the next 12 months, with the remainder recognized afterwards.
Contract Balances
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):
7
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
March 31,
2022		December 31,
2021
Trade accounts receivable$17,721 $25,942 
Contract assets, which are included in “Prepaid expenses and other current assets”$1,896 $1,736 
Contract assets, long-term, which are included in “Other assets”$571 $1,070 
Deferred revenue (current)$9,780 $12,128 
Deferred revenue (non-current)$1,600 $2,187 
The contract liabilities of $11.4 million and $14.3 million as of March 31, 2022 and December 31, 2021, respectively, consisted of deferred revenue related to extended warranty service agreements, strategic partnerships and services agreements and advanced automation systems arrangements. Revenue recorded during the three months ended March 31, 2022 included $4.6 million of previously deferred revenue that was included in contract liabilities as of December 31, 2021.
Sales-type Lease Arrangements
The Company also enters into sales-type lease arrangements with certain qualified customers. Revenue related to lease elements from sales-type leases is presented as product revenue and was nil and $1.7 million for the three months ended March 31, 2022 and 2021, respectively.
The following table presents the future maturity of the Company’s fixed-term customer leases and reconciles the undiscounted cash flows from the amounts due from customers under such arrangements as of March 31, 2022 (in thousands):
Year ending December 31,Sales-Type
Leases
Remainder of 2022$1,655 
2023445 
2024853 
Total undiscounted cash flows2,953 
Less: unearned income368 
Total amounts due from customers, gross$2,585 
(5)Balance Sheet Accounts
Inventory
The following table shows the components of inventory (in thousands):
March 31,
2022		December 31,
2021
Raw materials$8,861 $8,296 
Finished goods6,804 6,251 
Total$15,665 $14,547 
Prepaid expenses and other current assets
The following table shows the components of prepaid expenses and other current assets (in thousands):
8
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
March 31,
2022		December 31,
2021
Contract asset$1,896 $1,736 
Vendor deposits2,712 2,802 
Deferred costs512 561 
Prepaid insurance1,640 2,944 
Other (1)3,544 3,942 
Total$10,304 $11,985 

(1) Other includes primarily prepaid rent expenses, software licenses and prepaid VAT.

Accrued expenses and other current liabilities
The following table shows the components of accrued expenses and other current liabilities (in thousands):
March 31,
2022		December 31,
2021
Accrued payroll and employee related expenses$4,697 $6,757 
Lease liability – short-term2,984 2,941 
Accrued product warranty914 1,085 
Accrued legal expenses680 504 
Other (1)641 1,138 
Total$9,916 $12,425 

(1) Other includes primarily accrued income taxes, sales taxes, accrued royalties and other miscellaneous accruals.

(6)Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement.
The carrying amounts of the Company’s cash equivalents, accounts receivable and accounts payable approximate fair value due to their relatively short maturities. The Company classifies its cash equivalents, which are comprised primarily of money market funds, within Level 1, as it uses quoted market prices in the determination of fair value.
9
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):
March 31,
2022		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,141 $25,141 $— $— 
Total$25,141 $25,141 $— $— 


December 31,
2021		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,138 $25,138 $— $— 
Total$25,138 $25,138 $— $— 

The carrying values and fair values of the Company’s financial instruments not measured at fair value were as follows (in thousands):
March 31, 2022December 31, 2021
Carrying
Value		Fair ValueCarrying
Value		Fair Value
Long-term debt, including current maturities$19,778 $19,295 $19,762 $19,298 
The Company estimated the fair value of its long-term debt using a market-based approach that considers an average cost of debt. The Company has incorporated its own credit risk for all liability fair value measurements. Such fair value measurements are considered Level 2 under the fair value hierarchy.
The Company did not have any transfers of financial assets measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 for any of the periods presented.
10
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(7)Property and Equipment, net
Property and equipment, net comprised the following (in thousands):
March 31,
2022		December 31,
2021
Equipment, tooling and molds$37,050 $33,972 
Computer software and equipment2,845 3,019 
Furniture, fixtures and other1,955 1,891 
Leasehold improvements10,750 6,105 
Construction in process756 4,803 
Total property and equipment53,356 49,790 
Less: Accumulated depreciation(23,443)(21,798)
Property and equipment, net$29,913 $27,992 
Total depreciation expense for the three months ended March 31, 2022 and 2021 was $1.9 million and $1.3 million, respectively.
During the three months ended March 31, 2022 and 2021, losses on the impairment and disposal of property and equipment was not material.
(8)Leases
The Company leases office, manufacturing, distribution and laboratory facilities in Emeryville, California under multiple operating leases. During the third quarter of 2021, the Company extended the term for its leases related to the facilities in Emeryville and these leases will now expire in 2029. Also, during the third quarter of 2021, the Company entered into a seven year lease of space for office and laboratory operations in Lexington, Massachusetts, which commenced on July 1, 2021.
The Company also leases two facilities in Shanghai, China for office and laboratory facilities under operating lease agreements that were entered into in July 2020. These leases expire at various dates, the latest of which is August 2023.
Future payments associated with the Company’s operating lease liabilities as of March 31, 2022 is as follows (in thousands):
Operating leases
Undiscounted lease payments for the year ending December 31,
Remainder of 2022$3,148 
20234,276 
20244,355 
20254,486 
20264,621 
Thereafter12,222 
Total undiscounted lease payments33,108 
Less: implied interest(5,131)
Less: tenant improvement allowances receivable(1,426)
Present value of operating lease payments26,551 
Less: current portion (1)(2,984)
Total long-term operating lease liabilities$23,567 
11
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
(1) Included in the balance sheet caption “Accrued expenses and other current liabilities.”
Rent expense for the three months ended March 31, 2022 and 2021 was $1.1 million and $0.8 million, respectively. Under the terms of the lease agreements, the Company is also responsible for certain variable lease payments that are not included in the measurement of the lease liability. Variable lease payments for operating leases were $0.8 million and $0.5 million for the three months ended March 31, 2022 and 2021, respectively, including non-lease components such as common area maintenance fees.
The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):
Three months ended March 31,
20222021
Right-of-use assets obtained for new operating lease liabilities $— $— 
Cash paid for amounts included in the measurement of lease liabilities$1,098 $691 
The following summarizes additional information related to operating leases:
March 31, 2022December 31, 2021
Weighted-average remaining lease term (years)7.277.51
Weighted-average discount rate4.67 %4.67 %
The Company also enters into leasing transactions in which the Company is the lessor, which to date have been classified as sales-type leases. See Note 4 of these condensed consolidated financial statements for the related lease disclosures.
(9)Notes Payable
On May 23, 2018, the Company entered into a Loan and Security Agreement with East West Bank (“EWB”) providing it the ability to borrow up to $20.0 million. The loan facility was fully drawn as of May 23, 2018.
On June 30, 2021, the Company entered into an Amended and Restated Loan and Security Agreement (the “Agreement”) with EWB. Pursuant to the Agreement, EWB provided a $20.0 million term loan (the “Term Loan”) which was used to refinance the term loan outstanding under the Loan and Security Agreement dated May 23, 2018. The Term Loan matures in 48 months and bears a fixed interest rate of 4.17%. The Term Loan has an initial interest-only period of 24 months, which can be extended to up to 36 months based on the achievement of certain liquidity measures, and can be pre-paid without penalty at any time.
The Agreement grants EWB a security interest in and liens on all assets of the Company, excluding intellectual property, which is subject to a double negative pledge. In addition, certain other terms of the original agreements as previously in effect were amended by the Agreement, including certain financial covenants. The Amended and Restated Loan and Security Agreement was accounted for as a debt modification and the Company capitalized incremental debt issuance costs.
Furthermore, the Agreement also provided the Company with a new $10.0 million revolving credit (the “Revolving Line”), which bears interest on the outstanding daily balance thereof of 0.70% above the Prime Rate (as defined in the Agreement). No amounts were outstanding under the Revolving Line as of March 31, 2022.
The Agreement contains certain financial and non-financial covenants. As of March 31, 2022, the Company was in compliance with the terms and covenants of the Agreement.
The following is a schedule of payments due on notes payable as of March 31, 2022 (in thousands):
12
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
March 31,
2022
Year Ending December 31:
Remainder of 2022$637 
20236,617 
202410,406 
20254,210 
Total payments due21,870 
Less:
Interest payments, loan discounts and financing costs(2,092)
Current portion, less loan discounts and financing costs— 
Notes payable$19,778 
Total interest cost incurred for the three months ended March 31, 2022 and 2021 was $0.2 million and $0.4 million, respectively.
(10)Stock Compensation Plans
Stock-based compensation
Stock-based compensation related to the Company's stock-based awards was recorded as an expense and allocated as follows (in thousands):
Three months ended March 31,
20222021
Cost of sales$51 $42 
Research and development1,581 1,061 
General and administrative2,211 1,372 
Sales and marketing1,550 2,019 
Total stock-based compensation$5,393 $4,494 
Stock-based compensation capitalized in inventory was not material as of March 31, 2022 and December 31, 2021.
On March 10, 2022, the Company granted the newly appointed Chief Executive Officer of the Company 1,017,177 RSUs, 339,059 stock options and 678,118 performance-based stock options (“PSOs”). The RSUs and stock options vest quarterly over 3 years and the stock options have a 10 year term.
The PSOs have a 7-year performance period, a 10-year term and vest based upon certain market conditions and a continued service-based requirement. Market condition-related vesting is triggered based on the Company’s stock price reaching certain goals that range from two to 20 times the Company share price on the date of grant.
Although no awards will vest until a market condition is satisfied, as of March 31, 2022 the Company began recording stock-based compensation expense for each vesting tranche based on the estimated achievement date of the specified stock price target. The valuation and probability of achievement for each tranche is determined using a Monte Carlo simulation. The same Monte Carlo simulation is used as the basis for determining the expected achievement date. As the probability of achievement is factored in as part of the Monte Carlo simulation, the expense for these tranches will be recognized concurrently over each tranche’s estimated achievement date even if some or all of the options never vest. If the related market condition for a tranche is achieved earlier than
13
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
expected, all unamortized expense for such tranche will be recognized immediately. As of March 31, 2022, none of the PSOs had vested.
(11)Income Taxes
The Company’s provision for income taxes was $20 thousand and $17 thousand, respectively, for the three months ended March 31, 2022 and 2021. For the three months ended March 31, 2022 and 2021, income from operations before taxes consisted of amounts related to U.S. operations and the Company’s foreign operations. The Company maintains a full valuation allowance on its deferred tax assets, and intends to do so until there is sufficient evidence to support the reversal of all or some portion of these allowances.
(12)Statements of Cash Flows
The supplemental cash flow information consists of the following (in thousands):
Three months ended March 31,
20222021
Cash paid for interest$137 $337 
Non-cash investing and financing activities
Inventory transferred to property and equipment (1)$— $2,813 
Change in accounts payable and accrued liabilities related to purchases of property and equipment$(482)$751 
(1) The non-cash transfer of inventory to property and equipment principally relates to Beacons that were transferred to the Company’s BioFoundry operations in the first and second quarter of 2021. As a result of the growth of the Company’s BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in the Company’s BioFoundry operations will be categorized as “Purchase of property and equipment.”
(13)Commitments and Contingencies
Legal Proceedings
From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. The Company records a liability in its financial statements for these matters when a loss is known and considered probable and the amount can be reasonably estimated. The Company does not recognize gain contingencies until they are realized. Legal costs incurred relating to loss contingencies are expensed as incurred.
AbCellera Biologics Litigation
In July 2020, AbCellera Biologics Inc. (“AbCellera”) filed a complaint in the United States District Court for the District of Delaware, alleging that the Company infringed and continues to infringe, directly and indirectly, the following patents exclusively licensed by AbCellera by making, using, offering for sale, selling and/or importing the Company’s Beacon and Culture Station instruments and the OptoSelect chips, and sale of the Opto Plasma B Discovery Workflow: U.S. Patent Nos. 10,107,812, 10,274,494, 10,466,241, 10,578,618, 10,697,962, 10,087,408, 10,421,936 and 10,704,018 (“AbCellera I”).
In August 2020, AbCellera filed a second complaint in the United States District Court for the District of Delaware, making the same allegations with regard to U.S. Patent Nos. 10,718,768, 10,738,270, 10,746,737, and 10,753,933 (“AbCellera II”). In September 2020, AbCellera filed amended complaints in each of AbCellera I and AbCellera II adding The University of British Columbia (“UBC”) as a named plaintiff. Also in September 2020, AbCellera and UBC filed a third complaint in the United States District Court for the District of Delaware,
14
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
making the same allegations with regard to U.S. Patent Nos. 10,775,376, 10,775,377, and 10,775,378 (“AbCellera III”). AbCellera and UBC are seeking, among other things, judgment of infringement, a permanent injunction and damages (including lost profits, a reasonable royalty, reasonable costs and attorney’s fees and treble damages for willful infringement). In addition to procedural motions, the Company has filed an answer and counterclaims in response to each of the AbCellera I, AbCellera II and AbCellera III lawsuits. The Company’s counterclaims in each lawsuit include counts for declaratory judgment of non-infringement of the asserted patents, for declaratory judgment of invalidity of the asserted patents and for declaratory judgment of unenforceability of the asserted patents due to inequitable conduct. The Company filed a motion to transfer the AbCellera I, AbCellera II and AbCellera III lawsuits to the United States District Court for the Northern District of California, which was granted and where the lawsuits have been consolidated and are now pending (the “consolidated lawsuit”). On May 6, 2021, and pursuant to Court Order, AbCellera and UBC reduced, without prejudice, the asserted patents in the consolidated lawsuit to the following: US Patent Nos. 10,087,408, 10,421,936, 10,738,270, 10,697,962, 10,753,933, 10,775,376 and 10,775,378.
On July 1, 2021, the court granted the Company’s motion to amend its answer and counterclaims to add federal and state unfair competition counterclaims against AbCellera Biologics; on July 22, 2021, the Company filed its amended answer and counterclaims. Also on July 1, 2021 the court issued a Case Management Order that, among other things, requires AbCellera and UBC to reduce the number of asserted patents to no more than two, and the total asserted patent claims to no more than four per patent prior to the trial.
Also in July 2021, the Company filed petitions for Inter Partes Review (“IPR”) with the United States Patent & Trademark Office (“USPTO”), challenging the validity of various asserted claims of U.S. Patent No. 10,087,408 and all asserted claims of U.S. Patent No. 10,421,936, then filed a motion in the district court to stay the consolidated lawsuit pending the outcome of the IPR proceedings. In August 2021, the Company filed a third petition for IPR with the USPTO, challenging the validity of all asserted claims of U.S. Patent No. 10,739,270. Also in August 2021, the court granted the Company’s motion to stay the consolidated AbCellera I, AbCellera II, and AbCellera III lawsuits pending the outcome of the IPR proceedings.
In January 2022, the Patent Trial and Appeal Board (“PTAB”) of the USPTO issued a decision instituting IPR on U.S. Patent No. 10,087,408 and a decision denying IPR on U.S. Patent No. 10,421,936. In February 2022, the PTAB issued a decision denying IPR on U.S. Patent No. 10,739,270.
In August 2020, the Company filed a complaint in the United States District Court for the Northern District of California against AbCellera and Lineage BioSciences, Inc., an entity previously acquired by AbCellera (“AbCellera IV”). The complaint included two counts of unfair competition and one count of a declaratory judgment of non-infringement of U.S. Patent No. 10,058,839. The Company was seeking, among other things, damages and a judgment of non-infringement. In October 2020, the Company filed an amended complaint asserting the same three counts and AbCellera and Lineage filed a motion to dismiss the amended complaint, which was granted, without prejudice, in part. In light of the Company’s amended answer and counterclaims in the consolidated lawsuits, which were amended to include its federal and state unfair competition claims as discussed above, in July 2021 the Company filed a notice of dismissal without prejudice in the AbCellera IV lawsuit, resulting in its termination.
The Company believes that the patent assertions by AbCellera and UBC are without merit and intends to defend itself vigorously. The Company also intends to proceed with its claims and counterclaims against AbCellera and UBC. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in these lawsuits could subject the Company to significant liabilities, require it to seek licenses from or pay royalties to AbCellera and/or UBC, or prevent it from manufacturing, selling or using certain of its products, any of which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects.
Securities Class Action
15
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
In December 2021, Victor J. Ng filed a securities class action on behalf of all purchasers of Berkeley Lights common stock between July 17, 2020 and September 14, 2021, inclusive, alleging that the Company and certain of the Company’s current and former senior executives had violated §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder (the “Securities Class Action”). The Company believes that the assertions in the Securities Class Action are without merit and intends to defend itself vigorously. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in the Securities Class Action could subject the Company to significant liabilities, which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects.
Derivative Action
In March 2022, Trung Nguyen filed a shareholder derivative complaint on behalf of nominal defendant Berkeley Lights, Inc., alleging that certain of the Company’s current and former directors and certain of the Company’s current and former senior executives breached their fiduciary duties to the Company. The complaint also alleged that certain of the Company’s current and former directors and former senior executives used material, non-public information to improperly profit from the sale of Company stock, and that certain of the Company’s current and former senior executives owe the Company contribution for violations of sections 10(b) and 21D of the Securities Exchange Act of 1934.
The Company is not currently involved in any other claims or legal actions, nor is management aware of any potential claims or legal actions, for which the ultimate disposition could have a material adverse effect on the Company’s financial position, results of operations, or liquidity.
No provision has been made for litigation because the Company believes that it is not probable that a liability had been incurred as of March 31, 2022.
Product Warranty
The Company provides a 13-month assurance-type warranty, generally beginning on the shipment date, on its platforms and chip consumables. The table below represents the activity in the product warranty accrual included in accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):
Three months ended March 31,
20222021
Balance, beginning of period$1,085 $1,271 
Adjustments to existing warranties(245)(218)
Provision for new warranties163 375 
Settlement of pre-existing warranties(89)(160)
Balance, end of period$914 $1,268 
(14)Net Loss Attributable to Common Stockholders Per Share
Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards. Awards granted with performance conditions are excluded from the shares used to compute diluted earnings per share until the performance conditions associated with the awards are met.
The following table sets forth the computation of basic and diluted earnings per common share (in thousands, except share and per share data):
16
Berkeley Lights, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Three months ended March 31,
20222021
Numerator
Net loss attributable to common stockholders, basic and diluted$(21,426)$(15,435)
Denominator
Weighted-average shares used to compute net income per share, basic and diluted67,697,48865,259,398
Net loss per share
Net loss per share attributable to common stockholders, basic and diluted$(0.32)$(0.24)
Since the Company was in a loss position for all periods presented, basic net loss per share attributable to common stockholders is the same as diluted net loss per share attributable to common stockholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented as they had an anti-dilutive effect:
Three months ended March 31,
20222021
Options to purchase common stock7,020,591 8,399,147 
Restricted stock units3,629,310 356,725 
Total10,649,901 8,755,872 
(15)Segments
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company has one business activity and there are no segment managers who are held accountable for operations. Accordingly, the Company has one operating segment. The Company’s principal operations and decision-making functions are located in the United States.
The following table provides the Company’s revenues by geographical market based on the location where the services were provided or to which product was shipped (in thousands):
Three months ended March 31,
20222021
North America$13,715 $7,362 
Asia Pacific (1)5,035 8,431 
Europe1,456 2,835 
Total$20,206 $18,628 
(1) Asia Pacific includes Australia.
As of March 31, 2022 and December 31, 2021, substantially all of the Company’s long-lived assets were located in the United States.
17

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, operations and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “predict,” “potential,” “positioned,” “seek,” “should,” “target,” “will,” “would” and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
Forward-looking statements are based on management’s current expectations, estimates, forecasts and projections about our business and the industry in which we operate, and management’s beliefs and assumptions are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this Quarterly Report on Form 10-Q may turn out to be inaccurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
You should read the following discussion of our financial condition and results of operations in conjunction with our unaudited condensed financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and notes thereto and management’s discussion and analysis of financial condition and results of operations for the fiscal year ended December 31, 2021 included in Annual Report on Form 10-K and filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2022. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed in Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021, elsewhere in this Quarterly Report on Form 10-Q, and our other reports filed with the SEC.
Overview
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. This is a new way to capture and interpret the qualitative language of biology and translate it into single-cell specific digital information, referred to as Digital Cell Biology. We currently focus on enabling the large and rapidly growing markets of antibody therapeutics, cell therapy, gene therapy, agricultural biology and synthetic biology with our platform.
The Berkeley Lights Platform can be used to characterize the performance of cells relevant to the desired cell-based product early in the discovery process and then connect this phenotypic data to the genetic code for each
18

cell. In contrast, current genomic technologies find sequences first and fail to deliver the functional information early in the process. Performing functional validation early means letting poorly performing cells fail early while rapidly advancing the best candidates forward, before incurring significant research and development expense. Our platform repeats this process of fail and advance many times throughout the process, delivering the best cells for what we believe will deliver the best product.
Our platform is a fully integrated, end-to-end solution, comprised of advanced automation systems, proprietary consumables, including our OptoSelect chips and reagent kits, and advanced application and workflow software. Customers load onto our system their live cell samples, as well as media and reagents, then the cells are imported onto our OptoSelect chips where integrated workflows are performed to assess specific cell functions and attributes. Our platform captures and delivers rich single-cell data to find the best cells. Our platform leverages our proprietary OptoElectro Positioning (“OEP”) technology, which enables deterministic positioning of living single cells and other micro-objects using light. OEP is a core technology of our platform and allows for a high level of control over live single cells or other micro-objects throughout the functional characterization process.
Our commercial workflows, each of which are distinct offerings, are made up of four modules we call Import, Culture, Assay and Export. These modules can be adapted, interchanged and deployed with a variety of single-cell assays to address specific applications and a variety of cell types. We believe this versatility facilitates rapid development of new workflow offerings and virtually unlimited workflow commercialization opportunities. We have developed and will continue to develop and commercialize proprietary workflows across large markets by leveraging existing workflows and assays. Over time, our goal is to enable customers to standardize many of their processes on our platform utilizing our workflows. We believe we are the only company commercializing a platform that can do this in a scalable way.
We commercially launched our platform in December of 2016, which included the Beacon system and the alpha version of our Opto Cell Line Development 1.0 workflow, targeted to the antibody therapeutics market. From the initial launch of our platform through March 31, 2022, we have commercially launched ten workflows. In June of 2019, we launched our desktop Lightning system targeted for assay development and lower throughput workflows, and in early 2020 we launched our Culture Station instrument.
We focus a substantial portion of our resources on platform, workflow and assay development, as well as on business development and sales and marketing. Our research and development efforts are primarily focused on developing new workflows and assay capabilities, as well as new advanced systems and OptoSelect chips and reagent kits, to meet both our customers’ needs and to address new markets.
We generally outsource all of our production manufacturing. Design work, prototyping and pilot manufacturing are performed in-house before outsourcing to third party contract manufacturers. Our outsourced production strategy is intended to drive cost leverage and scale, and avoid the high capital outlays and fixed costs related to constructing and operating a manufacturing facility. The contract manufacturers of our systems are located in the United States. Contract manufacturers for reagent kits and OptoSelect chip components are located in the United States, Asia and Europe. Certain of our suppliers of components and materials are single source suppliers. We perform final manufacture and assembly steps of our OptoSelect chips in-house.
Our customer base includes several of the largest biopharmaceutical companies in the world, as well as biotechnology companies, leading contract research organizations, synthetic biology companies and academic institutions. While we have seen significant growth in our customer and installed base, we believe we are still in the very early stages of platform adoption, with the majority our historical revenue derived from early adopters of our technology for research and development purposes.
We have financed our operations primarily from the issuance and sale of equity securities, borrowings under our long-term debt agreement, and to a lesser extent from cash generated by product and service sales. On July 21, 2020, we closed our initial public offering (the “IPO”), in which we sold 9,315,000 shares of common stock
19

(which included 1,215,000 shares that were sold pursuant to the full exercise of the IPO underwriters’ option to purchase additional shares) at a price to the public of $22.00 per share. We received aggregate net proceeds of $187.9 million after deducting, offering costs, underwriting discounts and commissions of $17.0 million.
Since our inception in 2011, we have incurred net losses in each year. Our net losses were $21.4 million and $15.4 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, we had an accumulated deficit of $285.0 million and cash and cash equivalents totaling $164.7 million. We expect to continue to incur significant expenses and operating losses for the foreseeable future.
Certain of our financial results and other key operational developments for the three months ended March 31, 2022 include the following:
•Total revenue for the three months ended March 31, 2022 was $20.2 million compared to $18.6 million for the same period in 2021.
•Gross profit in absolute dollars and gross margin for the three months ended March 31, 2022 increased compared to the same period in 2021.
COVID-19 Update

The COVID-19 pandemic has had, and continues to have, a significant impact around the world, prompting governments and businesses to take unprecedented measures, including temporary closures of businesses, quarantines and shelter in place orders. Pandemic related lockdowns in China throughout the first quarter of 2022 adversely impacted the operation of our office in Shanghai which is where the majority of our employees in our Asia Pacific region reside. During the three months ended March 31, 2022, our production, shipping and customer service functions have remained operational to maintain a continuous supply of products both to our customers and for our internal research and development activities. We continue to closely monitoring global supply issues around materials, parts and components, including plastics and integrated circuit chips, and we have not experienced any material supply issue to date. The ultimate impact of COVID-19 on our operations and financial performance in future periods remains uncertain and will depend on many factors outside our control, including the timing, extent, trajectory and duration of the pandemic, the emergence of new variants, the development, availability, distribution and effectiveness of vaccines and treatments, and related government actions to prevent and manage disease spread, all of which are uncertain and cannot be predicted. Refer to Part I, Item 1A of our 2021 Form 10-K under the heading “Risk Factors” for more information.
Components of results of operations
Revenue
Our revenue consists of both product revenue and service revenue, which is generated through the following revenue streams: (i) direct platform sales, (ii) recurring revenue, and (iii) strategic partnerships and services agreements. Sales of advanced automation systems, recurring revenue from consumables, workflow subscription agreements, and workflow licenses are defined as product revenue, and revenue from strategic partnership and services agreements and extended or enhanced warranty contracts, feasibility studies and platform support are defined as service revenue in our consolidated results of operations. We launched our Tech Access subscription model in June 2021.




20

The following tables provide an overview of our revenue streams and how we report revenue in our consolidated statements of operations and comprehensive loss (in thousands):

Income Statement Classification
Product or Service sold
Revenue Stream
Product revenue
Sale of advanced automation system (Beacon and Lightning system, Culture Station)
Direct platform sales
Software
Direct platform sales
Fixed term sales-type lease arrangements with qualified customers
Direct platform sales
Annual renewable workflow licenses, quarterly workflow subscriptions, annual or multi-year subscriptions arrangements (e.g. TechAccess)
Recurring revenue
Consumables and reagent kits (e.g. OptoSelect chips)
Recurring revenue
Service revenue
Strategic partnerships, joint development and collaboration agreements where we provide services for development of new workflows, cells or organism types
Strategic partnerships and services
Application support, installation and training
Direct platform sales
Fixed fee extended warranty and service programs
Recurring revenue

We renamed our joint development and partnership offering to strategic partnerships and services in the fourth quarter of 2021.

Three months ended March 31, 2022
ProductServiceTotal
(in thousands)
Direct platform sales$6,747 $657 $7,404 
Recurring revenue3,027 2,416 5,443 
Strategic partnerships and services— 7,359 7,359 
Total revenue$9,774 $10,432 $20,206 

21

Three months ended March 31, 2021
ProductServiceTotal
(in thousands)
Direct platform sales$10,586 $530 $11,116 
Recurring revenue2,947 1,447 4,394 
Strategic partnerships and services— 3,118 3,118 
Total revenue$13,533 $5,095 $18,628 

The following table provides information by revenue stream for the periods presented:
Three months ended March 31,
(in thousands, except percentages)20222021ChangeChange
Direct platform sales$7,404 $11,116 $(3,712)(33)%
Recurring revenue5,443 4,394 1,049 24 %
Strategic partnerships and services7,359 3,118 4,241 136 %
Total revenue$20,206 $18,628 $1,578 8 %
Costs of sales, gross profit and gross margin
Product cost of sales. Cost of sales associated with our products primarily consists of manufacturing related costs incurred in the production process, including personnel and related costs, costs of component materials, labor and overhead, packaging and delivery costs and allocated costs, including facilities and information technology. These costs also include the costs associated with the standard assurance-type product warranty provided on our platforms, which are recorded at the time of sale.
Service cost of sales. Cost of sales associated with our services primarily consists of personnel and related costs, expenses related to the development of customized platforms and workflows, feasibility studies on our platforms and service and warranty costs to support our customers. We maintain continuous efforts to increase reliability and uptime of our advanced automation systems.
Gross profit and gross margin. Gross profit is calculated as revenue less cost of sales. Gross margin is gross profit expressed as a percentage of revenue. Our gross profit in future periods will depend on a variety of factors, including: market conditions that may impact our pricing; sales mix among platform access options, including the regional mix of sales; sales mix changes among consumables, advanced automation systems and services; product mix changes between established products and new products; excess and obsolete inventories; our cost structure for manufacturing operations relative to volume; and product warranty obligations. We expect cost of sales to increase in absolute dollars in future periods as our revenue grows, and as we plan to hire additional employees to support our manufacturing, operations, service and support organizations.
Gross profit was $13.8 million and $12.5 million for the three months ended March 31, 2022 and 2021, respectively.
Operating expenses
Research and development. Research and development costs primarily consist of salaries, benefits, incentive compensation, stock-based compensation, laboratory supplies, materials expenses and allocated facilities and IT costs for employees and contractors engaged in research and product development. We expense all research and development costs in the period in which they are incurred.
22

We plan to continue to invest in our research and development efforts, including hiring additional employees, to enhance existing products and develop new products. As a result, we expect that our research and development expenses will continue to increase in absolute dollars in future periods. We expect these expenses to vary from period to period as a percentage of revenue.
General and administrative. Our general and administrative expenses primarily consist of salaries, benefits and stock-based compensation costs for employees in our executive, accounting and finance, legal and human resource functions, as well as professional services fees, such as consulting, audit, tax and legal fees, general corporate costs and allocated overhead expenses. We expect that our general and administrative expenses will continue to increase in absolute dollars, primarily due to increased headcount to support anticipated growth in the business and due to incremental costs associated with operating as a public company. We expect these expenses to vary from period to period as a percentage of revenue.
Sales and marketing. Our sales and marketing expenses consist primarily of salaries, benefits, sales commissions and stock-based compensation costs for employees within our commercial sales functions, as well as marketing, travel expenses and allocated facilities and IT costs. We expect our sales and marketing expenses to increase in absolute dollars as we expand our commercial sales, marketing and business development teams, increase our presence globally and increase marketing activities to drive awareness and adoption of our platform. While these expenses may vary from period to period as a percentage of revenue, we expect these expenses to increase as a percent of sales in the short-term as we continue to grow our commercial organization to support anticipated growth in the business.
Other income (expense)
Interest expense. Interest expense consists primarily of interest related to borrowings under our debt obligations.
Interest income. Interest income primarily consists of interest earned on our cash and cash equivalents which are invested in cash deposits and in money market funds.
Other income (expense), net. Other income (expense), net consists primarily of foreign currency exchange gains and losses. Foreign currency exchange gains and losses relate to transactions and asset and liability balances denominated in currencies other than the U.S. dollar, primarily related to our operations in the United Kingdom and China. We expect our foreign currency gains and losses to continue to fluctuate in the future due to changes in foreign currency exchange rates.
Provision for income taxes
Our provision for income taxes consists primarily of foreign taxes and state taxes in the United States. The Company maintains a full valuation allowance on its deferred tax assets and intends to do so until there is sufficient evidence to support the reversal of all or some portion of these allowances. As we expand the scale and scope of our international business activities, any changes in taxation of such activities may increase our overall provision for income taxes in the future.
23

Results of operations
The following tables set forth our results of operations for the periods presented:
Three months ended March 31,
(in thousands)20222021
Revenue:
Product revenue$9,774 $13,533 
Service revenue10,432 5,095 
Total revenue20,206 18,628 
Cost of sales:
Product cost of sales2,695 3,703 
Service cost of sales3,684 2,474 
Total cost of sales (1)
6,379 6,177 
Gross profit13,827 12,451 
Operating expenses:
Research and development (1)
17,573 13,027 
General and administrative (1)
11,716 8,967 
Sales and marketing (1)
5,811 5,606 
Total operating expenses35,100 27,600 
Loss from operations(21,273)(15,149)
Other income (expense):
Interest expense(224)(354)
Interest income34 66 
Other income, net57 19 
Loss before income taxes(21,406)(15,418)
Provision for income taxes20 17 
Net loss and comprehensive loss$(21,426)$(15,435)
(1)Amounts include stock-based compensation as follows:
Three months ended March 31,
(in thousands)20222021
Cost of sales$51 $42 
Research and development1,581 1,061 
General and administrative2,211 1,372 
Sales and marketing1,550 2,019 
Total stock-based compensation expense$5,393 $4,494 

24

Comparison of the three months ended March 31, 2022 and 2021
Revenue
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Product revenue$9,774 $13,533 $(3,759)(28 %)
Service revenue10,432 5,095 5,337 105 %
Total revenue$20,206 $18,628 $1,578 8 %
Product revenue decreased by $3.8 million, or 28%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The decrease was primarily driven by lower platform sales of $2.1 million and lower revenue from lease arrangements of $1.7 million. During the three months ended March 31, 2022, we sold four platforms as compared to eight platforms sold in the three months ended March 31, 2021.
Service revenue increased by $5.3 million, or 105%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was primarily driven by higher revenue associated with strategic partnerships and services agreements of $4.2 million as a result of the execution of new customer agreements as well as an increase from sales in service warranty and application support arrangements of $1.1 million.
Our product and service revenue can fluctuate from period to period as a result of, among other things, the timing of the sales cycles for our platforms, such as the Beacon and Lightning, as well as the timing of revenues recognized under our strategic partnership and services agreements.
Cost of sales, gross profit and gross margin
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Product cost of sales$2,695$3,703$(1,008)(27 %)
Service cost of sales3,6842,4741,210 49 %
Total cost of sales$6,379$6,177$202 3 %
Gross profit$13,827$12,451$1,376 11 %
Gross margin68 %67 %
Product cost of sales decreased by $1.0 million, or 27%, for the three months ended March 31, 2022, respectively, compared to the three months ended March 31, 2021, primarily as a result of lower product revenues.
Service cost of sales increased by $1.2 million, or 49% for the three months ended March 31, 2022, respectively, compared to the three months ended March 31, 2021. The increase was primarily due to costs incurred for strategic partnerships and services agreements, as well as increased costs for extended warranty services as a result of the nature and timing of work performed under such arrangements.
Gross profit increased by $1.4 million, or 11%, for the three months ended March 31, 2022 compared to the three months ended March 31, 2021. Gross margin increased by 1% for the three months ended March 31, 2022 compared to the three months ended March 31, 2021. The increase in gross margin was driven by the mix of products sold and services provided in the quarter, primarily due to the fact that the strategic partnerships and
25

services agreements we entered into in 2021 have a higher margin than our previous strategic partnership and services agreements.
Operating expenses
Research and development
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Research and development$17,573 $13,027 $4,546 35 %
Research and development expense increased by $4.5 million, or 35%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was due to a $2.4 million increase in personnel-related expenses, including a $0.5 million increase in stock-based compensation expense, primarily due to increased headcount as a result of our continued growth, as well as a $2.1 million increase in other costs, which primarily represent testing and qualification materials and other costs related to various projects to develop and improve systems, workflows, consumables and assays.
General and administrative
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
General and administrative $11,716 $8,967 $2,749 31 %
General and administrative expense increased by $2.7 million, or 31%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was due to a $1.6 million increase in personnel-related expenses, including a $0.8 million increase in stock-based compensation expense, a $1.1 million increase in other costs, primarily consisting of IT expenses, including software subscription fees, outside legal fees, including patent litigation and consulting fees.
Sales and marketing
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Sales and marketing$5,811 $5,606 $205 4 %
Sales and marketing expense increased by $0.2 million, or 4%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was primarily due to a $0.6 million increase in marketing, advertising and other costs, partially offset by a $0.4 million decrease in personnel and related costs primarily as a result of lower stock-based compensation.




26

Interest expense
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Interest expense$224 $354 $(130)(37 %)
Interest expense decreased by $0.1 million, or 37%, for the three months ended March 31, 2022, compared to the three months ended March 31, 2021 as a result of refinancing our loan from East West Bank, which now carries a lower interest rate.
Interest income
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Interest income $34 $66 $(32)(48 %)
Interest income resulted primarily from our cash and short-term deposits. The decrease was primarily due to lower interest received on our cash and short-term deposits due to lower average cash balances during the first quarter of 2022.
Other income (expense), net
Three months ended March 31,Three month change
(in thousands, except percentages)20222021Amount%
Other income, net $57 $19 $38 200 %
Other income for the three months ended March 31, 2022 and 2021 was mainly comprised of foreign exchange gains and losses and other miscellaneous income.
Liquidity and capital resources
As of March 31, 2022, we had approximately $164.7 million in cash and cash equivalents which were primarily held in U.S. short-term bank deposit accounts and money market funds. Restricted cash of $0.3 million serves as collateral for our corporate credit card program. We have generated negative cash flows from operations since inception through March 31, 2022.
We expect to incur additional operating losses in the foreseeable future as we continue to invest in the research and development of our product offerings, commercialize and launch platforms, and expand into new markets. Our future capital requirements will depend on many factors including our revenue growth rate, research and development efforts, the timing and extent of additional capital expenditures to invest in existing and new facilities as well as our manufacturing operations, the expansion of sales and marketing and the introduction of new products. Our future capital needs may also depend upon the impacts of the COVID-19 pandemic. We have and may in the future enter into arrangements to acquire or invest in businesses, services and technologies, and any such acquisitions or investments could significantly increase our capital needs.
Based on our current business plan, we believe our existing cash and cash equivalents and anticipated cash flows from operations will be sufficient to meet our working capital and capital expenditure needs over at least the next 12 months.
27

Sources of liquidity
Since our inception, we have financed our operations primarily from the issuance and sale of our equity securities, borrowings under long-term debt agreements, and to a lesser extent, cash generated by product and service sales. In July 2020, we completed our IPO, resulting in the receipt of aggregate proceeds of $187.9 million, net of offering costs, underwriter discounts and commissions of $17.0 million.
East West Bank Loan and Security Agreement
On May 23, 2018, we entered into a Loan and Security Agreement with East West Bank (“EWB”) providing it the ability to borrow up to $20.0 million. The loan facility was fully drawn as of May 23, 2018.
On June 30, 2021, we entered into an Amended and Restated Loan and Security Agreement (the “Agreement”) with EWB. Pursuant to the Agreement, EWB provided a $20.0 million term loan (the “Term Loan”) which was used to refinance the term loan outstanding under the Loan and Security Agreement dated May 23, 2018. The Term Loan matures in 48 months and bears interest at a fixed rate of 4.17%. The Term Loan has an initial interest-only period of 24 months, which can be extended to up to 36 months based on the achievement of certain liquidity measures, and can be pre-paid without penalty at any time.
The Agreement grants EWB a security interest in and liens on all of our assets, excluding intellectual property, which is subject to a double negative pledge. In addition, certain other terms of the original agreements as previously in effect were amended by the Agreement, including certain financial covenants. The Amended and Restated Loan and Security Agreement was accounted for as a debt modification and we capitalized incremental debt issuance costs.
Furthermore, the Agreement also provided the Company with a new $10.0 million revolving credit line (the “Revolving Line”), which bears interest on the outstanding daily balance thereof of 0.70% above the Prime Rate (as defined in the Agreement). No amount was outstanding under the Revolving Line as at March 31, 2022.
We were in compliance with all covenants under the Agreement as of March 31, 2022.
Cash flows
The following table summarizes our cash flows for the periods presented:
Three months ended March 31,
(in thousands)20222021
Net cash (used in) provided by:
Operating activities$(10,069)$(11,360)
Investing activities(4,375)(402)
Financing activities1,022 8,519 
Net decrease in cash and cash equivalents and restricted cash$(13,422)$(3,243)

Operating activities

Net cash used in operating activities of $10.1 million for the three months ended March 31, 2022 was primarily due to a net loss of $21.4 million, partially offset by non-cash adjustments of $8.3 million, mainly consisting of stock-based compensation and depreciation expense and a net cash inflow from changes in our operating assets and liabilities of $3.0 million, primarily due to a decrease in our accounts receivable.

Net cash used in operating activities of $11.4 million for the three months ended March 31, 2021 was primarily due to a net loss of $15.4 million and net cash outflows of $2.3 million from changes in our net operating assets and liabilities, partially offset by non-cash charges of $6.4 million, mainly consisting of stock-based
28

compensation and depreciation. Cash outflow from our net operating assets and liabilities was primarily due to a $2.7 million increase in inventories resulting from an increase raw materials and finished goods to support revenue growth and anticipated demand, an increase of $3.5 million in accounts receivable due to an in increase in revenue and the timing of invoicing and a $1.0 million increase in prepaid and other current assets resulting from the overall growth in our business and operations, partially offset by a $5.7 million increase in deferred revenue and accounts payable due to the timing of advanced billings and revenue recognition as well as the timing of vendor invoicing and related payments.

Investing activities

Net cash used in investing activities was $4.4 million during the three months ended March 31, 2022 compared to $0.4 million in the three months ended March 31, 2021. Capital expenditures for the first quarter of 2022 include the expansion of our BioFoundry operations to support current and planned programs as well as leasehold improvements related to our new offices in Boston, Massachusetts. Capital expenditures for the three months ended March 31, 2021, exclude a $2.8 million non-cash transfer of Beacons that were purchased into inventory and later transferred to property and equipment. As a result of the growth of our BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in our BioFoundry operations are categorized as “Purchase of property and equipment.”
Financing activities
Net cash provided by financing activities was $1.0 million during the three months ended March 31, 2022 compared to $8.5 million for the three months ended March 31, 2021. Net cash provided by financing activities during the three months ended March 31, 2022 and March 31, 2021 related to proceeds received from the issuance of common stock upon the exercise of stock options as well as proceeds received related to the issuance of common stock under our employee stock purchase plan.
Concentration of credit risk
Most of the Company’s customers are located in the United States and Asia Pacific. For the three months ended March 31, 2022, three customers accounted for 18%, 13% and 10% of revenue. For the three months ended March 31, 2021, two customers accounted for 11%, and 10% of revenue.
As of March 31, 2022, four customers comprised 22%, 14%, 11% and 10% of accounts receivable. As of December 31, 2021, three customers accounted for 15%, 11% and 11% of accounts receivable.
Contractual obligations and commitments
There have been no material changes to our contractual obligations as of March 31, 2022, as compared to those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2021.
Off-balance sheet arrangements
We do not have, and did not have during the periods presented, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Critical accounting policies and estimates
We have prepared our condensed consolidated financial statements in accordance with United States generally accepted accounting principles. Our preparation of these condensed consolidated financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue,
29

expenses and related disclosures. We evaluate our estimates on an ongoing basis. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could therefore differ materially from these estimates under different assumptions or conditions.
There have been no significant changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates disclosed in the section titled “Management’s Discussion and Analysis of Financial Condition and Operations” included in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on February 28, 2022, with the following exceptions.
Stock-Based Compensation
We maintain an incentive compensation plan under which incentive stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants.
Stock-based compensation expense is based on the grant date fair value of the award. We determine the fair value of RSUs based on the closing value of our stock price listed on the Nasdaq at the date of the grant.
We estimate the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a performance goal tied to the Company share price (i.e. a market condition) we use a Monte Carlo simulation to estimate the fair value.
The fair value of stock option and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur.
Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis.
For performance stock options and awards not initially assessed as probable of achievement, we record a cumulative adjustment to compensation expense in the period we change our determination that a performance condition becomes probable of being achieved. We cease recognition of compensation expense in any periods where we determine the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.
The fair value of stock options with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.
Item 3.    Quantitative and Qualitative Disclosures about Market Risk.
Interest rate risk
Customer financing exposure. We are indirectly exposed to interest rate risk because many of our customers depend on debt financings to purchase our platforms and systems. An increase in interest rates could make it challenging for our customers to obtain the capital necessary to make such purchases on favorable terms, or at all. Such factors could reduce demand or lower the price we can charge for our platforms and systems, thereby reducing our net sales and gross profit.
30

Bank deposit and money market exposure. As of March 31, 2022, we had cash and cash equivalents, including restricted cash, of $164.9 million, which consisted primarily of money market funds and bank deposits. The primary objective of our investment is to preserve principal and provide liquidity. These money market funds and bank deposits generate interest income at variable rates below 1%. A hypothetical 100 basis point decrease in interest rates would have no material effect on our interest income and financial results.
Foreign currency risk
Through March 31, 2022, we did not generate any revenue denominated in foreign currencies. While we incur certain expenses in foreign currencies, especially related to our foreign offices, the impact of changes in exchange rates has been immaterial as of March 31, 2022 for these expenses. As we expand our presence in international markets, to the extent we are required to enter into agreements denominated in a currency other than the US dollar, our results of operations and cash flows may increasingly be subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. To date, we have not entered into any hedging arrangements with respect to foreign currency risk. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates.
Item 4.    Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on that evaluation, our principal executive officer and principal financial officer concluded that as of March 31, 2022 our disclosure controls and procedures were effective at a reasonable assurance level to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
We also carried out an evaluation, under the supervision and with the participation of management, including our principal executive officer and principal financial officer, of our “internal control over financial reporting” to determine whether any changes in our internal control over financial reporting occurred during the three months ended March 31, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, there were no such changes in our internal control over financial reporting that occurred during the three months ended March 31, 2022.
Limitations on the Effectiveness of Controls
Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any system of controls must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there
31

can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
32

Part II. OTHER INFORMATION.
Item 1.    Legal Proceedings.
See Note 13, “Commitments and Contingencies” under the heading “Legal Proceedings” in the Notes to the Unaudited Condensed Consolidated Financial Statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for legal proceedings and related matters.
Item 1A. Risk Factors.
Factors that could cause or contribute to differences in our future financial and operating results include those discussed in the risk factors set forth in our Annual Report on Form 10-K filed with the SEC on February 28, 2022. The risks described in our Form 10-K and this Report are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on the Company. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.
There have been no material changes to the risk factors set forth in the Annual Report on Form 10-K filed with the SEC on February 28, 2022.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.
Sale of Unregistered Securities
There were no unregistered sales of the Company's equity securities during the three months ended March 31, 2022.
Use of Proceeds from our IPO
On July 21, 2020, we closed our IPO, in which we issued and sold 9,315,000 shares of our common stock, including the full exercise of the underwriters’ over-allotment option, at a public offering price of $22.00 per share for aggregate offering proceeds of $204.9 million. All of the shares of common stock issued and sold in the offering were registered under the Securities Act of 1933, as amended, pursuant to a registration statement on Form S-1 (File No. 333-239487), which was declared effective by the SEC on July 16, 2020.
Cash used since the IPO is described elsewhere in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our periodic reports filed with the SEC. As of the date of this filing, there has been no material change in the planned use of proceeds from our IPO as described in the final prospectus for our IPO dated July 16, 2020 filed with the SEC on July 17, 2020.
Item 3.    Defaults Upon Senior Securities.
Not applicable.
Item 4.    Mine Safety Disclosures.
Not applicable.
Item 5.    Other Information.
None.
33

Item 6. Exhibits.
The following exhibits are filed with this Quarterly Report on Form 10-Q:
Incorporated by Reference
Exhibit NumberExhibit TitleFormFile No.ExhibitFiling DateFiled Herewith
8-K001-393883.17/21/2020
8-K001-393883.27/21/2020
8-K001-3938810.13/2/2022
X
X
X
X
X
X
X
101.INSXBRL Instance Document.X
101.SCHXBRL Taxonomy Extension Schema Document.X
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.X
101.LABXBRL Taxonomy Extension Label Linkbase Document.X
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File - formatted in Inline XBRL and included as Exhibit 101X
*This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in such filings
34

Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Berkeley Lights, Inc.


Date:5/9/2022By:  /s/ J. Paul McClaskey
J. Paul McClaskey
Chief Accounting Officer
(Authorized Signatory and Principal Financial Officer)
35
 EX-10.2 2 ex-102transitionandseparat.htm EX-10.2 Document

EXHIBIT 10.2


TRANSITION AND RELEASE AGREEMENT

This Transition and Release Agreement (the “Agreement”) is entered into by and between Kurt Wood (“Employee”) and Berkeley Lights, Inc. (the “Company”), dated as of March 8, 2022 (the “Agreement Date”) and effective as of the eighth (8th) day following the date on which Employee signs this Agreement if not revoked in accordance with Section 6(g) below (the “Effective Date”). The purpose of this Agreement is to provide separation pay to ease Employee’s transition related to the Company and to settle and resolve any and all disputes and controversies of any nature existing between Employee and the Company, including, but not limited to, any claims arising out of Employee’s employment with, and transition related to, the Company.

1.Separation and Transition of Services.

(a)Separation. Employee’s last day of employment with the Company shall be April 1, 2022 (the “Separation Date”). Effective as of the Separation Date, Employee’s employment with the Company and all of its affiliates and status as an officer of the Company and all of its affiliates shall terminate and Employee shall cease to be an employee and an officer of all of the foregoing.

(b)Consulting Services. During the period (the “Consulting Period”) commencing on the Separation Date and ending on the later of (i) April 30, 2022 or (ii) if the Company’s first quarter earnings release has not been previously issued, May 8, 2022, or unless terminated earlier by the Company or Employee for any reason, (the “Consulting End Date”), Employee shall be available to provide services to the Company and its affiliates, on a non-exclusive and part-time basis, as a consultant and shall provide such reasonable services as may be requested by the Company or its affiliates (the “Transition Services”). During the Consulting Period, Employee may become an employee or consultant of any other company, provided, that Employee acknowledges and agrees that, during the Consulting Period, Employee shall not, directly or indirectly, become employed by or provide assistance to any commercial oriented life- sciences company. During the Consulting Period, Employee reaffirms his commitment to remain in compliance with the Confidentiality Agreement (as defined below), it being understood that the term “employment” as used in the Confidentiality Agreement shall include services as a consultant hereunder. If Employee violates the previous sentence, this Agreement and the Consulting Period shall be terminated immediately and the Employee shall have no further right or entitlement to the continued vesting of the Equity Award (as defined below).

(c)Consulting Fee. In exchange for the performance of the performance of the Transition Services during the Consulting Period, subject to Consultant continuing to provide the Transition Services through the Consulting End Date and Employee’s continued compliance with the terms and conditions of this Agreement and the Confidentiality Agreement, the Company shall pay to Employee an amount in cash equal to $50,000. Such amount shall be payable to Employee in two installments of
$25,000, with the first installment to be paid on or within five days following April 15, 2022 and the second installment to be paid on or within five days following the Consulting End Date.

(d)Return of Company Property. Employee represents and warrants that he shall, prior to the Consulting Period End Date, return to the Company any and all property and equipment of the Company, including (i) all keys, files, lists, books and records (and copies thereof) of, or in connection with, the Company’s business, equipment (including, but not limited to, computer hardware, software and printers, wireless handheld devices, cellular phones and pagers), access or credit cards, Company identification, and all other property belonging to the Company in Employee’s possession or control, and
(ii) all documents and copies, including hard and electronic copies, of documents in Employee’s possession relating to any confidential information, including without limitation, internal and external business forms, manuals, correspondence, notes and computer programs, and that Employee shall not make or retain any


copy or extract of any of the foregoing. To ensure the foregoing, prior to or on the Consulting Period End Date, Employee shall make available to the Company all devices, including cellular phones and laptop computers, and other property that may include Company confidential information, so that the Company has the prior opportunity to review, redact and/or retain any such documents containing confidential information on such devices.

(e)Equity Awards. As of the Separation Date, Employee will hold options to purchase those shares of Company common stock and Company restricted stock units pursuant to the Company’s equity incentive plans and the individual agreements evidencing such grants (collectively, the “Equity Awards”). In exchange for the performance of the Transition Services, during the Consulting Period, the Equity Awards shall continue to vest and, if applicable, become exercisable in accordance with their amended vesting schedules as provided in Section 3 below). Upon the Consulting End Date, Employee’s Equity Awards shall cease vesting and any unvested shares as of such date shall automatically terminate. Employee acknowledges that each unexercised “incentive stock option” within the meaning of the Internal Revenue Code of 1986, as amended, including the Acceleration Options, that remains unexercised following the three (3)-month anniversary of the Separation Date shall no longer qualify for favorable tax treatment as an incentive stock option.

(f)Benefits. As an independent contractor, Employee understands and agrees that, while performing any services for the Company or its affiliates after the Separation Date, Employee shall not be eligible to participate in or accrue benefits under any Company benefit plan for which status as an employee of the Company is a condition of such participation or accrual. To the extent that Employee was deemed eligible to participate, as an employee, in any Company benefit plan, he hereby waives his participation. Following the Separation Date, the Company shall notify Employee of any right to continue group health plan coverage sponsored by the Company or an affiliate of the Company pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), which Employee may elect to receive at Employee’s expense in accordance with the provisions of COBRA.

(g)Independent Contractor Status. Employee and the Company acknowledge and agree that, during the Consulting Period, Employee shall be an independent contractor. During the Consulting Period and thereafter, Employee shall not be an agent or employee of the Company and shall not be authorized to act on behalf of the Company. Employee agrees to indemnify and hold the Company and the other entities released herein harmless for any tax claims or penalties resulting from any failure by Employee to make required personal income and self-employment tax payments.

2.Accrued Obligations. Upon the Separation Date, the Company will pay to Employee (i) all accrued salary, and (ii) all accrued, unused paid time off through the Separation Date, and (iii) any unreimbursed business expenses incurred by Employee, in accordance with Company policy, prior to the Separation Date (collectively, the “Accrued Obligations”). Employee agrees that prior to the Separation Date, Employee has submitted Employee’s final documented expense reimbursement statement reflecting all business expenses Employee incurred through the Separation Date, if any, for which Employee seeks reimbursement. Employee is entitled to these payments regardless of whether Employee executes this Agreement. For the avoidance of doubt, Employee shall not be eligible to receive any bonus payment for his service for the year in which the Separation Date occurs.

3.Separation Benefits. In consideration of, and subject to and conditioned upon (i) Employee’s timely execution and non-revocation of this Agreement and (ii) Employee’s continued compliance with the terms and conditions of this Agreement and the Confidentiality Agreement, the Company shall pay to Employee an amount equal to a pro-rata portion of his annual bonus for the first quarter of calendar year 2022, based on achievement of the performance goals at target (whereby Employee’s target annual bonus for 2022 was based on 50% of his annual base salary). Such payment,


shall be paid, less applicable withholdings and deductions, on the later to occur of the Effective Date or the first payroll date following the Separation Date.

4.SEC Reporting. Employee acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), he will have continuing obligations under and he will continue to abide by Section 16(a) and 16(b) of the Exchange Act to report his transactions in Company common stock for six (6) months following the Separation Date.

5.Warranty. Employee acknowledges that all benefits under Section 3 constitute additional compensation to which Employee would not be entitled except for Employee’s decision to sign this Agreement and to abide by the terms of this Agreement. Employee acknowledges that, upon receipt of the Accrued Obligations, Employee has received all monies and other benefits due to Employee as a result of his employment with and separation from the Company, other than any continued vesting of Equity Awards during the Consulting Period. Employee further represents that to the best of Employee’s knowledge he has not sustained a work-related injury or illness which he has not previously reported to the Company.

6.Release of Known and Unknown Claims.

(a)General Release. In exchange for the benefits set forth in Section 3 above, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Employee agrees unconditionally and forever to release and discharge the Company and its affiliated, related, parent and subsidiary corporations, as well as its past and present parents, subsidiaries, affiliates, associates, members, stockholders, employee benefit plans, attorneys, agents, representatives, partners, joint ventures, predecessors, successors, assigns, insurers, owners, employees, officers, directors and all persons acting by, through, under, or in concert with them, or any of them (hereinafter the “Releasees”) from any and all manner of claims, actions, causes of action, in law or in equity, demands, rights, or damages of any kind or nature which he may now have, or ever have, whether known or unknown, fixed or contingent, including any claims, causes of action or demands of any nature (hereinafter called “Claims”), that Employee now has or may hereafter have against the Releasees by reason of any and all acts, omissions, events or facts occurring or existing prior to Employee’s execution of this release, including, without limitation, Claims related to any expense reimbursement and claims related to equity of the Company. The Claims released hereunder specifically include, but are not limited to, any claims for fraud; breach of contract; breach of implied covenant of good faith and fair dealing; inducement of breach; interference with contract; wrongful or unlawful discharge or demotion; violation of public policy; sexual or any other type of assault and battery; invasion of privacy; intentional or negligent infliction of emotional distress; intentional or negligent misrepresentation; conspiracy; failure to pay wages, benefits, vacation pay, severance pay, commissions, equity, attorneys’ fees, or other compensation of any sort; failure to accommodate disability, including pregnancy; discrimination or harassment on the basis of pregnancy, race, color, sex, gender, national origin, ancestry, religion, disability, handicap, medical condition, marital status, sexual orientation or any other protected category; any claim under the Age Discrimination in Employment Act, as amended, 29 U.S.C. § 621 et seq. (“ADEA”); the Older Workers’ Protection Benefit Act of 1990; Title VII of the Civil Rights Act of 1964, as amended, by the Civil Rights Act of 1991, 42 U.S.C. § 2000 et seq.; Equal Pay Act, as amended, 29 U.S.C. § 206(d); the Civil Rights Act of 1866, 42 U.S.C. § 1981; the Family and Medical Leave Act of 1993, 29 U.S.C. § 2601 et seq.; the Americans with Disabilities Act of 1990, 42 U.S.C. § 12101 et seq.; the False Claims Act, 31 U.S.C. § 3729 et seq.; the Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1001 et seq.; the Worker Adjustment and Retraining Notification Act (“WARN”), as amended, 29 U.S.C. § 2101 et seq.; the Fair Labor Standards Act, 29 U.S.C.
§ 215 et seq.; the California Fair Employment and Housing Act, as amended, Cal. Lab. Code § 12940 et seq.; the California Equal Pay Law, as amended, Cal. Lab. Code §§ 1197.5(a),1199.5; the Moore-Brown- Roberti Family Rights Act of 1991, as amended, Cal. Gov’t Code §§12945.2, 19702.3; the California WARN Act, Cal. Lab. Code § 1400 et seq.; the California False Claims Act, Cal. Gov’t Code § 12650 et


seq.; the California Corporate Criminal Liability Act, Cal. Penal Code § 387; the California Labor Code; and any federal, state or local laws of similar effect.

(b)Claims Not Released. This release shall not apply to: the Company’s obligations to provide the separation benefits under Section 3 of this Agreement; Employee’s right to indemnification under any applicable indemnification agreement with the Company, the Company’s governing documents or applicable law; Employee’s right to assert claims for workers’ compensation or unemployment benefits; Employee’s right to bring to the attention of the Equal Employment Opportunity Commission (“EEOC”) claims of discrimination (provided, however, that Employee releases his right to secure any damages for alleged discriminatory treatment); any right to communicate directly with, cooperate with, or provide information to, any federal, state or local government regulator; any right to file an unfair labor practice charge under the National Labor Relations Act (“NLRA”); Employee’s vested rights under any retirement or welfare benefit plan of the Company; or any other rights that may not be waived by an employee under applicable law.

(c)Unknown Claims. Employee acknowledges that Employee has been advised of and is familiar with the provisions of California Civil Code section 1542, which provides as follows:

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”

Employee, being aware of said code section, hereby expressly waives any rights he may have thereunder, as well as under any other statutes or common law principles of similar effect.

(d)Representations. Employee represents and warrants that there has been no assignment or other transfer of any interest in any Claim which he may have against Releasees, or any of them, and Employee agrees to indemnify and hold Releasees, and each of them, harmless from any liability, Claims, demands, damages, costs, expenses and attorneys’ fees incurred by Releasees, or any of them, as the result of any such assignment or transfer or any rights or Claims under any such assignment or transfer. It is the intention of the parties that this indemnity does not require payment as a condition precedent to recovery by the Releasees against Employee under this indemnity. Employee agrees that if he hereafter commences any suit arising out of, based upon, or relating to any of the Claims released hereunder or in any manner asserts against Releasees, or any of them, any of the Claims released hereunder, then Employee agrees to pay to Releasees, and each of them, in addition to any other damages caused to Releasees thereby, all attorneys’ fees incurred by Releasees in defending or otherwise responding to said suit or Claim.

(e)No Actions. Employee represents and warrants to the Company that Employee has no pending actions, Claims or charges of any kind. Employee agrees that if Employee hereafter commences, joins in, or in any manner seeks relief through any suit arising out of, based upon, or relating to any of the Claims released hereunder or in any manner asserts against the Releasees any of the Claims released hereunder, then Employee will pay to the Releasees against whom such Claim(s) is asserted, in addition to any other damages caused thereby, all attorneys’ fees incurred by such Releasees in defending or otherwise responding to said suit or Claim; provided, however, that Employee shall not be obligated to pay the Releasees’ attorneys’ fees to the extent such fees are attributable to: (i) claims under the ADEA or a challenge to the validity of the release of claims under the ADEA; or (ii) Employee’s right to file a charge with the EEOC; however, Employee hereby waives any right to any damages or individual relief resulting from any such charge.


(f)No Admission. Employee understands and agrees that neither the payment of money nor the execution of this Agreement shall constitute or be construed as an admission of any liability whatsoever by the Releasees.

(g)Older Worker’s Benefit Protection Act. In accordance with the Older Worker’s Benefit Protection Act, Employee is hereby advised as follows:

(i)Employee has read this Agreement and understands its terms and effect, including the fact that Employee is agreeing to release and forever discharge the Company and each of the Releasees from any Claims released in this Agreement.

(ii)Employee understands that, by entering into this Agreement, Employee does not waive any Claims that may arise after the date of Employee’s execution of this Agreement, including without limitation any rights or claims that Employee may have to secure enforcement of the terms and conditions of this Agreement.

(iii)Employee has signed this Agreement voluntarily and knowingly in exchange for the consideration described in this Agreement, which Employee acknowledges is adequate and satisfactory to Employee and in addition to any other benefits to which Employee is otherwise entitled.

(iv)The Company advises Employee to consult with an attorney prior to executing this Agreement.

(v)Employee has twenty-one (21) days to review and decide whether or not to sign this Agreement. If Employee signs this Agreement prior to the expiration of such period, Employee acknowledges that Employee has done so voluntarily, had sufficient time to consider the Agreement, to consult with counsel and that Employee does not desire additional time and hereby waives the remainder of the twenty-one (21) day period. In the event of any changes to this Agreement, whether or not material, Employee waives the restarting of the twenty-one (21) day period.

(vi)Employee has seven (7) days after signing this Agreement to revoke this Agreement and this Agreement will become effective upon the expiration of that revocation period. If Employee revokes this Agreement during such seven (7)-day period, this Agreement will be null and void and of no force or effect on either the Company or Employee and Employee will not be entitled to any of the payments or benefits which are expressly conditioned upon the execution and non-revocation of this Agreement.

(vii)If Employee wishes to revoke this Agreement, Employee shall deliver written notice stating his or her intent to revoke this Agreement to [    ], on or before 11:59 p.m. PT on the seventh (7th) day after the date on which Employee signs this Agreement.

7.Protection of Confidential Information. Subject to Section 9 below, Employee hereby reaffirms the covenants, terms and conditions set forth in the proprietary information and invention assignment agreement between the Company and Employee (the “Confidentiality Agreement”) and acknowledges that the Confidentiality Agreement shall survive termination of Employee’s employment and remain in full force and effect in accordance with its terms, including, without limitation, the confidentiality information and non-solicitation restrictive covenants set forth therein.

8.Non-disparagement. Subject to Section 9 below, following the Separation Date, Employee agrees not to publish or disseminate, directly or indirectly, any statements, whether written or oral, that are or could be harmful to or reflect negatively on any of the Company or any of its affiliates, or that are


otherwise disparaging of any of the Company, its affiliates or any of their past or present officers, directors, employees, advisors, agents, policies, procedures, practices, decision-making, conduct, professionalism or compliance with standards. The Company agrees that it shall instruct its officers and members of its Board of Directors to not publish or disseminate, directly or indirectly, any statements, whether written or oral, that are or could be harmful to or reflect negatively on Employee, or that are otherwise disparaging of Employee. Nothing in this Section 8 shall prevent Employee or any the Company from testifying truthfully in response to a subpoena or other legal process; nor shall anything herein prevent Employee from discussing terms and conditions of Employee’s employment with the Company, as permitted by the National Labor Relations Act and California law, including but not limited to discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful, or communicating directly with, cooperating with, or providing information to, any federal, state or local government regulator, including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, or the
U.S. Department of Justice.

9.Exceptions. Notwithstanding anything in this Agreement to the contrary, nothing contained in this Agreement or the Confidentiality Agreement shall prohibit Employee (or Employee’s attorney) from (i) filing a charge with, reporting possible violations of federal law or regulation to, participating in any investigation by, or cooperating with the U.S. Securities and Exchange Commission (“SEC”), the Financial Industry Regulatory Authority (“FINRA”), the EEOC, the NLRB, the Occupational Safety and Health Administration, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice or any other securities regulatory agency, self-regulatory authority or federal, state or local regulatory authority (collectively, “Government Agencies”), or making other disclosures that are protected under the whistleblower provisions of applicable law or regulation, (ii) communicating directly with, cooperating with, or providing information (including trade secrets) in confidence to any Government Agencies for the purpose of reporting or investigating a suspected violation of law, or from providing such information to Employee’s attorney or in a sealed complaint or other document filed in a lawsuit or other governmental proceeding, and/or (iii) receiving an award for information provided to any Government Agency. Pursuant to 18 USC Section 1833(b), Employee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (x) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (y) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Further, nothing in this Agreement is intended to or shall preclude Employee from providing truthful testimony in response to a valid subpoena, court order, regulatory request or other judicial, administrative or legal process or otherwise as required by law. If Employee is required to provide testimony, then unless otherwise directed or requested by a Governmental Agency or law enforcement, Employee shall notify the Company in writing as promptly as practicable after receiving any such request of the anticipated testimony and at least ten (10) days prior to providing such testimony (or, if such notice is not possible under the circumstances, with as much prior notice as is possible) to afford the Company a reasonable opportunity to challenge the subpoena, court order or similar legal process.

10.Ongoing Cooperation. Subject to Section 9 above, Employee agrees that Employee will assist and cooperate with the Company and its affiliates, (i) concerning reasonable requests for information about the business of the Company or its affiliates or Employee’s involvement and participation therein;
(ii) in connection with the defense, prosecution or investigation of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company or its subsidiaries or affiliates, including any proceeding before any arbitral, administrative, judicial, legislative, or other body or agency, including testifying in any proceeding to the extent such claims, actions, investigations or proceedings relate to services performed or required to be performed by Employee, pertinent knowledge possessed by Employee, or any act or omission by Employee; and (iii) and in connection with any investigation or review


by any federal, state or local regulatory, quasi- or self-regulatory or self-governing authority or organization (including, without limitation, the SEC and FINRA) as any such investigation or review relates to services performed or required to be performed by Employee, pertinent knowledge possessed by Employee, or any act or omission by Employee. Employee’s full cooperation shall include, but not be limited to, being available to meet and speak with officers or employees of the Company, its affiliates and/or their counsel at reasonable times and locations, executing accurate and truthful documents, appearing at the Company’s request as a witness at depositions, trials or other proceedings without the necessity of a subpoena, and taking such other actions as may reasonably be requested by the Company and/or its counsel to effectuate the foregoing. In requesting such services, the Company will consider other commitments that Employee may have at the time of the request. The Company acknowledges its obligations under that certain Indemnification Agreement with the Employee, and covenants and agrees that it will continue to adhere to its obligations under the Indemnification Agreement, including in respect of the pending securities class action lawsuit initiated in December 2021..

11.Governing Law. This Agreement shall be construed under the laws of the State of California, both procedural and substantive.

12.Waiver. The failure to enforce any provision of this Agreement shall not be construed to be a waiver of such provision or to affect the validity of this Agreement or the right of any party to enforce this Agreement.

13.Headings. The headings in this Agreement are provided solely for convenience, and are not intended to be part of, nor to affect or alter the interpretation or meaning of, this Agreement.

14.Severability. If any sentence, phrase, section, subsection or portion of this Agreement is found to be illegal or unenforceable, such action shall not affect the validity or enforceability of the remaining sentences, phrases, sections, subsections or portions of this Agreement, which shall remain fully valid and enforceable.

15.Assignment. This Agreement is personal to Employee and shall not be assignable by Employee. The rights of the Company under this Agreement may be assigned by the Company, in its sole discretion, including to any of its affiliates or any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company. This Agreement shall insure to the benefit of, and be binding on, the Company and its successors and assigns.

16.Ambiguities. Both parties have participated in the negotiation of this Agreement and, thus, it is understood and agreed that the general rule that ambiguities are to be construed against the drafter shall not apply to this Agreement. In the event that any language of this Agreement is found to be ambiguous, each party shall have an opportunity to present evidence as to the actual intent of the parties with respect to any such ambiguous language.

17.Entire Agreement/Integration. This Agreement, together with the Confidentiality Agreement and the Equity Award agreements, constitutes the entire agreement between Employee and the Company concerning the subject matter hereof. No covenants, agreements, representations, or warranties of any kind, other than those set forth herein, have been made to any party hereto with respect to this Agreement. All prior discussions and negotiations have been and are merged and integrated into, and are superseded by, this Agreement. No amendments to this Agreement will be valid unless written and signed by Employee and an authorized representative of the Company.


18.Consultation with Counsel. Employee acknowledges (i) that Employee has thoroughly read and considered all aspects of this Agreement, that Employee understands all its provisions and that Employee is voluntarily entering into this Agreement, and (ii) that he has been represented by, or had the opportunity to be represented by independent counsel of his own choice in connection with the negotiation and execution of this Agreement and has been advised to do so by the Company, and (ii) that he has read and understands the Agreement, is fully aware of its legal effect, and has entered into it freely based on his own judgment. Without limiting the generality of the foregoing, Employee acknowledges that he or she has had the opportunity to consult with his own independent tax advisors with respect to the tax consequences to him or her of this Agreement and the payments hereunder, and that he is relying solely on the advice of his independent advisors for such purposes. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.


PLEASE READ CAREFULLY. THIS AGREEMENT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. EMPLOYEE AGREES TO THE TERMS OF THIS AGREEMENT AND VOLUNTARILY ENTERS INTO IT WITH THE INTENT TO BE BOUND HEREBY.

If the above accurately reflects Employee’s understanding, please date and sign the enclosed copy of this Agreement in the places indicated below and return that copy to me by the date that is after the Separation Date but on or before twenty one (21) days after the Agreement Date.



    


Dated:March 8, 2022EMPLOYEE
/s/ Kurt Wood
Kurt Wood
Dated:March 8, 2022COMPANY
/s/ Greg Lucier
Greg Lucier
Chairman of the Board





 EX-10.3 3 ex-103employmentagreements.htm EX-10.3 Document

        EXHIBIT 10.3
BERKELEY LIGHTS INC.


EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”), entered into as of March 8, 2022 and is effective as of such date provided that employment will not commence until tthe Effective Date (as defined below), is between Berkeley Lights, Inc., a Delaware corporation (the “Company”) and Siddhartha Kadia, PhD (“Executive” and, together with the Company, the “Parties”).

WHEREAS, Executive presently serves as a non-employee member of the Company’s board of directors and this Agreement shall not affect such service (other than with respect to committees that Executive presently serves on);

WHEREAS, the Company now desires to assure itself of the services of Executive by engaging Executive to perform services as an employee of the Company effective as of March 9, 2022 (the date Executive actually commences employment with the Company, the “Effective Date”) under the terms hereof; and

WHEREAS, Executive desires to provide services to the Company on the terms herein provided.

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:

1.Employment.

(a)General. The Company shall employ Executive upon the terms and conditions provided herein effective as of the Effective Date.

(b)Position and Duties. Effective as of the Effective Date, Executive: (i) shall serve as the Company’s sole Chief Executive Officer, with responsibilities, duties, and authority usual and customary for such position, subject to direction by the Board of Directors of the Company (the “Board”); (ii) shall report directly to the Board; and (iii) agrees to comply with all present and future written policies, requirements, rules and regulations, and reasonable directions and requests by the Board, of the Company in connection with the Company’s business. At the Company’s request, Executive shall serve the Company and/or its subsidiaries and affiliates in such other capacities in addition to the foregoing as the Company shall designate, provided that such additional capacities are consistent with Executive’s position as the Company’s sole Chief Executive Officer. In the event that Executive serves in any one or more of such additional capacities, Executive’s compensation shall not automatically be increased on account of such additional service.

(c)Principal Office. Executive shall primarily perform services for the Company at the Company’s offices located in Emeryville, California or, with the Company’s consent, at any other place in connection with the fulfillment of Executive’s role with the Company; provided, however, that the Company may from time to time require Executive to travel temporarily to other locations in connection with the Company’s business. In the event the
1

Company establishes an office in San Diego, Executive and the Board shall mutually agree to revisit this Section 1(c) and the housing stipend in Section 3(d) in reasonable good faith.

(d)Exclusivity. Except with the prior written approval of the Board (which the Board may grant or withhold in its sole and absolute discretion), Executive shall devote Executive’s best efforts and full working time, attention, and energies to the business of the Company, except during any paid vacation or other excused absence periods. Notwithstanding the foregoing, Executive may, without violating this Section 1(d), (i) as a passive investment, own publicly traded securities in such form or manner as will not require any services by Executive in the operation of the entities in which such securities are owned; (ii) engage in charitable and civic activities; or (iii) engage in other personal passive investment activities, in each case, so long as such interests or activities do not materially interfere to the extent such activities do not, individually or in the aggregate, interfere with or otherwise prevent the performance of Executive’s duties and responsibilities hereunder. Executive may also serve as a member of the board of directors or board of advisors of another organization provided (i) such organization is not a competitor of the Company; (ii) Executive receives prior written approval from the Board; and (iii) such activities do not individually or in the aggregate interfere with the performance of Executive’s duties under this Agreement, violate the Company’s standards of conduct then in effect, or raise a conflict under the Company’s conflict of interest policies. For the avoidance of doubt, the Board has approved Executive’s service with those organizations set forth on Exhibit A, such approval to continue until such time as such service interferes with the performance of Executive’s duties under this Agreement, violates the Company’s standards of conflict or raises a conflict under the Company’s conflict of interest policies.

2.Term. The period of Executive’s employment under this Agreement shall commence on the Effective Date and shall continue until Executive’s employment with the Company is terminated pursuant to Section 5. The phrase “Term” as used in this Agreement shall refer to the entire period of employment of Executive by the Company.

3.Compensation and Related Matters.

(a)Annual Base Salary. During the Term, Executive shall receive a base salary at the rate of $700,000 per year (as may be adjusted from time to time, the “Annual Base Salary”), subject to withholdings and deductions and pro-rated for any partial employment during the Term, which shall be paid to Executive in accordance with the customary payroll practices and procedures of the Company (but with pro-rata installments at least once per calendar month). Such Annual Base Salary shall be reviewed and subject to increase by the Board not less than annually.

(b)Annual Bonus. Executive shall be eligible to receive a discretionary annual bonus based on Executive’s achievement of performance objectives established by the Board, such bonus to be targeted at 100% of Executive’s Annual Base Salary (the “Annual Bonus”). Any Annual Bonus shall be paid at the same time annual bonuses are paid to other executives of the Company generally, subject to Executive’s continuous employment through the last day of the applicable performance year. Notwithstanding the foregoing, for calendar year 2022, Executive shall be guaranteed his Annual Bonus assuming achievement of performance goals at 100% of target, pro-rated for his partial service from the Effective Date through December 31, 2022, subject to his continued employment with the Company through December 31, 2022.
2

Such guaranteed target Annual Bonus for calendar 2022 shall be paid to Executive, less applicable withholdings and deductions, prior to March 15, 2023.

(c)Benefits. Executive shall be entitled to participate in such employee and executive benefit plans and programs as the Company may from time to time offer to provide to its executives, subject to the terms and conditions of such plans. Notwithstanding the foregoing, nothing herein is intended, or shall be construed, to require the Company to institute or continue any particular plan or benefit. Executive’s prior and future services to the Company shall be (i) indemnified by the Company to the maximum extent permitted by law and (ii) covered under a Company paid directors and officers errors and omissions liability insurance policy.

(d)Housing Stipend. The Company and Executive agree that for each of the first twelve (12) calendar months that occur during the Term (including, without limitation, April 2022), the Company shall pay to Executive an additional amount in cash equal to $10,000 for temporary lodging and travel expenses associated with Executive’s travel to the Company’s headquarters. Such payment shall be payable to Executive on the first payroll of each calendar month, less applicable withholdings and deductions, subject to Executive’s continued service through the applicable payment date. For the avoidance of doubt, this housing stipend shall only be payable for the first twelve (12) calendar months of the Term.

(e)Business Expenses. The Company shall reimburse Executive for all reasonable, documented, out-of-pocket travel and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s applicable expense reimbursement policies and procedures as are in effect from time to time. Such business expense reimbursement shall include the Company directly paying Executive’s counsel for any and all legal fees and related costs actually incurred in connection with this Agreement and any related agreements, up to a maximum amount of $25,000. Such payment shall be made in 2022 and within thirty (30) days of receiving appropriate documentation related to these legal fees/costs.

(f)Vacation. Executive will be entitled to paid vacation in accordance with the Company’s vacation policy, as in effect from time to time.

(g)No Mitigation or Offset. Executive shall have no duty of mitigation and there shall be no right of offset with respect to any compensatory payment or benefit provided (or to be provided) to Executive under this Agreement or any other agreement or plan.

4.Equity Awards.

(a)Initial RSUs. Within 15 days after the Effective Date, Executive shall be granted under the Company’s 2020 Incentive Award Plan (“Plan”) that number of restricted stock units underlying the Company’s common stock (the “RSUs”), which represents 1.5% of the Outstanding Common Shares (as defined below) as of the date of the Public Announcement (as defined below) rounded down to the nearest whole share, provided that Executive is employed by the Company on the date of grant. Subject to Executive remaining as a “Service Provider” (as defined in the Plan) through the applicable vesting date, 1/12th of the total number of RSUs will vest and be settled on each quarterly anniversary of the Effective Date.
3

(b)Initial Stock Option. Within 15 days after the Effective Date, Executive shall be granted under the Plan an option to purchase that number of shares of the Company’s common stock (the “Initial Option”), which represents 0.5% of the Outstanding Common Shares as of the date of the Public Announcement rounded down to the nearest whole share, with an exercise price per share equal to the fair market value of a share of the Company’s common stock on the date of grant, provided that Executive is employed by the Company on the date of grant. Subject to Executive remaining as a “Service Provider” (as defined in the Plan) through the applicable vesting date, 1/12th of the total number of shares subject to the Initial Option will vest on each quarterly anniversary of the Effective Date.

(c)Performance Stock Option. Within 15 days after the Effective Date, Executive shall be granted under the Plan an option to purchase that number of shares of the Company’s common stock (the “Performance Option” and, collectively with the RSUs and the Initial Option, the “Equity Awards”), which represents 1.0% of the Outstanding Common Shares as of the date of the Public Announcement rounded down to the nearest whole share, with an exercise price per share equal to the fair market value of a share of the Company’s common stock on the date of grant, provided that Executive is employed by the Company on the date of grant. Vesting and exercisability of the shares subject to the Performance Option shall be contingent on the satisfaction of both a service-based requirement (the “Service-Based Requirement”) and a performance-based requirement (the “Performance-Based Requirement”).

(i)Service-Based Requirement: The Service-Based Requirement will be incrementally satisfied as to 20% of the shares subject to the Performance Option on each anniversary of the Effective Date, subject to Executive remaining as a “Service Provider” (as defined in the Plan) through such date. The Service-Based Requirement shall be deemed satisfied in full in the event Executive experiences a Covered Termination (as defined in the Severance Agreement, defined below), effective as of immediately prior to the “Termination of Service” (as defined in the Plan), subject to Executive otherwise complying with the requirements set forth in the Severance Agreement.

(ii)Performance-Based Requirement: Upon the occurrence of a Determination Date prior to the “Termination Date” (as defined below), the Performance-Based Requirement will be satisfied in respect of that percentage of the total number of shares subject to the Performance Option determined based on the Stock Value being at least equal to the applicable Stock Price Goal in accordance with the following table. For avoidance of doubt, upon the achievement of a Stock Price Goal, any Stock Price Goal with a lower threshold value will also then have been achieved if not previously satisfied.



Stock Price Goal
Number of Performance-Based Shares that incrementally vest upon Achievement of a Stock Price Goal
Stock Price Goal 1
20% of the total Performance Option shares
Stock Price Goal 2
20% of the total Performance Option shares
Stock Price Goal 3
20% of the total Performance Option shares
Stock Price Goal 4
20% of the total Performance Option shares
Stock Price Goal 5
20% of the total Performance Option shares
4

Only if the Determination Date is as a result of a Change in Control (as defined in the Severance Agreement) and the Stock Price Goal achieved is between the above levels as of such Change in Control, the percentage of shares that will satisfy the Performance-Based Requirement shall be determined using linear interpolation. For the avoidance of doubt, if the Determination Date for the shares occurs as a result of a Change in Control, the Performance-Based Requirement shall be deemed satisfied immediately prior to the closing of such Change in Control in which such metrics will be achieved, rather than after the closing of such transaction.

Notwithstanding the foregoing, even if a Stock Price Goal is not achieved as a result of a Change in Control, at a minimum that number of shares subject to the Performance Option shall be accelerated such that the Stock Value Executive is eligible to receive with respect to the shares subject to the Equity Awards in the Change in Control is equal to at least $8,000,000. In the event the Stock Value Executive is eligible to receive with respect to the shares subject to the Equity Awards (after giving effect to full acceleration of the shares subject to the Performance Option) is less than $8,000,000 in the aggregate, then the Company shall pay to Executive a one-time cash bonus equal to the difference between (i) $8,000,000 and (ii) the Stock Value in the Change in Control Executive is eligible to receive with respect to the shares subject to the Equity Awards. Such cash bonus shall be payable upon the closing of the Change in Control, less applicable withholdings and deductions, subject to Executive not experiencing a Termination of Service prior to such date. Notwithstanding the foregoing, in the event Executive experiences a Covered Termination during a Change in Control Period (each as defined in the Severance Agreement), then Executive shall remain eligible to receive such cash bonus, payable at the closing of the Change in Control, provided Executive otherwise complies with the requirements in Section 4 of the Severance Agreement.

(iii)Vesting of Shares Following Satisfaction of Both Service-Based and Performance-Based Requirements: No shares subject to the Performance Option will vest or become exercisable (in whole or in part) if only one (or if neither) of the Service-Based Requirement and the Performance-Based Requirement is satisfied. If both the Service-Based Requirement and the Performance-Based Requirement are satisfied, each share subject to the Performance Option will vest and become exercisable on the first date upon which both of those requirements were satisfied with respect to that particular share.

(iv)Termination of Shares Subject to the Performance Option: The shares subject to the Performance Option shall terminate upon the first to occur of the following (such date, the “Termination Date”): (i) solely in respect of shares for which the Service-Based Requirement or the Performance-Based Requirement has not been satisfied, the date of Executive’s Termination of Service (subject to any accelerated vesting for the Service-Based Requirement), (ii) solely in respect of shares for which both the Service-Based Requirement and the Performance-Based Requirement has been satisfied, twelve (12) months following Executive’s Termination of Service, (iii) the tenth (10th) anniversary of the date of grant, (iv) in the event none of the Performance-Based Requirements have been satisfied as of the consummation of a Change in Control, the closing of such Change in Control, (v) in the event the Performance-Based Requirement has been satisfied as of the consummation of a Change in Control, the closing of such Change in Control in which the Performance Option is not assumed, continued or substituted for (as determined under Sections 9.2 or 9.3 of the Plan) or (vi) for any shares which have not satisfied the Performance-Based Requirement, the seventh anniversary of the Effective Date.
5

Notwithstanding the foregoing, all of the shares subject to the Performance Option, including any vested and non-vested portion, terminate immediately upon Executive’s Termination of Service for Cause (as defined in the Severance Agreement).

(v)Definitions:

(1)“Base Price” shall mean the closing trading price per share of the Company’s common stock as of the last trading day prior to the public announcement of Executive becoming the Company’s Chief Executive Officer (the “Public Announcement”).

(2)“Determination Date” means the occurrence of (i) a Change in Control or (ii) any date (prior to a Change in Control) when the Stock Value first equals or exceeds a Stock Price Goal. Determination Dates are eligible to occur any time following the Effective Date until the earlier to occur of (a) the date 100% of the shares subject to the Performance Option have satisfied the Performance-Based Requirement and (b) the Termination Date.

(3)“Stock Price Goal” means one of the below five separate stock price threshold values which each reflect a multiple of the Base Price:

Stock Price Goal
Threshold Value
Stock Price Goal 1
200% of Base Price
Stock Price Goal 2
400% of Base Price
Stock Price Goal 3
800% of Base Price
Stock Price Goal 4
1500% of Base Price
Stock Price Goal 5
2000% of Base Price

(4)“Stock Value” means: (I) upon the date of a Change in Control, the dollar amount of cash and the value of any securities or other property paid to the holders of shares of Company common stock as consideration in a Change in Control, on a per common share basis (and in the case of a Change in Control that is an asset sale, any additional consideration paid to the Company but not to the holders of common stock, on a per share basis, had such amounts been paid to the holders of Shares), as reasonably determined in good faith by the Board (but in all cases not inconsistent with the value ascribed to such items in the Change in Control transaction documents); and (II) upon any date between the 90th day after the Public Announcement and the day before a Change in Control, the average of the closing trading price per share of the Company’s common stock over the immediately trailing 90 day period.

(vi)Adjustments. In the event that any dividend or other distribution (whether in the form of cash, shares of the Company’s common stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger (except for a Change in Control), consolidation, split-up, spin-off, combination, reclassification, repurchase, or exchange of shares of the Company’s common stock or other securities of the Company, or other change in the corporate structure of the Company affecting the shares of the Company’s common stock occurs (other than any ordinary dividends or other ordinary distributions), the Board, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made
6

available under the Performance Option, shall (consistent with Section 9.1 in the Plan) make appropriate proportionate and equitable adjustments to the Stock Price Goal(s) set forth above to the extent such Stock Price Goal(s) have not yet been achieved.

(d)Generally. The Equity Awards, and any shares acquired upon exercise, will be subject to the terms and conditions of the Plan and an individual award agreement to be entered into between Executive and the Company (provided that such other terms are not inconsistent with the terms of this Agreement). For the purposes of this Agreement, “Outstanding Common Shares” shall be the number of outstanding shares of common stock of the Company, as of the close of the business day preceding the date of determination. Executive shall be permitted in satisfying the payment for any applicable exercise price with respect to the Initial Option and/or the Performance Option through net exercise. Executive may also elect in his discretion to implement a SEC Rule 10b5-1 trading plan in accordance with the Securities Act of 1933.

(e)Future Awards. Commencing in calendar year 2025, Executive shall be eligible for annual stock options and other equity awards as may be determined by the Board.

5.Termination.

(a)At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and shall continue to be at-will, as defined under applicable law. This means that it is not for any specified period of time and can be terminated by Executive or by the Company at any time, with or without advance notice, and for any or no particular reason or cause. This “at-will” nature of Executive’s employment shall remain unchanged during Executive’s tenure as an employee and may not be changed, except in an express writing signed by Executive and a duly-authorized officer of the Company. If Executive’s employment terminates for any lawful reason, Executive shall not be entitled to any payments, benefits, damages, award, or compensation other than as provided in this Agreement.

(b)Notice of Termination. During the Term, any termination of Executive’s employment by the Company or by Executive (other than by reason of death) shall be communicated by written notice (a “Notice of Termination”) from one Party hereto to the other Party hereto (i) indicating the specific termination provision in this Agreement or the Severance Agreement, as defined below, relied upon, if any, (ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, and (iii) specifying the Date of Termination (as defined below). The failure by the Company to set forth in the Notice of Termination all of the facts and circumstances which contribute to a showing of Cause shall not waive any right of the Company hereunder or preclude the Company from asserting such fact or circumstance in enforcing their rights hereunder. The failure by the Executive to set forth in the Notice of Termination all of the facts and circumstances which contribute to a showing of Good Reason shall not waive any right of the Executive hereunder or preclude the Executive from asserting such fact or circumstance in enforcing their rights hereunder.

(c)Date of Termination. For purposes of this Agreement, “Date of Termination” shall mean the date of the termination of Executive’s employment with the Company specified in a Notice of Termination.
7

(d)Deemed Resignation. Upon termination of Executive’s employment for any reason, Executive shall be deemed to have resigned from all offices and board memberships, if any, then held with the Company or any of its affiliates, and, at the Company’s request, Executive shall execute such documents as are necessary or desirable to effectuate such resignations.

(e)Executive’s Obligations upon Termination.

(i)Cooperation. Executive shall provide Executive’s reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder; provided the Company shall indemnify and hold harmless Executive with respect to any such cooperation and promptly reimburse Executive for Executive’s reasonable costs and expenses (including legal counsel selected by Executive and reasonably acceptable to the Company) and such cooperation shall not unreasonably burden Executive or unreasonably interfere with any subsequent employment that Executive may undertake.

(ii)Return of Company Property. Executive hereby acknowledges and agrees that all Company Property (as defined below) and equipment furnished to, or prepared by, Executive in the course of, or incident to, Executive’s employment, belongs to the Company and shall be promptly returned to the Company upon termination of Executive’s employment (and will not be kept in Executive’s possession or delivered to anyone else). For purposes of this Agreement, “Company Property” includes, without limitation, all books, manuals, records, reports, notes, contracts, lists, blueprints, and other documents, or materials, or copies thereof (including computer files), keys, building card keys, company credit cards, telephone calling cards, computer hardware and software, laptop computers, docking stations, cellular and portable telephone equipment, personal digital assistant (PDA) devices and all other proprietary information relating to the business of the Company or its subsidiaries or affiliates. Following Termination of Service, Executive shall not retain any written or other tangible material containing any proprietary information of the Company or its subsidiaries or affiliates.

6.Consequences of Termination.

(a)Payments of Accrued Obligations upon all Terminations of Employment. Upon a termination of Executive’s employment for any reason, Executive (or Executive’s estate or legal representative, as applicable) shall be entitled to receive, within 30 days after Executive’s Date of Termination (or such earlier date as may be required by applicable law): (i) any portion of Executive’s Annual Base Salary earned through Executive’s Date of Termination not theretofore paid, (ii) any expenses owed to Executive under Section 3, (iii) any accrued but unused paid time- off owed to Executive, (iv) any Annual Bonus earned but unpaid as of the Date of Termination, and (v) any amount arising from Executive’s participation in, or benefits under, any employee benefit plans, programs, or arrangements under Section 3, which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs, or arrangements. Except as otherwise set forth in Section 6(b), the payments and benefits described in this Section 6(a) shall be the only payments and benefits payable in the event of Executive’s termination of employment for any reason.
8

(b)Severance Payments. Executive shall be eligible for certain severance payments and benefits upon qualifying terminations of employment as set forth in that certain Change in Control and Severance Agreement by and between the Company and Executive, executed between the Parties as of the date of this Agreement (the “Severance Agreement”).

7.Assignment and Successors. The Company shall assign its rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise). This Agreement shall be binding upon and inure to the benefit of the Company, Executive, and their respective successors, assigns, personnel, and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive’s rights or obligations may be assigned or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only by will, operation of law, or as otherwise provided herein.

8.Miscellaneous Provisions.

(a)Confidentiality Agreement; Work Eligibility. As a condition of Executive’s employment with the Company, Executive shall execute and abide by the Company standard form proprietary information and inventions assignment agreement (the “Confidentiality Agreement”). As a condition of Executive’s employment with the Company, Executive is required to provide evidence of Executive’s identity and eligibility for employment in the United States.

(b)Governing Law. This Agreement shall be governed, construed, interpreted, and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of California, without giving effect to any principles of conflicts of law, whether of the State of California or any other jurisdiction, and where applicable, the laws of the United States, that would result in the application of the laws of any other jurisdiction.

(c)Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

(d)Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement. Signatures delivered by facsimile or PDF shall be deemed effective for all purposes.

(e)Entire Agreement. The terms of this Agreement, together with the Confidentiality Agreement and the Severance Agreement, are intended by the Parties to be the final expression of their agreement with respect to the employment of Executive by the Company and supersede all prior understandings and agreements, whether written or oral, regarding Executive’s service to the Company. The Parties further intend that this Agreement, together with the Severance Agreement and Confidentiality Agreement, shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement or the Confidentiality Agreement. Notwithstanding the foregoing, in the event of any conflict between
9

the terms of any other agreement or Company policy and the terms of this Agreement, the terms of this Agreement shall prevail and govern.

(f)Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in writing signed by Executive and a duly authorized representative of the Company. By an instrument in writing similarly executed, Executive or a duly authorized representative of the Company, as applicable, may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder shall preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.

(g)Dispute Resolution. To ensure the timely and economical resolution of disputes that arise in connection with this Agreement, Executive and the Company agree that any and all controversies, claims and disputes arising out of or relating to this Agreement, including without limitation any alleged violation of its terms, shall be resolved solely and exclusively by final and binding arbitration held in Alameda County, California through JAMS in conformity with the then-existing JAMS employment arbitration rules, which can be found at https://www.jamsadr.com/rules-employment-arbitration/. The arbitration provisions of this Agreement shall be governed by and enforceable pursuant to the Federal Arbitration Act. In all other respects for provisions not governed by the Federal Arbitration Act, this Agreement shall be construed in accordance with the laws of the State of California, without reference to conflicts of law principles. The arbitrator shall: (a) provide adequate discovery for the resolution of the dispute; and (b) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall award the prevailing Party attorneys’ fees and expert fees, if any. Notwithstanding the foregoing, it is acknowledged that it will be impossible to measure in money the damages that would be suffered if the Parties fail to comply with any of the obligations imposed on them under Section 8(a), and that in the event of any such failure, an aggrieved person will be irreparably damaged and will not have an adequate remedy at law. Any such person shall, therefore, be entitled to seek injunctive relief, including specific performance, to enforce such obligations, and if any action shall be brought in equity to enforce any of the provisions of Section 8(a), none of the Parties shall raise the defense, without a good faith basis for raising such defense, that there is an adequate remedy at law. Executive and the Company understand that by agreement to arbitrate any claim pursuant to this Section 8(g), they will not have the right to have any claim decided by a jury or a court, but shall instead have any claim decided through arbitration. Executive and the Company waive any constitutional or other right to bring claims covered by this Agreement other than in their individual capacities. Except as may be prohibited by applicable law, the foregoing waiver includes the ability to assert claims as a plaintiff or class member in any purported class or representative proceeding. The Company shall pay for all arbitration costs and fees that Executive would not have incurred if the dispute had been resolved in a court of law.

(h)Enforcement. If any provision of this Agreement is held to be illegal, invalid, or unenforceable under present or future laws, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid, or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement
10

shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid, or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid, or unenforceable provision as may be possible and be legal, valid, and enforceable.

(i)Notices. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, as follows:

(i)If to the Company, to the Board at the Company’s headquarters,

(ii)If to Executive, to the last address that the Company has in its personnel records for Executive, or

(iii)At any other address as any Party shall have specified by notice in writing to the other Party.

(j)Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local, or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.

(k)Whistleblower Protections and Trade Secrets. Notwithstanding anything to the contrary contained herein, nothing in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any United States governmental agency or entity in accordance with the provisions of and rules promulgated under Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or regulation (including the right to receive an award for information provided to any such government agencies). Furthermore, in accordance with 18 U.S.C. § 1833, notwithstanding anything to the contrary in this Agreement: (i) Executive shall not be in breach of this Agreement, and shall not be held criminally or civilly liable under any federal or state trade secret law (x) for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (y) for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney, and may use the trade secret information in the court proceeding, if Executive files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order.

9.Prior Employment. Executive represents and warrants that Executive’s acceptance of employment with the Company has not breached, and the performance of Executive’s duties hereunder will not breach, any duty owed by Executive to any prior employer or other person. Executive further represents and warrants to the Company that (a) the
11

performance of Executive’s obligations hereunder will not violate any agreement between Executive and any other person, firm, organization, or other entity; (b) Executive is not bound by the terms of any agreement with any previous employer or other party to refrain from competing, directly or indirectly, with the business of such previous employer or other party that would be violated by Executive entering into this Agreement and/or providing services to the Company pursuant to the terms of this Agreement; and (c) Executive’s performance of Executive’s duties under this Agreement will not require Executive to, and Executive shall not, rely on in the performance of Executive’s duties or disclose to the Company or any other person or entity or induce the Company in any way to use or rely on any trade secret or other confidential or proprietary information or material belonging to any previous employer of Executive.

10.Section 409A. The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date, (“Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. If Executive notifies the Company that Executive has received advice of tax counsel of a national reputation with expertise in Section 409A that any provision of this Agreement would cause Executive to incur any additional tax or interest under Section 409A (with specificity as to the reason therefor) or the Company independently makes such determination, the Company and Executive shall take commercially reasonable efforts to reform such provision to try to comply with or be exempt from Section 409A through good faith modifications to the minimum extent reasonably appropriate to conform with Section 409A. To the extent that any provision hereof is modified in order to comply with or be exempt from Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. Notwithstanding any provision to the contrary in this Agreement: (i) no amount or benefit that constitutes “deferred compensation” under Section 409A shall be provided pursuant to this Agreement unless the termination of Executive’s employment constitutes a “separation from service” within the meaning of Section 1.409A-1(h) of the Department of Treasury Regulations (“Separation from Service”);
(ii)for purposes of Section 409A, Executive’s right to receive installment payments shall be treated as a right to receive a series of separate and distinct payments; and (iii) to the extent that any reimbursement of expenses or in-kind benefits constitutes “deferred compensation” under Section 409A, such reimbursement or benefit shall be provided no later than December 31st of the year following the year in which the expense was incurred. The amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year.

11.Employee Acknowledgement. Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive’s own judgment.

[Signature Page Follows]









12

The Parties have executed this Agreement as of the date set forth at the start of the Agreement.


BERKELEY LIGHTS, INC
By:/s/ Gregory T. Lucier
Name:Gregory T. Lucier
Title:Chairman of the Board
EXECUTIVE
By:/s/ Siddhartha Kadia
Name:Siddhartha Kadia, PhD
Address:




                    







EXHIBIT A

Affiliations

Executive is a currently a member of the board of directors of the below entities: Public

•Isoplexis (Nasdaq: ISO)

•NuVasive (Nasdaq: NUVA)

•ALS limited (ASX: ALQ)

Private


•Bioskryb Genomics

•ATS

•SeQureDx
































 EX-10.4 4 ex-104changeinctrlseveranc.htm EX-10.4 Document

EXHIBIT 10.4

BERKELEY LIGHTS, INC.

CHANGE IN CONTROL AND SEVERANCE AGREEMENT

This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Siddhartha Kadia, PhD (“Executive”) and Berkeley Lights, Inc. (the “Company”), effective as of the date Executive commences employment with the Company (the “Effective Date”).

Background

A.The Board of Directors of the Company (the “Board”) recognizes that the possibility of an acquisition of the Company or an involuntary termination can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Board has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of such an event.

B.The Board believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive’s employment and to motivate Executive to maximize the value of the Company upon a Change in Control (as defined below) for the benefit of its stockholders.

C.The Board believes that it is imperative to provide Executive with severance benefits upon certain terminations of Executive’s service to the Company that enhance Executive’s financial security and provide incentive and encouragement to Executive to remain with the Company notwithstanding the possibility of such an event.

D.Unless otherwise defined herein, capitalized terms used in this Agreement are defined in Section 9 below.

Agreement

The parties hereto agree as follows:

1.Term of Agreement. This Agreement shall become effective as of the Effective Date and terminate upon the date that all obligations of the parties hereto with respect to this Agreement have been satisfied.

2.At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and shall continue to be “at-will,” as defined under applicable law. Except as provided in Section 5 below, if Executive’s employment terminates for any reason, Executive shall not be entitled to any severance payments, benefits or compensation other than as provided in this Agreement.

3.Covered Termination Outside a Change in Control Period. If Executive experiences a Covered Termination outside a Change in Control Period, then, subject to (i) Executive delivering to



the Company an executed general release of all claims against the Company and its affiliates in a form approved by the Company (a “Release of Claims”) that becomes effective and irrevocable in accordance with Section 14(a)(v) below, or such shorter period of time specified by the Company, following such Covered Termination and (ii) Executive’s continued compliance with Section 12 below, then in addition to any accrued but unpaid salary, benefits, vacation and expense reimbursements through the Termination Date payable in accordance with applicable law, the Company shall provide Executive with the following:

(a)Severance. During the period of time commencing on the Termination Date and ending on the twelve (12) month anniversary of the Termination Date, the Company shall continue to pay Executive his base salary at the rate in effect immediately prior to the Termination Date (disregarding any reduction to base salary in the prior 12 months). Such payments shall be made in accordance with the Company’s standard payroll practices, less applicable withholdings, beginning on the first payroll date following the date the Release of Claims becomes effective and irrevocable in accordance with Section 14(a)(v) below, and with the first installment including any amounts that would have been paid had the Release of Claims been effective and irrevocable on the Termination Date.

(b)Target Bonus. Executive shall be entitled to receive an amount equal to twelve
(12) months of Executive’s target annual bonus as if achievement of performance goals at one hundred percent (100%) of target had occurred at the rate in effect immediately prior to the Termination Date (disregarding any reduction to base salary or target annual bonus in the prior 12 months), payable in a cash lump sum, less applicable withholdings, on the first payroll date following the date the Release of Claims becomes effective and irrevocable in accordance with Section 14(a)(v) below.

(c)Continued Healthcare. If Executive timely elects to receive continued healthcare coverage pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall each calendar month directly pay, or reimburse Executive for, the Company’s portion of the premium (at the same rates in effect on the Termination Date) for Executive and Executive’s covered dependents through the earlier of (i) the twelve (12) month anniversary of the Termination Date and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s). Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Section 409A of the Internal Revenue Code of 1986, as amended, (the “Code”) under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments. After the Company ceases to pay premiums pursuant to this Section 3(b), Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance with the provisions of COBRA. Executive shall notify the Company immediately if Executive becomes covered by a group health plan of a subsequent employer.

4.Covered Termination During a Change in Control Period. If Executive experiences a Covered Termination during a Change in Control Period, then, subject to (i) Executive delivering to
2


the Company an executed Release of Claims that becomes effective and irrevocable in accordance with Section 14(a)(v) below, or such shorter period of time specified by the Company, following such Covered Termination and (ii) Executive’s continued compliance with Section 12 below, then in addition to any accrued but unpaid salary, benefits, vacation and expense reimbursements through the Termination Date payable in accordance with applicable law, the Company shall provide Executive with the following:

(a)Severance. During the period of time commencing on the Termination Date and ending on the eighteen (18) month anniversary of the Termination Date, the Company shall continue to pay Executive his base salary at the rate in effect immediately prior to the Termination Date (disregarding any reduction to base salary in the prior 12 months). Such payments shall be made in accordance with the Company’s standard payroll practices, less applicable withholdings, beginning on the first payroll date following the date the Release of Claims becomes effective and irrevocable in accordance with Section 14(a)(v) below, and with the first installment including any amounts that would have been paid had the Release of Claims been effective and irrevocable on the Termination Date.

(b)Target Bonus. Executive shall be entitled to receive an amount equal to eighteen (18) months of Executive’s target annual bonus as if achievement of performance goals at one hundred percent (100%) of target had occurred at the rate in effect immediately prior to the Termination Date (disregarding any reduction to base salary or target annual bonus in the prior 12 months), payable in a cash lump sum, less applicable withholdings, on the first payroll date following the date the Release of Claims becomes effective and irrevocable in accordance with Section 14(a)(v) below.

(c)Continued Healthcare. If Executive timely elects to receive continued healthcare coverage pursuant to the provisions of COBRA, the Company each calendar month shall directly pay, or reimburse Executive for, the Company’s portion of the premium (at the same rates in effect on the Termination Date) for Executive and Executive’s covered dependents through the earlier of (i) the eighteen (18) month anniversary of the Termination Date and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s). Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Section 409A of the Code under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments. After the Company ceases to pay premiums pursuant to this Section 4(c), Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance with the provisions of COBRA. Executive shall notify the Company immediately if Executive becomes covered by a group health plan of a subsequent employer.

(d)Equity Awards. Each outstanding and unvested equity award (excluding any such awards that vest in whole or in part based on the attainment of performance-vesting conditions), including, without limitation, each restricted stock, stock option, restricted stock unit and stock
3


appreciation right, held by Executive shall automatically become vested and, if applicable, exercisable and any forfeiture restrictions or rights of repurchase thereon shall immediately lapse with respect to one hundred percent (100%) of the shares subject thereto (excluding any such awards that vest in whole or in part based on the attainment of performance-vesting conditions, which shall be governed by the terms of the applicable award agreement), as of immediately prior to the Termination Date. To give effect to the foregoing, upon the Termination Date, (i) the vested portion of such equity awards shall be remain outstanding and/or be exercisable for the period(s) of time set forth in the applicable equity award agreements, (ii) Executive’s outstanding equity awards shall cease vesting, and (iii) the unvested shares subject to Executive’s outstanding equity awards shall remain outstanding (but unvested) until the earlier to occur of (A) the original expiration date of the equity award and (B) ninety (90) day anniversary of the Date of Termination (the “Equity Award Period”). In the event a Change in Control has not been consummated by end of the Equity Award Period, then the unvested portion of Executive’s equity awards shall terminate immediately without further action as of such date. For avoidance of doubt, any unvested time based service vesting conditions for any performance- vesting award shall be deemed satisfied and vested on the Termination Date.

5.Certain Reductions. Notwithstanding anything herein to the contrary, the Company shall reduce Executive’s severance benefits under this Agreement, in whole or in part, by any other severance benefits, pay in lieu of notice, or other similar benefits payable to Executive by the Company in connection with Executive’s termination, including but not limited to payments or benefits pursuant to (a) any applicable legal requirement, including, without limitation, the Worker Adjustment and Retraining Notification Act, or (b) any other Company agreement, arrangement, policy or practice relating to Executive’s termination of employment with the Company (but, for the avoidance of doubt, excluding any cash bonus payable to Executive under Section 4(c)(ii) of the Employment Agreement upon a Change in Control); provided, however, that nothing in this Section shall cause Executive to receive severance benefits in the aggregate that are less than the payments and benefits set forth in Sections 3 or 4 hereof, as applicable. The benefits provided under this Agreement are intended to satisfy, to the greatest extent possible, any and all statutory obligations that may arise out of Executive’s termination of employment. Such reductions shall be applied on a retroactive basis, with severance benefits paid first in time being recharacterized as payments pursuant to the Company’s statutory obligation.

6.Deemed Resignation. Upon termination of Executive’s service for any reason, Executive shall be deemed to have resigned from all offices and directorships, if any, then held with the Company or any of its affiliates, and, at the Company’s request, Executive shall execute such documents as are necessary or desirable to effectuate such resignations.

7.Other Terminations. If Executive’s employment with the Company terminates for any reason other than due to a Covered Termination, then Executive shall not be entitled to any benefits hereunder other than accrued but unpaid salary, vacation and expense reimbursements through the Termination Date in accordance with applicable law and to elect any continued healthcare coverage as may be required under COBRA or similar state law.

8.Limitation on Payments. Notwithstanding anything in this Agreement to the contrary, if any payment or distribution Executive would receive pursuant to this Agreement or otherwise (“Payment”) would (a) constitute a “parachute payment” within the meaning of Section 280G of the
4


Code and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall either be (i) delivered in full, or (ii) delivered as to such lesser extent which would result in no portion of such Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the largest payment, notwithstanding that all or some portion the Payment may be taxable under Section 4999 of the Code. The Company will select an adviser (which is not providing any services to the Company’s acquirer) with experience in performing calculations regarding the applicability of Section 280G of the Code and the Excise Tax, provided, that the adviser’s determination shall be made based upon “substantial authority” within the meaning of Section 6662 of the Code to perform the foregoing calculations. The Company shall bear all expenses with respect to the determinations by such adviser required to be made hereunder. The adviser shall provide its calculations to the Company and Executive within fifteen (15) calendar days after the date on which Executive’s right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company. Any good faith determinations of the adviser made hereunder shall be final, binding and conclusive upon the Company and Executive. Any reduction in payments or benefits pursuant to this Section 8 will occur in the following order: (1) reduction of cash payments; (2) cancellation of accelerated vesting of equity awards other than stock options; (3) cancellation of accelerated vesting of stock options; and (4) reduction of other benefits payable to Executive.

9.Definitions. The following terms used in this Agreement shall have the following meanings:

(a)“Cause” means the occurrence of any of the following: (i) Executive’s commission of any felony or other crime, in each case involving moral turpitude; (ii) Executive’s commission of any other act or omission involving fraud or intentional deceit with respect to the Company or any of its affiliates; (iii) any act or omission by Executive involving dishonesty that causes material injury to the Company or any of its affiliates; (iv) willful misconduct by Executive with respect to the Company or any of its subsidiaries; (v) any material breach of a fiduciary duty owed by Executive to the Company or its stockholders or Executive’s material contractual breach of this Agreement or any other agreement referred to herein (including the Confidential Information Agreement); or (vi) Executive’s willful continued failure to perform assigned duties consistent with his position after receiving written notification of the failure from the Company (and provided that the mere failure to attain performance objectives shall not constitute Cause). The determination that a termination of Executive’s employment is either for Cause or without Cause shall be made by the Board, in its reasonable good faith judgment. The Board shall provide Executive with written notice detailing the basis for the termination of employment for Cause. If the basis for Cause is curable, during the 30 day period after Executive has received such notice, Executive shall have an opportunity to cure or remedy such alleged Cause events and to present his case to the full Board (with the assistance of his own counsel).

(b)“Change in Control” has the meaning ascribed to such term under the Company’s 2020 Incentive Award Plan, as amended; provided, that such transaction must also constitute a “change in control event” within the meaning of Treasury Regulation Section 1.409A- 3(i)(5).
5


(c)“Change in Control Period” means the period of time commencing ninety (90) days prior to the closing of a Change in Control and ending on the twelve (12) month anniversary of the closing such Change in Control.

(d)“Covered Termination” means the termination of Executive’s employment by the Company other than for Cause or by Executive for Good Reason, in each case that, to the extent necessary, constitutes a Separation from Service.

(e)“Good Reason” shall mean that Executive has complied in all material respects with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events, without Executive’s prior written consent: (i) a material reduction of Executive’s annual base salary or annual target bonus amount (unless pursuant to a salary reduction program applicable generally to the Company’s senior management employees); (ii) a material reduction in Executive’s title, role or responsibilities or reporting relationship; (iii) relocation of Executive’s principal place of employment to a place greater than 50 miles from Executive’s then-current principal place of employment; or (iv) any material breach by the Company of any agreement with Executive.

(f)“Good Reason Process” shall mean that (i) Executive has reasonably determined in good faith that a “Good Reason” condition has occurred; (ii) Executive has notified the Company in writing of the first occurrence of the Good Reason condition within sixty (60) days of the first time the Executive becomes aware of the occurrence of such condition; (iii) Executive has cooperated in good faith with the Company’s efforts, for a period of thirty (30) days immediately following the Company’s receipt of such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) Executive terminates Executive’s employment with the Company within thirty (30) days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

(g)“Separation from Service” means a “separation from service” with the Company within the meaning of Section 409A of the Code and the Department of Treasury regulations and other guidance promulgated thereunder.

(h)“Termination Date” means the date on which Executive experiences a Covered
Termination.

10.Successors.

(a)Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business or assets which executes and delivers the assumption agreement described in this Section 10(a) or which becomes bound by the terms of this Agreement by operation of law.
6


(b)Executive’s Successors. The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

11.Notices. Any notices provided hereunder must be in writing and shall be deemed effective upon the earlier of personal delivery (including personal delivery by facsimile), delivery by email or the third day after mailing by first class mail, to the Company at its primary office location and to Executive at Executive’s address as listed in the Company’s books and records.

12.Confidentiality; Non-Disparagement.

(a)Confidentiality. Executive hereby expressly confirms Executive’s continuing obligations to the Company pursuant to that certain confidentiality agreement by and between the Company and Executive (the “Confidential Information Agreement”).

(b)Non-Disparagement. Executive agrees that Executive shall not disparage, criticize or defame the Company, its affiliates and their respective affiliates, directors, officers, agents, partners, stockholders or employees, either publicly or privately. Similarly, the Company agrees that it shall instruct its officers and directors to not disparage, criticize or defame Executive, either publicly or privately. Nothing in this Section 12(b) shall apply to any evidence or testimony required by any court, arbitrator or government agency.

(c)Whistleblower Protections and Trade Secrets. Notwithstanding anything to the contrary contained herein, nothing in this Agreement or the Confidentiality Agreement prohibits Executive from reporting possible violations of federal law or regulation to any United States governmental agency or entity in accordance with the provisions of and rules promulgated under Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or regulation (including the right to receive an award for information provided to any such government agencies). Furthermore, in accordance with 18 U.S.C. § 1833, notwithstanding anything to the contrary in this Agreement: (i) Executive shall not be in breach of this Agreement, and shall not be held criminally or civilly liable under any federal or state trade secret law (A) for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (B) for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney, and may use the trade secret information in the court proceeding, if Executive files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order.

13.Dispute Resolution. Unless otherwise prohibited by law or specified below, all disputes, claims and causes of action, in law or equity, arising from or relating to this Agreement or to Executive’s employment or the termination thereof shall be resolved solely and exclusively by the terms of Section 8(g) in the employment agreement, dated March 8, 2022, entered into by and between the Company and Executive (“Employment Agreement”).
7


14.Miscellaneous Provisions.

(a)Section 409A.

(i)Separation from Service. Notwithstanding any provision to the contrary in this Agreement, no amount constituting deferred compensation subject to Section 409A of the Code shall be payable pursuant to Sections 3 or 4 above unless Executive’s termination of employment constitutes a Separation from Service.

(ii)Specified Employee. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed at the time of his Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (A) the expiration of the six-month period measured from the date of Executive’s Separation from Service or (B) the date of Executive’s death. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 14(a)(ii) shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise provided herein.

(iii)Expense Reimbursements. To the extent that any reimbursements payable pursuant to this Agreement are subject to the provisions of Section 409A of the Code, any such reimbursements payable to Executive pursuant to this Agreement shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

(iv)Installments. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment.

(v)Release. Notwithstanding anything to the contrary in this Agreement, to the extent that any payments due under this Agreement as a result of Executive’s termination of employment are subject to Executive’s execution and delivery of a Release of Claims (the form of which is attached hereto), (A) the Company shall deliver the Release of Claims to Executive within ten business days following Executive’s Termination Date, and the Company’s failure to deliver a Release of Claims prior to the expiration of such ten business day period shall constitute a waiver of any requirement to execute a Release of Claims, (B) if Executive fails to execute the Release of Claims on or prior to the Release Expiration Date (as defined below) or timely revokes Executive’s acceptance of the Release of Claims thereafter, Executive shall not be entitled to any payments or benefits otherwise conditioned on the Release of Claims, and (C) in any case where Executive’s Termination Date and the Release Expiration Date fall in two separate taxable years, any payments required to be
8


made to Executive that are conditioned on the Release of Claims and are treated as nonqualified deferred compensation for purposes of Section 409A of the Code shall be made in the later taxable year. For purposes hereof, “Release Expiration Date” shall mean (1) if Executive is under 40 years old as of the Termination Date, the date that is seven (7) days following the date upon which the Company timely delivers the Release of Claims to Executive, or such shorter time prescribed by the Company, and (2) if Executive is 40 years or older as of the Termination Date, the date that is twenty one (21) days following the date upon which the Company timely delivers the Release of Claims to Executive, or, if Executive’s termination of employment is “in connection with an exit incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967), the date that is forty five (45) days following such delivery date. To the extent that any payments of nonqualified deferred compensation (within the meaning of Section 409A) due under this Agreement as a result of Executive’s termination of employment are delayed pursuant to this Section 14(a)(v), such amounts shall be paid in a lump sum on the first payroll date following the date that Executive executes and does not revoke the Release of Claims (and the applicable revocation period has expired) or, in the case of any payments subject to Section 14(a)(v)(C), on the first payroll date to occur in the subsequent taxable year, if later.

(b)Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local, or foreign withholding or other taxes or charges which the Company is required to withhold.

(c)Waiver. No provision of this Agreement shall be modified, waived or dis- charged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized member of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

(d)Whole Agreement. This Agreement, the Employment Agreement and the Confidential Information Agreement represent the entire understanding of the parties hereto with respect to the subject matter hereof and supersede all prior promises, arrangements and understandings regarding the same, whether written or unwritten. This Agreement may not be amended or terminated except in a written agreement (which expressly references this section) signed by the Company and Executive.

(e)Choice of Law. All questions concerning the construction, validity and interpretation of this Agreement will be governed by the laws of the State of California without regard to its conflicts of law provisions.

(f)Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid or unenforceable provisions had never been contained herein.
9


(g)Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.

(h)Executive Acknowledgement. Executive acknowledges that (i) Executive has consulted with or has had the opportunity to consult with independent counsel of Executive’s own choice concerning this Agreement, and has been advised to do so by the Company, and (ii) that Executive has read and understands the Agreement, is fully aware of its legal effect, and has entered into it freely based on Executive’s own judgment.

(Signature page follows)
10

BERKELEY LIGHTS, INC.
By:/s/ Gregory T. Lucier
Title:Chairman of the Board
Date:March 8, 2022
EXECUTIVE
By:/s/ Siddhartha Kadia, PhD
Date:March 8, 2022





ATTACHMENT

FORM OF RELEASE OF CLAIMS


GENERAL RELEASE OF CLAIMS1

This General Release of Claims (“Release”) is entered into as of    , 20 , between Siddhartha Kadia, PhD (“Executive”) and Berkeley Lights, Inc. (the “Company”) (collectively referred to herein as the “Parties”), effective eight days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Release as provided in Paragraph 2(d), below. This Agreement is being executed in connection with the terms of the Change in Control and Severance Agreement by and between the Parties dated as of March 8, 2022 (the “Severance Agreement”), which is incorporated herein by reference.

1.Termination of Employment. The Parties hereby acknowledge and agree that Executive’s employment, including his service in all positions that Executive held as an officer of the Company and as a member of the Company’s board of directors, ended effective as of [    ] (the “Termination Date”). The Parties acknowledge and agree that Executive is entitled to receive, and has received, payment of an amount equal to all accrued wages (including base salary and bonus compensation) earned through the Termination Date, including accrued vacation and any earned but unpaid annual performance bonus from the calendar year prior to the Termination Date, less applicable withholding, as well as reimbursement for all expenses incurred by Executive on behalf of the Company, which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documenting such expenses.

2.Executive’s Release of the Company. Executive understands that by agreeing to this Release, Executive is agreeing not to sue, or otherwise file any claim against, the Company or any of its employees or other agents for any reason whatsoever based on anything that has occurred as of the date Executive signs this Release.

(a)On behalf of Executive and Executive’s heirs and assigns, Executive hereby releases and forever discharges the “Releasees” hereunder, consisting of the Company, and each of its owners, affiliates, divisions, predecessors, successors, assigns, agents, directors, officers, partners, employees, and insurers, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, loss, cost or expense, of any nature whatsoever, known or unknown, fixed or contingent (hereinafter called “Claims”), which Executive now has or may hereafter have against the Releasees, or any of them, by reason of any matter, cause, or thing whatsoever from the beginning of time to the date hereof, including, without limiting the generality of the foregoing, any Claims arising out of, based upon, or relating to Executive’s hire, employment, remuneration or resignation by the Releasees, or any of them, including Claims arising under federal, state, or local laws relating to employment, Claims of any kind that may be brought in any court or administrative agency, any Claims arising under the Age Discrimination in Employment Act (“ADEA”), 29 U.S.C. § 621, et seq.; Title VII of the Civil Rights Act of 1964, as amended by the Civil Rights Act of 1991, 42 U.S.C. § 2000 et seq.; the Equal Pay Act, 29 U.S.C. § 206(d); the Civil Rights Act of 1866, 42 U.S.C. § 1981; the Family and Medical Leave Act of 1993, 29 U.S.C. § 2601 et seq.; the Americans with Disabilities Act of 1990, 42 U.S.C. § 12101 et seq.; the False Claims Act , 31 U.S.C. § 3729 et seq.; the Employee Retirement Income Security Act, 29 U.S.C. § 1001 et seq.; the Worker Adjustment and Retraining Notification Act, 29 U.S.C. § 2101 et seq.; the Fair Labor Standards Act, 29 U.S.C. § 215 et seq.; the Sarbanes-Oxley Act of 2002; the California Fair

1 NTD: To be updated for any changes in applicable law.
1

Employment and Housing Act, as amended, Cal. Lab. Code § 12940 et seq.; the California Equal Pay Law, as amended, Cal. Lab. Code §§ 1197.5(a),199.5; the Moore-Brown-Roberti Family Rights Act of 1991, as amended, Cal. Gov’t Code §§12945.2, 19702.3; California Labor Code §§ 1101, 1102; the California WARN Act, California Labor Code §§ 1400 et. seq; California Labor Code §§ 1102.5(a),(b); claims for wages under the California Labor Code and any other federal, state or local laws of similar effect; the employment and civil rights laws of California; Claims any other local, state or federal law governing employment; Claims for breach of contract; Claims arising in tort, including, without limitation, Claims of wrongful dismissal or discharge, discrimination, harassment, retaliation, fraud, misrepresentation, defamation, libel, infliction of emotional distress, violation of public policy, and/or breach of the implied covenant of good faith and fair dealing; and Claims for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney’s fees.

(b)Notwithstanding the generality of the foregoing, Executive does not release the following claims:

(i)Claims to enforce this Release;

(ii)Claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law;

(iii)Claims for workers’ compensation insurance benefits under the terms of any worker’s compensation insurance policy or fund of the Company;

(iv)Claims to continued participation in certain of the Company’s group benefit plans pursuant to the terms and conditions of COBRA;

(v)Claims to any benefit entitlements vested as the date of Executive’s employment termination, pursuant to written terms of any Company employee benefit plan;

(vi)Claims for indemnification under indemnification under the Company’s governing documents or any applicable law, and under the terms of any policy of insurance purchased by the Company;

(vii)Claims for the severance benefits Executive is entitled to receive in exchange for this Release under Section [3/4] of the Severance Agreement, including any current or future claims for vesting, acceleration of vesting, or any claims Executive may have as a stockholder of the Company; and

(viii)Executive’s right to bring to the attention of the Equal Employment Opportunity Commission claims of discrimination; provided, however, that Executive does release Executive’s right to secure any damages for alleged discriminatory treatment.

(c)EXECUTIVE ACKNOWLEDGES THAT EXECUTIVE HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS:

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST
2

IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”

BEING AWARE OF SAID CODE SECTION, EXECUTIVE HEREBY EXPRESSLY WAIVES ANY RIGHTS EXECUTIVE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.

(d)In accordance with the Older Workers Benefit Protection Act of 1990, Executive has been advised of the following:

(i)This section and this Release are written in a manner calculated to be understood by Executive;

(ii)Executive has the right to consult with an attorney before signing this Release;

(iii)Executive has been given at least [twenty-one (21)] days to consider this Release;

(iv)Executive has seven (7) days after signing this Release to revoke it, and Executive will not receive the severance benefits provided in Section [3/4] of the Severance Agreement unless and until such seven (7) day period has expired. If Executive wishes to revoke this Release, Executive must deliver notice of Executive’s revocation in writing, no later than 11:59 p.m. Pacific Time on the 7th day following Executive’s execution of this Release to [    ].

3.Executive Representations. Executive represents and warrants that:

(a)Executive has returned to the Company Property (as defined in that certain Employment Agreement by and between the Parties dated as of March 8, 2022 (the “Employment Agreement”)) which he had in his possession, custody or control at the time he signed this Release;

(b)Except as set forth herein or in any related agreement, Executive is not aware of any owed wages, commissions, bonuses or other compensation, other than wages through the date of the termination of Executive’s employment, any accrued, unused vacation earned through such date, and any severance payments that become due under the Employment Agreement;

(c)During the course of Executive’s employment Executive did not sustain any injuries for which Executive might be entitled to compensation pursuant to worker’s compensation law or Executive has disclosed any injuries of which he is currently, reasonably aware for which he might be entitled to compensation pursuant to worker’s compensation law; and

(d)Executive has not initiated any adversarial proceedings of any kind against the Company or against any other person or entity released herein, nor will Executive do so in the future, except as specifically allowed by this Release.
3

4.Maintaining Confidential Information. Executive reaffirms his obligations under that certain proprietary information and inventions assignment agreement entered into between Executive and the Company (the “Confidentiality Agreement”). Executive acknowledges and agrees that the severance benefits provided in the Severance Agreement shall be subject to Executive’s continued compliance with Executive’s obligations under the Confidentiality Agreement.

5.Non-Disparagement. Executive and the Company reaffirm their non-disparagement obligation under Section 12(b) of the Severance Agreement.

6.Cooperation. Executive reaffirms his ongoing cooperation covenant set forth in Section 5(b)(i) of the Employment Agreement.

7.SEC Reporting. Executive acknowledges that to the extent required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Executive will have continuing obligations under Section 16(a) and 16(b) of the Exchange Act to report matching transactions, and the Company acknowledges it will file on behalf of the Executive in accordance with current practice if notified by Executive, if any, in Company common stock for six (6) months following the Transition Date. Executive further acknowledges that any transactions by Executive involving Company securities will remain subject to securities laws in all respects, including, without limitation, laws regarding trading on the basis of material nonpublic information.

8.Severability. The provisions of this Release are severable. If any provision is held to be invalid or unenforceable, it shall not affect the validity or enforceability of any other provision.

9.Choice of Law. This Release shall in all respects be governed and construed in accordance with the laws of the State of California, including all matters of construction, validity and performance, without regard to conflicts of law principles.

10.Integration Clause. This Release and the severance benefits under the Severance Agreement contain the Parties’ entire agreement with regard to the separation of Executive’s employment, and supersede and replace any prior agreements as to those matters, whether oral or written, except for the Confidentiality Agreement, the Employment Agreement and any equity award agreements. This Release may not be changed or modified, in whole or in part, except by an instrument in writing signed by Executive and a duly authorized officer or director of the Company.

11.Execution in Counterparts. This Release may be executed in counterparts with the same force and effectiveness as though executed in a single document. Facsimile signatures shall have the same force and effectiveness as original signatures.

12.Intent to be Bound. The Parties have carefully read this Release in its entirety; fully understand and agree to its terms and provisions; and intend and agree that it is final and binding on all Parties.
4

IN WITNESS WHEREOF, and intending to be legally bound, the Parties have executed the foregoing on the dates shown below.




EXECUTIVEBERKELEY LIGHTS, INC.
By:
Siddhartha Kadia, PhDTitle
Date:Date:






5
 EX-31.1 5 ex-311blix20220331x10q.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Siddhartha Kadia, certify that:
(1)I have reviewed this Quarterly Report on Form 10-Q of Berkeley Lights, Inc.,
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the periods presented in this report;
(4)The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
(5)The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


May 9, 2022By:/s/ SIDDHARTHA KADIA
Name:Siddhartha Kadia, Ph.D.
Title:
Chief Executive Officer

 EX-31.2 6 ex-312blix20220331x10q.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Paul McClaskey, certify that:
(1)I have reviewed this Quarterly Report on Form 10-Q of Berkeley Lights, Inc.,
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the periods presented in this report;
(4)The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
(5)The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


May 9, 2022By:/s/ J. PAUL MCCLASKEY
Name:J. Paul McClaskey
Title:Chief Accounting Officer
(Principal Financial Officer)

 EX-32.1 7 ex-321blix20220331x10q.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Berkeley Lights, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 9, 2022By:/s/ SIDDHARTHA KADIA
Name:Siddhartha Kadia, Ph.D.
Title:
Chief Executive Officer
(Principal Executive Officer)


 EX-32.2 8 ex-322blix20220331x10q.htm EX-32.2 Document

EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Berkeley Lights, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 9, 2022By:/s/ J. PAUL MCCLASKEY
Name:J. Paul McClaskey
Title:Chief Accounting Officer
(Principal Financial Officer)

 EX-101.SCH 9 bli-20220331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - The Company and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - The Company and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - The Company and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2104102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2105103 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 2107104 - Disclosure - Revenue From Contracts With Customers link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Revenue From Contracts With Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Revenue from Contracts with Customer (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Revenue from Contracts with Customer (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details) link:presentationLink link:calculationLink link:definitionLink 2113105 - Disclosure - Balance Sheet Accounts link:presentationLink link:calculationLink link:definitionLink 2314302 - Disclosure - Balance Sheet Accounts (Tables) link:presentationLink link:calculationLink link:definitionLink 2415407 - Disclosure - Balance Sheet Accounts (Inventory) (Details) link:presentationLink link:calculationLink link:definitionLink 2416408 - Disclosure - Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2118106 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2319303 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Fair Value of Financial Instruments (Assets and Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 2122107 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 2323304 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2424412 - Disclosure - Property and Equipment, net (Schedule of Property and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - Property and Equipment, net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2126108 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2327305 - Disclosure - Leases (Table) link:presentationLink link:calculationLink link:definitionLink 2428414 - Disclosure - Leases (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2429415 - Disclosure - Leases (Maturity Schedule of Operating Lease Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2429415 - Disclosure - Leases (Maturity Schedule of Operating Lease Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2430416 - Disclosure - Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2431417 - Disclosure - Leases (Schedule of Additional Information Related to Operating Leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2132109 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 2333306 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 2434418 - Disclosure - Notes Payable (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2435419 - Disclosure - Notes Payable (Schedule of Payment Due on Notes Payable) (Details) link:presentationLink link:calculationLink link:definitionLink 2435419 - Disclosure - Notes Payable (Schedule of Payment Due on Notes Payable) (Details) link:presentationLink link:calculationLink link:definitionLink 2136110 - Disclosure - Stock Compensation Plans link:presentationLink link:calculationLink link:definitionLink 2337307 - Disclosure - Stock Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2438420 - Disclosure - Stock Compensation Plans (Stock-Based Compensation) (Details) link:presentationLink link:calculationLink link:definitionLink 2439421 - Disclosure - Stock Compensation Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2140111 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2441422 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2142112 - Disclosure - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2343308 - Disclosure - Statements of Cash Flows (Tables) link:presentationLink link:calculationLink link:definitionLink 2444423 - Disclosure - Statements of Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 2145113 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 2346309 - Disclosure - Commitment and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2447424 - Disclosure - Commitment and Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2448425 - Disclosure - Commitment and Contingencies (Product Warranty) (Details) link:presentationLink link:calculationLink link:definitionLink 2149114 - Disclosure - Net Loss Attributable to Common Stockholders Per Share link:presentationLink link:calculationLink link:definitionLink 2350310 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2451426 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2452427 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 2153115 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 2354311 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 2455428 - Disclosure - Segments (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 bli-20220331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 bli-20220331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 bli-20220331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Thereafter Lessee, Operating Lease Liability, Payments Due After Year Four Lessee, Operating Lease Liability, Payments Due After Year Four Customer [Domain] Customer [Domain] Leasehold improvements Leasehold Improvements [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net loss and comprehensive loss Net loss Net loss attributable to common stockholders, basic and diluted Net Income (Loss) Attributable to Parent Customer Three Customer Three [Member] Customer Three Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Risks and Uncertainties [Abstract] Accrued payroll and employee related expenses Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Interest payments, loan discounts and financing costs Long-term Debt, Interest Payable, Loan Discounts and Financing Cost Long-term Debt, Interest Payable, Loan Discounts and Financing Cost Revenue from Contract with Customer [Abstract] Schedule of receivables, contract assets and deferred revenue from contracts with customers Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Agricultural biology Agricultural Biology [Member] Agricultural Biology Other assets Other Assets, Noncurrent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Net decrease in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number 2024 Long-Term Debt, Maturity, Year Two Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Customer One Customer One [Member] Customer One Remainder of 2022 Long-Term Debt, Maturity, Remainder of Fiscal Year Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Organization, Consolidation and Presentation of Financial Statements [Abstract] Loss on disposal and impairment of property and equipment Impairment of Long-Lived Assets to be Disposed of Antidilutive securities excluded from the calculation of net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Schedule of inventory Schedule of Inventory, Current [Table Text Block] Research and development Research and Development Expense [Member] Building Building [Member] Counter claims filed Loss Contingency, Counter Claims Filed, Number Loss Contingency, Counter Claims Filed, Number Distributor channel Sales Channel, Through Intermediary [Member] Title of Individual [Domain] Title of Individual [Domain] Term Loan Term Loan [Member] Term Loan Award Type [Domain] Award Type [Domain] Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Notes payable Notes Payable, Noncurrent Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] Assets Assets [Abstract] 2025 Long-Term Debt, Maturity, Year Three Antibody therapeutics Antibody Therapeutics [Member] Antibody Therapeutics RSUs granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Concentration risk percentage Concentration Risk, Percentage Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Accumulated Deficit Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] Prepaid expenses, other current assets and other assets Increase (Decrease) in Prepaid Expense and Other Assets Settlement of pre-existing warranties Standard Product Warranty Accrual, Decrease for Payments Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Less: unearned income Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount Trade accounts receivable Increase (Decrease) in Accounts Receivable Type of Sales Channel Contract with Customer, Sales Channel [Axis] Right-of-use assets obtained for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Commitments and Contingencies Disclosure [Abstract] Prime Rate Prime Rate [Member] Number of operating segments Number of Operating Segments Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Net loss attributable to common stockholders per share, basic (in dollars per share) Earnings Per Share, Basic Rent expense Operating Lease, Expense 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Revenue From Contracts With Customers Revenue from Contract with Customer [Text Block] Cell therapy Cell Therapy [Member] Cell Therapy 2023 Long-Term Debt, Maturity, Year One Interest cost Interest Expense, Debt Measurement Basis [Domain] Fair Value Measurement [Domain] Interest-only period Debt Instrument, Interest-Only Period Debt Instrument, Interest-Only Period Change in accounts payable and accrued liabilities related to purchases of property and equipment Noncash Increase (Decrease) In Accounts Payable And Accrued Liabilities Related to Purchase Of Fixed Assets Noncash Increase (Decrease) In Accounts Payable And Accrued Liabilities Related to Purchase Of Fixed Assets Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Total payments due Long-term Debt, Gross Remainder of 2022 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Remainder of Fiscal Year Total Assets, Fair Value Disclosure Case management order, maximum number of patents allegedly infringed Loss Contingency, Case Management Order, Maximum Patents Allegedly Infringed, Number Loss Contingency, Case Management Order, Maximum Patents Allegedly Infringed, Number Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Denominator Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Provision for new warranties Standard Product Warranty Accrual, Increase for Warranties Issued Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Total liabilities and stockholders’ equity Liabilities and Equity Other Other Accrued Liabilities, Current Deferred revenue Deferred revenue (current) Contract with Customer, Liability, Current Service Service [Member] Additional paid-in capital Additional Paid in Capital Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Concentration Risk [Line Items] Concentration Risk [Line Items] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Accrued expenses and other current liabilities Total Accounts Payable and Accrued Liabilities, Current Net Loss Attributable to Common Stockholders Per Share Earnings Per Share [Text Block] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Operating expenses: Operating Expenses [Abstract] Entity Interactive Data Current Entity Interactive Data Current Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Minimum Minimum [Member] The Company and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Gross profit Gross Profit Amounts outstanding Long-term Line of Credit 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Case management order, maximum asserted patent claims per patent Loss Contingency, Case Management Order, Maximum Asserted Patent Claims Per Patent, Number Loss Contingency, Case Management Order, Maximum Asserted Patent Claims Per Patent, Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Address, State or Province Entity Address, State or Province Schedule of financial instruments not measured at fair value Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block] Current liabilities: Liabilities, Current [Abstract] Operating lease liabilities Increase (Decrease) in Operating Lease Liability General and administrative General and Administrative Expense Statements of Cash Flows Cash Flow, Supplemental Disclosures [Text Block] Notes Payable Debt Disclosure [Text Block] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Line of Credit Line of Credit [Member] Stock Compensation Plans Share-based Payment Arrangement [Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Accounting Policies [Abstract] Accrued legal expenses Accrued Professional Fees, Current Cost of sales: Cost of Revenue [Abstract] Present value of operating lease payments Operating Lease, Liability Schedule of disaggregation of revenue Revenue from External Customers by Products and Services [Table Text Block] Document Transition Report Document Transition Report Common stock, $0.00005 par value. Authorized 300,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding 67,820,115 and 67,595,535 shares at March 31, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Customer Customer Concentration Risk [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] PSO Performance Shares [Member] Commitments and contingencies (Note 13) Commitments and Contingencies Leases Lessee, Operating Leases [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Provision for excess and obsolete inventory Inventory Write-down Remainder of 2022 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Product warranty, term Product Warranty, Duration Product Warranty, Duration Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Cover [Abstract] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Summary of revenue by geographic areas Revenue from External Customers by Geographic Areas [Table Text Block] EWB Loan EWB Loan [Member] EWB Loan Less: implied interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current AbCellera, Non-Infringement AbCellera, Non-Infringement [Member] AbCellera, Non-Infringement Total revenue Net revenues Revenue from Contract with Customer, Excluding Assessed Tax Finished goods Inventory, Finished Goods, Net of Reserves Stock options Options to purchase common stock Share-based Payment Arrangement, Option [Member] Carrying Value Reported Value Measurement [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Document Quarterly Report Document Quarterly Report Common Stock Common Stock [Member] Variable Rate [Axis] Variable Rate [Axis] Changes in operating assets and liabilities: Increase (Decrease) In Operating Assets And Liabilities [Abstract] Increase (Decrease) In Operating Assets And Liabilities Segments Segment Reporting Disclosure [Text Block] Loss from operations Operating Income (Loss) Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Lease liability – short-term Less: current portion Operating Lease, Liability, Current Gene therapy Gene Therapy [Member] Gene Therapy Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Stock-based compensation Share-based Payment Arrangement, Noncash Expense Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Numerator Earnings Per Share, Numerator [Abstract] Earnings Per Share, Numerator Depreciation Depreciation Direct sales channel Sales Channel, Directly to Consumer [Member] Contract assets, long-term, which are included in “Other assets” Contract with Customer, Asset, Allowance for Credit Loss, Noncurrent Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Schedule of product warranty liability Schedule of Product Warranty Liability [Table Text Block] Operating lease, current [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other income, net Other Nonoperating Income (Expense) Long-term debt, including current maturities Long-term Debt, Fair Value Prepaid insurance Prepaid Insurance Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Total liabilities Liabilities Raw materials Inventory, Raw Materials, Net of Reserves Schedule of accrued expenses and other current liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Schedule of operating lease liabilities maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Common stock issued (in shares) Common Stock, Shares, Issued City Area Code City Area Code Accrued expenses and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Schedule of cash flow, supplemental disclosures Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Entity Address, City or Town Entity Address, City or Town Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Lease liability, long-term Total long-term operating lease liabilities Operating Lease, Liability, Noncurrent 2023 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One Interest expense Interest Expense Variable lease payments Variable Lease, Payment Accumulated deficit Retained Earnings (Accumulated Deficit) Lease term Lessee, Operating Lease, Term of Contract Litigation Case [Domain] Litigation Case [Domain] Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period RSU Restricted stock units Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Income Statement [Abstract] Concentration Risk [Table] Concentration Risk [Table] Fair Value Estimate of Fair Value Measurement [Member] Entity Registrant Name Entity Registrant Name Proceeds from issuance of common stock upon exercise of stock options Proceeds from Stock Options Exercised AbCellera And UBC AbCellera And UBC [Member] AbCellera And UBC Provision for income taxes Income Tax Expense (Benefit) Trade accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Asia Pacific Asia Pacific [Member] Adjustments to existing warranties Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Equity Components [Axis] Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Stock price goal multiplier of share price on date of grant Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Price Multiplier Of Date Of Grant Share Price Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Price Multiplier Of Date Of Grant Share Price Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Sales and marketing Selling and Marketing Expense [Member] Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accounts Receivable Accounts Receivable [Member] Inventory Total Inventory, Net Goods and services transferred over time Transferred over Time [Member] Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Statement of Financial Position [Abstract] Current portion, less loan discounts and financing costs Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Chief Executive Officer Chief Executive Officer [Member] Equity Component [Domain] Equity Component [Domain] Sales and marketing Selling and Marketing Expense 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Notes Payable Notes Payable to Banks [Member] Statement [Line Items] Statement [Line Items] Litigation Case [Axis] Litigation Case [Axis] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Restricted cash Restricted Cash, Noncurrent 2024 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Total amounts due from customers, gross Sales-type and Direct Financing Leases, Lease Receivable 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Debt Disclosure [Abstract] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Deferred revenue, net of current portion Deferred revenue (non-current) Contract with Customer, Liability, Noncurrent Segment Reporting [Abstract] Total undiscounted cash flows Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received Customer [Axis] Customer [Axis] Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Schedule of basic and diluted earnings per common share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Schedule of stock-based compensation Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Title of 12(b) Security Title of 12(b) Security Proceeds from issuance of common stock under employee stock purchase plan Proceeds from Issuance of Common Stock Total assets Assets Common stock authorized (in shares) Common Stock, Shares Authorized Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Net loss attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Title of Individual [Axis] Title of Individual [Axis] Document Type Document Type Less: tenant improvement allowances receivable Lessee, Operating Lease, Tenant Improvement Allowance Lessee, Operating Lease, Tenant Improvement Allowance Research and development Research and Development Expense Product and Service [Domain] Product and Service [Domain] Balance Sheet Accounts Supplemental Balance Sheet Disclosures [Text Block] Interest rate Debt Instrument, Interest Rate, Stated Percentage Contract liability , revenue recognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Revolving Credit Facility Revolving Credit Facility [Member] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Remaining performance obligation, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Furniture, fixtures and other Furniture and Fixtures [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Schedule of supplemental cash flow information related to operating leases and additional information Lease, Cost [Table Text Block] Geographical [Axis] Geographical [Axis] Weighted-average shares used in calculating net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net loss attributable to common stockholders per share, diluted (in dollars per share) Earnings Per Share, Diluted Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Customer Two Customer Two [Member] Customer Two Product Product [Member] Net loss and comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Contract liabilities Contract with Customer, Liability Customer Four Customer Four [Member] Customer Four Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Interest-only period with extensions Debt Instrument, Interest-Only Period With Extension Debt Instrument, Interest-Only Period With Extension Schedule of financial assets measured at fair value Fair Value, Assets Measured on Recurring Basis [Table Text Block] Inventory Increase (Decrease) in Inventories Common stock outstanding (in shares) Common Stock, Shares, Outstanding Total cost of sales Cost of Goods and Services Sold Revenue: Revenues [Abstract] Document Period End Date Document Period End Date Vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Accrued product warranty Product Warranty Accrual, Current Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Non-cash interest and other expense related to debt and note receivable agreements Noncash Income (Expense) Related to Debt and Note Receivable Agreements Noncash Income (Expense) Related to Debt and Note Receivable Agreements Equipment, tooling and molds Equipment, Tooling And Molds [Member] Equipment, Tooling And Molds Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Note payable, term (in years) Debt Instrument, Term Non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Deferred costs Deferred Costs, Current Significant Risks and Uncertainties Including Business and Credit Concentrations Concentration Risk Disclosure [Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Property and Equipment, net Property, Plant and Equipment Disclosure [Text Block] Total operating expenses Operating Expenses Schedule of payments due on notes payable Schedule of Long-term Debt Instruments [Table Text Block] Interest income Interest Income, Deposits with Financial Institutions Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Earnings Per Share [Abstract] Total property and equipment Property, Plant and Equipment, Gross Revenue Revenue from Contract with Customer Benchmark [Member] Remaining performance obligation, percentage Revenue, Remaining Performance Obligation, Percentage AbCellera, Unfair Competition AbCellera, Unfair Competition [Member] AbCellera, Unfair Competition Loss contingency accrual Loss Contingency Accrual Notes payable Long-term Debt, Excluding Current Maturities Total stock-based compensation Share-based Payment Arrangement, Expense Europe Europe [Member] Entity Current Reporting Status Entity Current Reporting Status Net loss per share Earnings Per Share, Basic and Diluted [Abstract] Lease income Sales-type Lease, Lease Income Construction in process Construction in Progress [Member] Contract assets, which are included in “Prepaid expenses and other current assets” Contract asset Contract with Customer, Asset, after Allowance for Credit Loss, Current Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Current assets: Assets, Current [Abstract] Leases [Abstract] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Contract with Customer, Sales Channel [Domain] Contract with Customer, Sales Channel [Domain] Exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Weighted-average shares used in calculating net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Income Taxes Income Tax Disclosure [Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Basis spread Debt Instrument, Basis Spread on Variable Rate Goods and services transferred at a point in time Transferred at Point in Time [Member] Measurement Basis [Axis] Measurement Basis [Axis] Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Statement of Cash Flows [Abstract] Other income (expense): Nonoperating Income (Expense) [Abstract] Credit Facility [Axis] Credit Facility [Axis] Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Schedule of prepaid expenses and other current assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] General and administrative General and Administrative Expense [Member] Entity Shell Company Entity Shell Company Number of facilities Number Of Facilities Number Of Facilities Total current liabilities Liabilities, Current Schedule of sales-type lease maturity Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Trade accounts payable Accounts Payable, Trade, Current Loss Contingencies [Table] Loss Contingencies [Table] Current Fiscal Year End Date Current Fiscal Year End Date Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other Other Assets, Current Statement [Table] Statement [Table] Number of counts in amended complaint Loss Contingency, Amended Complaint, Number Of Claims Loss Contingency, Amended Complaint, Number Of Claims Vendor deposits Deposits Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] North America North America [Member] Shares vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Balance, beginning of period Balance, end of period Standard Product Warranty Accrual Cost of sales Cost of Sales [Member] Adjustments to reconcile net loss to cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Computer software and equipment Computer Equipment [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Synthetic biology Synthetic Biology [Member] Synthetic Biology Inventory transferred to property and equipment Property, Plant and Equipment, Gross, Period Increase (Decrease) EX-101.PRE 13 bli-20220331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 bli-20220331_g1.jpg begin 644 bli-20220331_g1.jpg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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - shares
 3 Months Ended
Mar. 31, 2022
Apr. 30, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2022  
Document Transition Report false  
Entity File Number 001-39388  
Entity Registrant Name Berkeley Lights, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 35-2415390  
Entity Address, Address Line One 5858 Horton Street, Suite 320  
Entity Address, City or Town Emeryville  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94608  
City Area Code 510  
Local Phone Number 858-2855  
Title of 12(b) Security Common stock, $0.00005 par value  
Trading Symbol BLI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   67,826,564
Entity Central Index Key 0001689657  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Amendment Flag false  

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 164,674 $ 178,096
Trade accounts receivable 17,721 25,942
Inventory 15,665 14,547
Prepaid expenses and other current assets 10,304 11,985
Total current assets 208,364 230,570
Restricted cash 270 270
Property and equipment, net 29,913 27,992
Operating lease right-of-use assets 25,325 26,060
Other assets 1,985 2,361
Total assets 265,857 287,253
Current liabilities:    
Trade accounts payable 8,015 8,198
Accrued expenses and other current liabilities 9,916 12,425
Deferred revenue 9,780 12,128
Total current liabilities 27,711 32,751
Notes payable 19,778 19,762
Deferred revenue, net of current portion 1,600 2,187
Lease liability, long-term 23,567 24,337
Total liabilities 72,656 79,037
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00005 par value. Authorized 300,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding 67,820,115 and 67,595,535 shares at March 31, 2022 and December 31, 2021, respectively 4 4
Additional paid-in capital 478,231 471,820
Accumulated deficit (285,034) (263,608)
Total stockholders’ equity 193,201 208,216
Total liabilities and stockholders’ equity $ 265,857 $ 287,253
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.00005 $ 0.00005
Common stock authorized (in shares) 300,000,000 300,000,000
Common stock issued (in shares) 67,820,115 67,595,535
Common stock outstanding (in shares) 67,820,115 67,595,535
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 20,206 $ 18,628
Cost of sales:    
Total cost of sales 6,379 6,177
Gross profit 13,827 12,451
Operating expenses:    
Research and development 17,573 13,027
General and administrative 11,716 8,967
Sales and marketing 5,811 5,606
Total operating expenses 35,100 27,600
Loss from operations (21,273) (15,149)
Other income (expense):    
Interest expense (224) (354)
Interest income 34 66
Other income, net 57 19
Loss before income taxes (21,406) (15,418)
Provision for income taxes 20 17
Net loss and comprehensive loss (21,426) (15,435)
Net loss and comprehensive loss $ (21,426) $ (15,435)
Net loss attributable to common stockholders per share, diluted (in dollars per share) $ (0.32) $ (0.24)
Net loss attributable to common stockholders per share, basic (in dollars per share) $ (0.32) $ (0.24)
Weighted-average shares used in calculating net loss per share, basic (in shares) 67,697,488 65,259,398
Weighted-average shares used in calculating net loss per share, diluted (in shares) 67,697,488 65,259,398
Product    
Revenue:    
Total revenue $ 9,774 $ 13,533
Cost of sales:    
Total cost of sales 2,695 3,703
Service    
Revenue:    
Total revenue 10,432 5,095
Cost of sales:    
Total cost of sales $ 3,684 $ 2,474
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   64,486,246    
Beginning balance at Dec. 31, 2020 $ 244,781 $ 3 $ 436,662 $ (191,884)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options (in shares)   1,778,130    
Exercise of stock options 6,362 $ 1 6,361  
Vesting of restricted stock units (in shares)   5,000    
Employee stock purchase plan (in shares)   115,360    
Employee stock purchase plan 2,157   2,157  
Stock-based compensation 4,501   4,501  
Net loss (15,435)     (15,435)
Ending balance (in shares) at Mar. 31, 2021   66,384,736    
Ending balance at Mar. 31, 2021 242,366 $ 4 449,681 (207,319)
Beginning balance (in shares) at Dec. 31, 2021   67,595,535    
Beginning balance at Dec. 31, 2021 208,216 $ 4 471,820 (263,608)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options (in shares)   81,654    
Exercise of stock options 412   412  
Vesting of restricted stock units (in shares)   27,580    
Employee stock purchase plan (in shares)   115,346    
Employee stock purchase plan 610   610  
Stock-based compensation 5,389   5,389  
Net loss (21,426)     (21,426)
Ending balance (in shares) at Mar. 31, 2022   67,820,115    
Ending balance at Mar. 31, 2022 $ 193,201 $ 4 $ 478,231 $ (285,034)
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (21,426) $ (15,435)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 1,944 1,345
Stock-based compensation 5,393 4,494
Amortization of operating lease right-of-use assets 735 495
Non-cash interest and other expense related to debt and note receivable agreements 16 18
Provision for excess and obsolete inventory 195 44
Loss on disposal and impairment of property and equipment 28 13
Changes in operating assets and liabilities:    
Trade accounts receivable 8,221 (3,493)
Inventory (1,317) (2,744)
Prepaid expenses, other current assets and other assets 2,057 (1,036)
Trade accounts payable 298 2,690
Deferred revenue (2,935) 3,039
Accrued expenses and other current liabilities (2,552) (429)
Operating lease liabilities (726) (361)
Net cash used in operating activities (10,069) (11,360)
Cash flows from investing activities:    
Purchase of property and equipment (4,375) (402)
Net cash used in investing activities (4,375) (402)
Cash flows from financing activities:    
Proceeds from issuance of common stock upon exercise of stock options 412 6,362
Proceeds from issuance of common stock under employee stock purchase plan 610 2,157
Net cash provided by financing activities 1,022 8,519
Net decrease in cash and cash equivalents and restricted cash (13,422) (3,243)
Cash and cash equivalents and restricted cash at beginning of period 178,366 233,678
Cash and cash equivalents and restricted cash at end of period $ 164,944 $ 230,435
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.1
The Company and Basis of Presentation
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
The Company and Basis of Presentation The Company and Basis of Presentation
Description of Business
Berkeley Lights, Inc. (the “Company” or “Berkeley Lights”) is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights’ platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including the Company’s OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software.
Berkeley Lights and its consolidated subsidiaries are hereinafter referred to as the “Company”. The Company’s headquarters are in Emeryville, California.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.
Liquidity
The Company has experienced losses from its operations since its inception and has relied primarily on equity and debt financing to fund its operations to date. For the three months ended March 31, 2022, the Company had a consolidated net loss of $21.4 million and as of March 31, 2022 had an accumulated deficit of $285.0 million and unrestricted cash and cash equivalents of $164.7 million. Management expects to continue to incur significant expenses for the foreseeable future and to incur operating losses in the near term while the Company makes investments to support its anticipated growth. The Company believes that its cash and cash equivalents balance as of March 31, 2022 provides sufficient capital resources to continue its operations for at least 12 months from the issuance date of the accompanying consolidated financial statements.
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission and have not materially changed during the three months ended March 31, 2022, with the exception of the Company’s accounting policy for stock-based compensation, as the Company granted awards with market conditions for the first time during the three months ended March 31 2022, as described further below.
Stock-Based Compensation
The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants.
Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant.
The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value.
The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur.
Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis.
For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.
The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Risks and Uncertainties Including Business and Credit Concentrations
 3 Months Ended
Mar. 31, 2022
Risks and Uncertainties [Abstract]  
Significant Risks and Uncertainties Including Business and Credit Concentrations Significant Risks and Uncertainties Including Business and Credit Concentrations
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and trade receivables. The Company’s cash and cash equivalents are held by large, credit worthy financial institutions. The Company invests its excess cash in money market funds. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. Deposits in these banks may exceed the amounts of insurance provided on such deposits. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.
The Company controls credit risk through credit approvals and monitoring procedures. The Company performs periodic credit evaluations of its customers and generally does not require collateral. Accounts receivable are recorded net of an allowance for doubtful accounts. The allowance for doubtful accounts is based on management’s assessment of the collectability of specific customer accounts and the aging of the related invoices and represents the Company’s best estimate of expected credit losses in its existing trade accounts receivable. At each of March 31, 2022 and December 31, 2021, the Company had not recorded any material allowance for doubtful accounts.
Most of the Company’s customers are located in the United States and Asia Pacific. For the three months ended March 31, 2022, three customers accounted for 18%, 13% and 10% of revenue. For the three months ended March 31, 2021, two customers accounted for 11% and 10% of revenue.
As of March 31, 2022, four customers comprised 22%, 14%, 11% and 10% of accounts receivable. As of December 31, 2021, three customers accounted for 15%, 11% and 11% of accounts receivable.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue From Contracts With Customers
 3 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue From Contracts With Customers Revenue From Contracts With Customers
Disaggregation of Revenue
The following table depicts the disaggregation of revenue by type of customer or sales channel, market segment as defined by nature of workflows and activities of the end customer and timing of revenue recognition (in thousands):
Three months ended March 31,
20222021
Type of Sales Channel
Direct sales channel$15,486 $10,439 
Distributor channel4,720 8,189 
Net revenues$20,206 $18,628 
Market
Antibody therapeutics$14,225 $15,114 
Synthetic biology2,472 1,984 
Agricultural biology1,491 — 
Gene therapy1,774 1,225 
Cell therapy244 305 
Net revenues$20,206 $18,628 
Timing of Revenue Recognition
Goods and services transferred at a point in time$9,836 $13,064 
Goods and services transferred over time10,370 5,564 
Net revenues$20,206 $18,628 
Revenues by market are determined by the revenue associated with workflows that the Company’s customers are utilizing, primarily on the Company’s Beacon platform, or by the nature of the workflows that the Company is developing under strategic partnerships and services agreements. Revenues by geographical markets are presented in Note 15 to these condensed consolidated financial statements.
Performance Obligations
A significant number of the Company’s product and service sales, as well as its feasibility study arrangements, are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14 exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
As of March 31, 2022, the aggregate amount of remaining performance obligations that are unsatisfied or partially unsatisfied related to customer contracts in excess of one year was $6.9 million, which is included in deferred revenue on the Company’s condensed consolidated balance sheets, of which approximately 35% is expected to be recognized as revenue in the next 12 months, with the remainder recognized afterwards.
Contract Balances
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):
March 31,
2022		December 31,
2021
Trade accounts receivable$17,721 $25,942 
Contract assets, which are included in “Prepaid expenses and other current assets”$1,896 $1,736 
Contract assets, long-term, which are included in “Other assets”$571 $1,070 
Deferred revenue (current)$9,780 $12,128 
Deferred revenue (non-current)$1,600 $2,187 
The contract liabilities of $11.4 million and $14.3 million as of March 31, 2022 and December 31, 2021, respectively, consisted of deferred revenue related to extended warranty service agreements, strategic partnerships and services agreements and advanced automation systems arrangements. Revenue recorded during the three months ended March 31, 2022 included $4.6 million of previously deferred revenue that was included in contract liabilities as of December 31, 2021.
Sales-type Lease Arrangements
The Company also enters into sales-type lease arrangements with certain qualified customers. Revenue related to lease elements from sales-type leases is presented as product revenue and was nil and $1.7 million for the three months ended March 31, 2022 and 2021, respectively.
The following table presents the future maturity of the Company’s fixed-term customer leases and reconciles the undiscounted cash flows from the amounts due from customers under such arrangements as of March 31, 2022 (in thousands):
Year ending December 31,Sales-Type
Leases
Remainder of 2022$1,655 
2023445 
2024853 
Total undiscounted cash flows2,953 
Less: unearned income368 
Total amounts due from customers, gross$2,585 
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Accounts
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Accounts Balance Sheet Accounts
Inventory
The following table shows the components of inventory (in thousands):
March 31,
2022		December 31,
2021
Raw materials$8,861 $8,296 
Finished goods6,804 6,251 
Total$15,665 $14,547 
Prepaid expenses and other current assets
The following table shows the components of prepaid expenses and other current assets (in thousands):
March 31,
2022		December 31,
2021
Contract asset$1,896 $1,736 
Vendor deposits2,712 2,802 
Deferred costs512 561 
Prepaid insurance1,640 2,944 
Other (1)3,544 3,942 
Total$10,304 $11,985 

(1) Other includes primarily prepaid rent expenses, software licenses and prepaid VAT.

Accrued expenses and other current liabilities
The following table shows the components of accrued expenses and other current liabilities (in thousands):
March 31,
2022		December 31,
2021
Accrued payroll and employee related expenses$4,697 $6,757 
Lease liability – short-term2,984 2,941 
Accrued product warranty914 1,085 
Accrued legal expenses680 504 
Other (1)641 1,138 
Total$9,916 $12,425 
(1) Other includes primarily accrued income taxes, sales taxes, accrued royalties and other miscellaneous accruals.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement.
The carrying amounts of the Company’s cash equivalents, accounts receivable and accounts payable approximate fair value due to their relatively short maturities. The Company classifies its cash equivalents, which are comprised primarily of money market funds, within Level 1, as it uses quoted market prices in the determination of fair value.
The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):
March 31,
2022		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,141 $25,141 $— $— 
Total$25,141 $25,141 $— $— 


December 31,
2021		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,138 $25,138 $— $— 
Total$25,138 $25,138 $— $— 

The carrying values and fair values of the Company’s financial instruments not measured at fair value were as follows (in thousands):
March 31, 2022December 31, 2021
Carrying
Value		Fair ValueCarrying
Value		Fair Value
Long-term debt, including current maturities$19,778 $19,295 $19,762 $19,298 
The Company estimated the fair value of its long-term debt using a market-based approach that considers an average cost of debt. The Company has incorporated its own credit risk for all liability fair value measurements. Such fair value measurements are considered Level 2 under the fair value hierarchy.
The Company did not have any transfers of financial assets measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 for any of the periods presented.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment, net
 3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment, net Property and Equipment, net
Property and equipment, net comprised the following (in thousands):
March 31,
2022		December 31,
2021
Equipment, tooling and molds$37,050 $33,972 
Computer software and equipment2,845 3,019 
Furniture, fixtures and other1,955 1,891 
Leasehold improvements10,750 6,105 
Construction in process756 4,803 
Total property and equipment53,356 49,790 
Less: Accumulated depreciation(23,443)(21,798)
Property and equipment, net$29,913 $27,992 
Total depreciation expense for the three months ended March 31, 2022 and 2021 was $1.9 million and $1.3 million, respectively.
During the three months ended March 31, 2022 and 2021, losses on the impairment and disposal of property and equipment was not material.
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Leases
 3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
Leases Leases
The Company leases office, manufacturing, distribution and laboratory facilities in Emeryville, California under multiple operating leases. During the third quarter of 2021, the Company extended the term for its leases related to the facilities in Emeryville and these leases will now expire in 2029. Also, during the third quarter of 2021, the Company entered into a seven year lease of space for office and laboratory operations in Lexington, Massachusetts, which commenced on July 1, 2021.
The Company also leases two facilities in Shanghai, China for office and laboratory facilities under operating lease agreements that were entered into in July 2020. These leases expire at various dates, the latest of which is August 2023.
Future payments associated with the Company’s operating lease liabilities as of March 31, 2022 is as follows (in thousands):
Operating leases
Undiscounted lease payments for the year ending December 31,
Remainder of 2022$3,148 
20234,276 
20244,355 
20254,486 
20264,621 
Thereafter12,222 
Total undiscounted lease payments33,108 
Less: implied interest(5,131)
Less: tenant improvement allowances receivable(1,426)
Present value of operating lease payments26,551 
Less: current portion (1)(2,984)
Total long-term operating lease liabilities$23,567 
(1) Included in the balance sheet caption “Accrued expenses and other current liabilities.”
Rent expense for the three months ended March 31, 2022 and 2021 was $1.1 million and $0.8 million, respectively. Under the terms of the lease agreements, the Company is also responsible for certain variable lease payments that are not included in the measurement of the lease liability. Variable lease payments for operating leases were $0.8 million and $0.5 million for the three months ended March 31, 2022 and 2021, respectively, including non-lease components such as common area maintenance fees.
The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):
Three months ended March 31,
20222021
Right-of-use assets obtained for new operating lease liabilities $— $— 
Cash paid for amounts included in the measurement of lease liabilities$1,098 $691 
The following summarizes additional information related to operating leases:
March 31, 2022December 31, 2021
Weighted-average remaining lease term (years)7.277.51
Weighted-average discount rate4.67 %4.67 %
The Company also enters into leasing transactions in which the Company is the lessor, which to date have been classified as sales-type leases. See Note 4 of these condensed consolidated financial statements for the related lease disclosures.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Payable
 3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Notes Payable Notes Payable
On May 23, 2018, the Company entered into a Loan and Security Agreement with East West Bank (“EWB”) providing it the ability to borrow up to $20.0 million. The loan facility was fully drawn as of May 23, 2018.
On June 30, 2021, the Company entered into an Amended and Restated Loan and Security Agreement (the “Agreement”) with EWB. Pursuant to the Agreement, EWB provided a $20.0 million term loan (the “Term Loan”) which was used to refinance the term loan outstanding under the Loan and Security Agreement dated May 23, 2018. The Term Loan matures in 48 months and bears a fixed interest rate of 4.17%. The Term Loan has an initial interest-only period of 24 months, which can be extended to up to 36 months based on the achievement of certain liquidity measures, and can be pre-paid without penalty at any time.
The Agreement grants EWB a security interest in and liens on all assets of the Company, excluding intellectual property, which is subject to a double negative pledge. In addition, certain other terms of the original agreements as previously in effect were amended by the Agreement, including certain financial covenants. The Amended and Restated Loan and Security Agreement was accounted for as a debt modification and the Company capitalized incremental debt issuance costs.
Furthermore, the Agreement also provided the Company with a new $10.0 million revolving credit (the “Revolving Line”), which bears interest on the outstanding daily balance thereof of 0.70% above the Prime Rate (as defined in the Agreement). No amounts were outstanding under the Revolving Line as of March 31, 2022.
The Agreement contains certain financial and non-financial covenants. As of March 31, 2022, the Company was in compliance with the terms and covenants of the Agreement.
The following is a schedule of payments due on notes payable as of March 31, 2022 (in thousands):
March 31,
2022
Year Ending December 31:
Remainder of 2022$637 
20236,617 
202410,406 
20254,210 
Total payments due21,870 
Less:
Interest payments, loan discounts and financing costs(2,092)
Current portion, less loan discounts and financing costs— 
Notes payable$19,778 
Total interest cost incurred for the three months ended March 31, 2022 and 2021 was $0.2 million and $0.4 million, respectively.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Compensation Plans
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock Compensation Plans Stock Compensation Plans
Stock-based compensation
Stock-based compensation related to the Company's stock-based awards was recorded as an expense and allocated as follows (in thousands):
Three months ended March 31,
20222021
Cost of sales$51 $42 
Research and development1,581 1,061 
General and administrative2,211 1,372 
Sales and marketing1,550 2,019 
Total stock-based compensation$5,393 $4,494 
Stock-based compensation capitalized in inventory was not material as of March 31, 2022 and December 31, 2021.
On March 10, 2022, the Company granted the newly appointed Chief Executive Officer of the Company 1,017,177 RSUs, 339,059 stock options and 678,118 performance-based stock options (“PSOs”). The RSUs and stock options vest quarterly over 3 years and the stock options have a 10 year term.
The PSOs have a 7-year performance period, a 10-year term and vest based upon certain market conditions and a continued service-based requirement. Market condition-related vesting is triggered based on the Company’s stock price reaching certain goals that range from two to 20 times the Company share price on the date of grant.
Although no awards will vest until a market condition is satisfied, as of March 31, 2022 the Company began recording stock-based compensation expense for each vesting tranche based on the estimated achievement date of the specified stock price target. The valuation and probability of achievement for each tranche is determined using a Monte Carlo simulation. The same Monte Carlo simulation is used as the basis for determining the expected achievement date. As the probability of achievement is factored in as part of the Monte Carlo simulation, the expense for these tranches will be recognized concurrently over each tranche’s estimated achievement date even if some or all of the options never vest. If the related market condition for a tranche is achieved earlier than
expected, all unamortized expense for such tranche will be recognized immediately. As of March 31, 2022, none of the PSOs had vested.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
 3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income TaxesThe Company’s provision for income taxes was $20 thousand and $17 thousand, respectively, for the three months ended March 31, 2022 and 2021. For the three months ended March 31, 2022 and 2021, income from operations before taxes consisted of amounts related to U.S. operations and the Company’s foreign operations. The Company maintains a full valuation allowance on its deferred tax assets, and intends to do so until there is sufficient evidence to support the reversal of all or some portion of these allowances.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Cash Flows
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Statements of Cash Flows Statements of Cash Flows
The supplemental cash flow information consists of the following (in thousands):
Three months ended March 31,
20222021
Cash paid for interest$137 $337 
Non-cash investing and financing activities
Inventory transferred to property and equipment (1)$— $2,813 
Change in accounts payable and accrued liabilities related to purchases of property and equipment$(482)$751 
(1) The non-cash transfer of inventory to property and equipment principally relates to Beacons that were transferred to the Company’s BioFoundry operations in the first and second quarter of 2021. As a result of the growth of the Company’s BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in the Company’s BioFoundry operations will be categorized as “Purchase of property and equipment.”
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Commitment and Contingencies
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Proceedings
From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. The Company records a liability in its financial statements for these matters when a loss is known and considered probable and the amount can be reasonably estimated. The Company does not recognize gain contingencies until they are realized. Legal costs incurred relating to loss contingencies are expensed as incurred.
AbCellera Biologics Litigation
In July 2020, AbCellera Biologics Inc. (“AbCellera”) filed a complaint in the United States District Court for the District of Delaware, alleging that the Company infringed and continues to infringe, directly and indirectly, the following patents exclusively licensed by AbCellera by making, using, offering for sale, selling and/or importing the Company’s Beacon and Culture Station instruments and the OptoSelect chips, and sale of the Opto Plasma B Discovery Workflow: U.S. Patent Nos. 10,107,812, 10,274,494, 10,466,241, 10,578,618, 10,697,962, 10,087,408, 10,421,936 and 10,704,018 (“AbCellera I”).
In August 2020, AbCellera filed a second complaint in the United States District Court for the District of Delaware, making the same allegations with regard to U.S. Patent Nos. 10,718,768, 10,738,270, 10,746,737, and 10,753,933 (“AbCellera II”). In September 2020, AbCellera filed amended complaints in each of AbCellera I and AbCellera II adding The University of British Columbia (“UBC”) as a named plaintiff. Also in September 2020, AbCellera and UBC filed a third complaint in the United States District Court for the District of Delaware,
making the same allegations with regard to U.S. Patent Nos. 10,775,376, 10,775,377, and 10,775,378 (“AbCellera III”). AbCellera and UBC are seeking, among other things, judgment of infringement, a permanent injunction and damages (including lost profits, a reasonable royalty, reasonable costs and attorney’s fees and treble damages for willful infringement). In addition to procedural motions, the Company has filed an answer and counterclaims in response to each of the AbCellera I, AbCellera II and AbCellera III lawsuits. The Company’s counterclaims in each lawsuit include counts for declaratory judgment of non-infringement of the asserted patents, for declaratory judgment of invalidity of the asserted patents and for declaratory judgment of unenforceability of the asserted patents due to inequitable conduct. The Company filed a motion to transfer the AbCellera I, AbCellera II and AbCellera III lawsuits to the United States District Court for the Northern District of California, which was granted and where the lawsuits have been consolidated and are now pending (the “consolidated lawsuit”). On May 6, 2021, and pursuant to Court Order, AbCellera and UBC reduced, without prejudice, the asserted patents in the consolidated lawsuit to the following: US Patent Nos. 10,087,408, 10,421,936, 10,738,270, 10,697,962, 10,753,933, 10,775,376 and 10,775,378.
On July 1, 2021, the court granted the Company’s motion to amend its answer and counterclaims to add federal and state unfair competition counterclaims against AbCellera Biologics; on July 22, 2021, the Company filed its amended answer and counterclaims. Also on July 1, 2021 the court issued a Case Management Order that, among other things, requires AbCellera and UBC to reduce the number of asserted patents to no more than two, and the total asserted patent claims to no more than four per patent prior to the trial.
Also in July 2021, the Company filed petitions for Inter Partes Review (“IPR”) with the United States Patent & Trademark Office (“USPTO”), challenging the validity of various asserted claims of U.S. Patent No. 10,087,408 and all asserted claims of U.S. Patent No. 10,421,936, then filed a motion in the district court to stay the consolidated lawsuit pending the outcome of the IPR proceedings. In August 2021, the Company filed a third petition for IPR with the USPTO, challenging the validity of all asserted claims of U.S. Patent No. 10,739,270. Also in August 2021, the court granted the Company’s motion to stay the consolidated AbCellera I, AbCellera II, and AbCellera III lawsuits pending the outcome of the IPR proceedings.
In January 2022, the Patent Trial and Appeal Board (“PTAB”) of the USPTO issued a decision instituting IPR on U.S. Patent No. 10,087,408 and a decision denying IPR on U.S. Patent No. 10,421,936. In February 2022, the PTAB issued a decision denying IPR on U.S. Patent No. 10,739,270.
In August 2020, the Company filed a complaint in the United States District Court for the Northern District of California against AbCellera and Lineage BioSciences, Inc., an entity previously acquired by AbCellera (“AbCellera IV”). The complaint included two counts of unfair competition and one count of a declaratory judgment of non-infringement of U.S. Patent No. 10,058,839. The Company was seeking, among other things, damages and a judgment of non-infringement. In October 2020, the Company filed an amended complaint asserting the same three counts and AbCellera and Lineage filed a motion to dismiss the amended complaint, which was granted, without prejudice, in part. In light of the Company’s amended answer and counterclaims in the consolidated lawsuits, which were amended to include its federal and state unfair competition claims as discussed above, in July 2021 the Company filed a notice of dismissal without prejudice in the AbCellera IV lawsuit, resulting in its termination.
The Company believes that the patent assertions by AbCellera and UBC are without merit and intends to defend itself vigorously. The Company also intends to proceed with its claims and counterclaims against AbCellera and UBC. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in these lawsuits could subject the Company to significant liabilities, require it to seek licenses from or pay royalties to AbCellera and/or UBC, or prevent it from manufacturing, selling or using certain of its products, any of which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects.
Securities Class Action
In December 2021, Victor J. Ng filed a securities class action on behalf of all purchasers of Berkeley Lights common stock between July 17, 2020 and September 14, 2021, inclusive, alleging that the Company and certain of the Company’s current and former senior executives had violated §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder (the “Securities Class Action”). The Company believes that the assertions in the Securities Class Action are without merit and intends to defend itself vigorously. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in the Securities Class Action could subject the Company to significant liabilities, which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects.
Derivative Action
In March 2022, Trung Nguyen filed a shareholder derivative complaint on behalf of nominal defendant Berkeley Lights, Inc., alleging that certain of the Company’s current and former directors and certain of the Company’s current and former senior executives breached their fiduciary duties to the Company. The complaint also alleged that certain of the Company’s current and former directors and former senior executives used material, non-public information to improperly profit from the sale of Company stock, and that certain of the Company’s current and former senior executives owe the Company contribution for violations of sections 10(b) and 21D of the Securities Exchange Act of 1934.
The Company is not currently involved in any other claims or legal actions, nor is management aware of any potential claims or legal actions, for which the ultimate disposition could have a material adverse effect on the Company’s financial position, results of operations, or liquidity.
No provision has been made for litigation because the Company believes that it is not probable that a liability had been incurred as of March 31, 2022.
Product Warranty
The Company provides a 13-month assurance-type warranty, generally beginning on the shipment date, on its platforms and chip consumables. The table below represents the activity in the product warranty accrual included in accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):
Three months ended March 31,
20222021
Balance, beginning of period$1,085 $1,271 
Adjustments to existing warranties(245)(218)
Provision for new warranties163 375 
Settlement of pre-existing warranties(89)(160)
Balance, end of period$914 $1,268 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Attributable to Common Stockholders Per Share
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Net Loss Attributable to Common Stockholders Per Share Net Loss Attributable to Common Stockholders Per Share
Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards. Awards granted with performance conditions are excluded from the shares used to compute diluted earnings per share until the performance conditions associated with the awards are met.
The following table sets forth the computation of basic and diluted earnings per common share (in thousands, except share and per share data):
Three months ended March 31,
20222021
Numerator
Net loss attributable to common stockholders, basic and diluted$(21,426)$(15,435)
Denominator
Weighted-average shares used to compute net income per share, basic and diluted67,697,48865,259,398
Net loss per share
Net loss per share attributable to common stockholders, basic and diluted$(0.32)$(0.24)
Since the Company was in a loss position for all periods presented, basic net loss per share attributable to common stockholders is the same as diluted net loss per share attributable to common stockholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented as they had an anti-dilutive effect:
Three months ended March 31,
20222021
Options to purchase common stock7,020,591 8,399,147 
Restricted stock units3,629,310 356,725 
Total10,649,901 8,755,872 
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Segments
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Segments Segments
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company has one business activity and there are no segment managers who are held accountable for operations. Accordingly, the Company has one operating segment. The Company’s principal operations and decision-making functions are located in the United States.
The following table provides the Company’s revenues by geographical market based on the location where the services were provided or to which product was shipped (in thousands):
Three months ended March 31,
20222021
North America$13,715 $7,362 
Asia Pacific (1)5,035 8,431 
Europe1,456 2,835 
Total$20,206 $18,628 
(1) Asia Pacific includes Australia.
As of March 31, 2022 and December 31, 2021, substantially all of the Company’s long-lived assets were located in the United States.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.1
The Company and Basis of Presentation (Policies)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.
Stock-Based Compensation
Stock-Based Compensation
The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants.
Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant.
The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value.
The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur.
Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis.
For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.
The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue From Contracts With Customers (Tables)
 3 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue
The following table depicts the disaggregation of revenue by type of customer or sales channel, market segment as defined by nature of workflows and activities of the end customer and timing of revenue recognition (in thousands):
Three months ended March 31,
20222021
Type of Sales Channel
Direct sales channel$15,486 $10,439 
Distributor channel4,720 8,189 
Net revenues$20,206 $18,628 
Market
Antibody therapeutics$14,225 $15,114 
Synthetic biology2,472 1,984 
Agricultural biology1,491 — 
Gene therapy1,774 1,225 
Cell therapy244 305 
Net revenues$20,206 $18,628 
Timing of Revenue Recognition
Goods and services transferred at a point in time$9,836 $13,064 
Goods and services transferred over time10,370 5,564 
Net revenues$20,206 $18,628 
Schedule of receivables, contract assets and deferred revenue from contracts with customers The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):
March 31,
2022		December 31,
2021
Trade accounts receivable$17,721 $25,942 
Contract assets, which are included in “Prepaid expenses and other current assets”$1,896 $1,736 
Contract assets, long-term, which are included in “Other assets”$571 $1,070 
Deferred revenue (current)$9,780 $12,128 
Deferred revenue (non-current)$1,600 $2,187 
Schedule of sales-type lease maturity
The following table presents the future maturity of the Company’s fixed-term customer leases and reconciles the undiscounted cash flows from the amounts due from customers under such arrangements as of March 31, 2022 (in thousands):
Year ending December 31,Sales-Type
Leases
Remainder of 2022$1,655 
2023445 
2024853 
Total undiscounted cash flows2,953 
Less: unearned income368 
Total amounts due from customers, gross$2,585 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Accounts (Tables)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of inventory
The following table shows the components of inventory (in thousands):
March 31,
2022		December 31,
2021
Raw materials$8,861 $8,296 
Finished goods6,804 6,251 
Total$15,665 $14,547 
Schedule of prepaid expenses and other current assets The following table shows the components of prepaid expenses and other current assets (in thousands):
March 31,
2022		December 31,
2021
Contract asset$1,896 $1,736 
Vendor deposits2,712 2,802 
Deferred costs512 561 
Prepaid insurance1,640 2,944 
Other (1)3,544 3,942 
Total$10,304 $11,985 

(1) Other includes primarily prepaid rent expenses, software licenses and prepaid VAT.
Schedule of accrued expenses and other current liabilities
The following table shows the components of accrued expenses and other current liabilities (in thousands):
March 31,
2022		December 31,
2021
Accrued payroll and employee related expenses$4,697 $6,757 
Lease liability – short-term2,984 2,941 
Accrued product warranty914 1,085 
Accrued legal expenses680 504 
Other (1)641 1,138 
Total$9,916 $12,425 
(1) Other includes primarily accrued income taxes, sales taxes, accrued royalties and other miscellaneous accruals.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of financial assets measured at fair value
The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):
March 31,
2022		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,141 $25,141 $— $— 
Total$25,141 $25,141 $— $— 


December 31,
2021		Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds$25,138 $25,138 $— $— 
Total$25,138 $25,138 $— $— 
Schedule of financial instruments not measured at fair value
The carrying values and fair values of the Company’s financial instruments not measured at fair value were as follows (in thousands):
March 31, 2022December 31, 2021
Carrying
Value		Fair ValueCarrying
Value		Fair Value
Long-term debt, including current maturities$19,778 $19,295 $19,762 $19,298 
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment, net (Tables)
 3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
Property and equipment, net comprised the following (in thousands):
March 31,
2022		December 31,
2021
Equipment, tooling and molds$37,050 $33,972 
Computer software and equipment2,845 3,019 
Furniture, fixtures and other1,955 1,891 
Leasehold improvements10,750 6,105 
Construction in process756 4,803 
Total property and equipment53,356 49,790 
Less: Accumulated depreciation(23,443)(21,798)
Property and equipment, net$29,913 $27,992 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Table)
 3 Months Ended
Mar. 31, 2022
Leases [Abstract]  
Schedule of operating lease liabilities maturity
Future payments associated with the Company’s operating lease liabilities as of March 31, 2022 is as follows (in thousands):
Operating leases
Undiscounted lease payments for the year ending December 31,
Remainder of 2022$3,148 
20234,276 
20244,355 
20254,486 
20264,621 
Thereafter12,222 
Total undiscounted lease payments33,108 
Less: implied interest(5,131)
Less: tenant improvement allowances receivable(1,426)
Present value of operating lease payments26,551 
Less: current portion (1)(2,984)
Total long-term operating lease liabilities$23,567 
(1) Included in the balance sheet caption “Accrued expenses and other current liabilities.”
Schedule of supplemental cash flow information related to operating leases and additional information
The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):
Three months ended March 31,
20222021
Right-of-use assets obtained for new operating lease liabilities $— $— 
Cash paid for amounts included in the measurement of lease liabilities$1,098 $691 
The following summarizes additional information related to operating leases:
March 31, 2022December 31, 2021
Weighted-average remaining lease term (years)7.277.51
Weighted-average discount rate4.67 %4.67 %
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Payable (Tables)
 3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Schedule of payments due on notes payable The following is a schedule of payments due on notes payable as of March 31, 2022 (in thousands):
March 31,
2022
Year Ending December 31:
Remainder of 2022$637 
20236,617 
202410,406 
20254,210 
Total payments due21,870 
Less:
Interest payments, loan discounts and financing costs(2,092)
Current portion, less loan discounts and financing costs— 
Notes payable$19,778 
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Compensation Plans (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation
Stock-based compensation related to the Company's stock-based awards was recorded as an expense and allocated as follows (in thousands):
Three months ended March 31,
20222021
Cost of sales$51 $42 
Research and development1,581 1,061 
General and administrative2,211 1,372 
Sales and marketing1,550 2,019 
Total stock-based compensation$5,393 $4,494 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Cash Flows (Tables)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of cash flow, supplemental disclosures
The supplemental cash flow information consists of the following (in thousands):
Three months ended March 31,
20222021
Cash paid for interest$137 $337 
Non-cash investing and financing activities
Inventory transferred to property and equipment (1)$— $2,813 
Change in accounts payable and accrued liabilities related to purchases of property and equipment$(482)$751 
(1) The non-cash transfer of inventory to property and equipment principally relates to Beacons that were transferred to the Company’s BioFoundry operations in the first and second quarter of 2021. As a result of the growth of the Company’s BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in the Company’s BioFoundry operations will be categorized as “Purchase of property and equipment.”
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Commitment and Contingencies (Tables)
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of product warranty liability The table below represents the activity in the product warranty accrual included in accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):
Three months ended March 31,
20222021
Balance, beginning of period$1,085 $1,271 
Adjustments to existing warranties(245)(218)
Provision for new warranties163 375 
Settlement of pre-existing warranties(89)(160)
Balance, end of period$914 $1,268 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Attributable to Common Stockholders Per Share (Tables)
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per common share The following table sets forth the computation of basic and diluted earnings per common share (in thousands, except share and per share data):
Three months ended March 31,
20222021
Numerator
Net loss attributable to common stockholders, basic and diluted$(21,426)$(15,435)
Denominator
Weighted-average shares used to compute net income per share, basic and diluted67,697,48865,259,398
Net loss per share
Net loss per share attributable to common stockholders, basic and diluted$(0.32)$(0.24)
Schedule of antidilutive securities excluded from computation of earnings per share The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented as they had an anti-dilutive effect:
Three months ended March 31,
20222021
Options to purchase common stock7,020,591 8,399,147 
Restricted stock units3,629,310 356,725 
Total10,649,901 8,755,872 
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Segments (Tables)
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Summary of revenue by geographic areas
The following table provides the Company’s revenues by geographical market based on the location where the services were provided or to which product was shipped (in thousands):
Three months ended March 31,
20222021
North America$13,715 $7,362 
Asia Pacific (1)5,035 8,431 
Europe1,456 2,835 
Total$20,206 $18,628 
(1) Asia Pacific includes Australia.
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.1
The Company and Basis of Presentation (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Net loss attributable to common stockholders, basic and diluted $ (21,426) $ (15,435)  
Accumulated deficit (285,034)   $ (263,608)
Cash and cash equivalents $ 164,674   $ 178,096
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Risks and Uncertainties Including Business and Credit Concentrations (Details) - Customer
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Revenue | Customer One      
Concentration Risk [Line Items]      
Concentration risk percentage 18.00% 11.00%  
Revenue | Customer Two      
Concentration Risk [Line Items]      
Concentration risk percentage 13.00% 10.00%  
Revenue | Customer Three      
Concentration Risk [Line Items]      
Concentration risk percentage 10.00%    
Accounts Receivable | Customer One      
Concentration Risk [Line Items]      
Concentration risk percentage 22.00%   15.00%
Accounts Receivable | Customer Two      
Concentration Risk [Line Items]      
Concentration risk percentage 14.00%   11.00%
Accounts Receivable | Customer Three      
Concentration Risk [Line Items]      
Concentration risk percentage 11.00%   11.00%
Accounts Receivable | Customer Four      
Concentration Risk [Line Items]      
Concentration risk percentage 10.00%    
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Disaggregation of Revenue [Line Items]    
Net revenues $ 20,206 $ 18,628
Goods and services transferred at a point in time    
Disaggregation of Revenue [Line Items]    
Net revenues 9,836 13,064
Goods and services transferred over time    
Disaggregation of Revenue [Line Items]    
Net revenues 10,370 5,564
Antibody therapeutics    
Disaggregation of Revenue [Line Items]    
Net revenues 14,225 15,114
Synthetic biology    
Disaggregation of Revenue [Line Items]    
Net revenues 2,472 1,984
Agricultural biology    
Disaggregation of Revenue [Line Items]    
Net revenues 1,491 0
Gene therapy    
Disaggregation of Revenue [Line Items]    
Net revenues 1,774 1,225
Cell therapy    
Disaggregation of Revenue [Line Items]    
Net revenues 244 305
Direct sales channel    
Disaggregation of Revenue [Line Items]    
Net revenues 15,486 10,439
Distributor channel    
Disaggregation of Revenue [Line Items]    
Net revenues $ 4,720 $ 8,189
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue from Contracts with Customer (Narrative) (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]      
Remaining performance obligation $ 6,900,000    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Contract liabilities 11,400,000   $ 14,300,000
Contract liability , revenue recognized 4,600,000    
Lease income $ 0 $ 1,700,000  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Remaining performance obligation, percentage 35.00%    
Remaining performance obligation, period 12 months    
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]    
Trade accounts receivable $ 17,721 $ 25,942
Contract assets, which are included in “Prepaid expenses and other current assets” 1,896 1,736
Contract assets, long-term, which are included in “Other assets” 571 1,070
Deferred revenue (current) 9,780 12,128
Deferred revenue (non-current) $ 1,600 $ 2,187
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details)
$ in Thousands
Mar. 31, 2022
USD ($)
Revenue from Contract with Customer [Abstract]  
Remainder of 2022 $ 1,655
2023 445
2024 853
Total undiscounted cash flows 2,953
Less: unearned income 368
Total amounts due from customers, gross $ 2,585
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Accounts (Inventory) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Raw materials $ 8,861 $ 8,296
Finished goods 6,804 6,251
Total $ 15,665 $ 14,547
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Contract asset $ 1,896 $ 1,736
Vendor deposits 2,712 2,802
Deferred costs 512 561
Prepaid insurance 1,640 2,944
Other 3,544 3,942
Total $ 10,304 $ 11,985
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued payroll and employee related expenses $ 4,697 $ 6,757
Lease liability – short-term 2,984 2,941
Accrued product warranty 914 1,085
Accrued legal expenses 680 504
Other 641 1,138
Total $ 9,916 $ 12,425
Operating lease, current [Extensible Enumeration] Total Total
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments (Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Money market funds $ 25,141 $ 25,138
Total 25,141 25,138
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Money market funds 25,141 25,138
Total 25,141 25,138
Significant Other Observable Inputs (Level 2)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Money market funds 0 0
Total 0 0
Significant Unobservable Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Money market funds 0 0
Total $ 0 $ 0
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details) - Significant Other Observable Inputs (Level 2) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt, including current maturities $ 19,778 $ 19,762
Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt, including current maturities $ 19,295 $ 19,298
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment, net (Schedule of Property and Equipment) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 53,356 $ 49,790
Less: Accumulated depreciation (23,443) (21,798)
Property and equipment, net 29,913 27,992
Equipment, tooling and molds    
Property, Plant and Equipment [Line Items]    
Total property and equipment 37,050 33,972
Computer software and equipment    
Property, Plant and Equipment [Line Items]    
Total property and equipment 2,845 3,019
Furniture, fixtures and other    
Property, Plant and Equipment [Line Items]    
Total property and equipment 1,955 1,891
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Total property and equipment 10,750 6,105
Construction in process    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 756 $ 4,803
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment, net (Narrative) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Property, Plant and Equipment [Abstract]    
Depreciation $ 1,944 $ 1,345
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Narrative) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2022
USD ($)
facility
Mar. 31, 2021
USD ($)
Sep. 30, 2021
Lessee, Lease, Description [Line Items]      
Number of facilities | facility 2    
Rent expense $ 1.1 $ 0.8  
Variable lease payments $ 0.8 $ 0.5  
Building      
Lessee, Lease, Description [Line Items]      
Lease term     7 years
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Maturity Schedule of Operating Lease Liabilities) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Remainder of 2022 $ 3,148  
2023 4,276  
2024 4,355  
2025 4,486  
2026 4,621  
Thereafter 12,222  
Total undiscounted lease payments 33,108  
Less: implied interest (5,131)  
Less: tenant improvement allowances receivable (1,426)  
Present value of operating lease payments 26,551  
Less: current portion (2,984) $ (2,941)
Total long-term operating lease liabilities $ 23,567 $ 24,337
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Leases [Abstract]    
Right-of-use assets obtained for new operating lease liabilities $ 0 $ 0
Cash paid for amounts included in the measurement of lease liabilities $ 1,098 $ 691
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Schedule of Additional Information Related to Operating Leases) (Details)
Mar. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Weighted-average remaining lease term (in years) 7 years 3 months 7 days 7 years 6 months 3 days
Weighted-average discount rate 4.67% 4.67%
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Payable (Narrative) (Details) - USD ($)
 3 Months Ended
Jun. 30, 2021
Mar. 31, 2022
Mar. 31, 2021
May 23, 2018
Debt Instrument [Line Items]        
Interest cost   $ 200,000 $ 400,000  
Notes Payable | EWB Loan        
Debt Instrument [Line Items]        
Maximum borrowing capacity       $ 20,000,000
Notes Payable | Term Loan        
Debt Instrument [Line Items]        
Maximum borrowing capacity $ 20,000,000      
Note payable, term (in years) 48 months      
Interest rate 4.17%      
Interest-only period 24 months      
Interest-only period with extensions 36 months      
Line of Credit | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing capacity $ 10,000,000      
Amounts outstanding   $ 0    
Line of Credit | Revolving Credit Facility | Prime Rate        
Debt Instrument [Line Items]        
Basis spread 0.70%      
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Payable (Schedule of Payment Due on Notes Payable) (Details) - Notes Payable - Term Loan
$ in Thousands
Mar. 31, 2022
USD ($)
Debt Instrument [Line Items]  
Remainder of 2022 $ 637
2023 6,617
2024 10,406
2025 4,210
Total payments due 21,870
Interest payments, loan discounts and financing costs (2,092)
Current portion, less loan discounts and financing costs 0
Notes payable $ 19,778
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Compensation Plans (Stock-Based Compensation) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation $ 5,393 $ 4,494
Cost of sales    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation 51 42
Research and development    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation 1,581 1,061
General and administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation 2,211 1,372
Sales and marketing    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation $ 1,550 $ 2,019
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Compensation Plans (Narrative) (Details) - Chief Executive Officer
 3 Months Ended
Mar. 10, 2022
shares
Mar. 31, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options granted (in shares) 339,059  
RSU    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSUs granted (in shares) 1,017,177  
Vesting period 3 years  
Stock options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 3 years  
Expiration period 10 years  
PSO    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options granted (in shares) 678,118  
Vesting period 7 years  
Expiration period 10 years  
Shares vested (in shares)   0
PSO | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock price goal multiplier of share price on date of grant 2  
PSO | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock price goal multiplier of share price on date of grant 20  
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]    
Provision for income taxes $ 20 $ 17
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash paid for interest $ 137 $ 337
Non-cash investing and financing activities    
Inventory transferred to property and equipment 0 2,813
Change in accounts payable and accrued liabilities related to purchases of property and equipment $ (482) $ 751
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.22.1
Commitment and Contingencies (Narrative) (Details)
 1 Months Ended 3 Months Ended
Jul. 01, 2021
patent
claim
Oct. 31, 2020
claim
Aug. 31, 2020
claim
Mar. 31, 2022
USD ($)
Loss Contingencies [Line Items]        
Number of counts in amended complaint   3    
Loss contingency accrual | $       $ 0
Product warranty, term       13 months
AbCellera And UBC        
Loss Contingencies [Line Items]        
Case management order, maximum number of patents allegedly infringed | patent 2      
Case management order, maximum asserted patent claims per patent 4      
AbCellera, Unfair Competition        
Loss Contingencies [Line Items]        
Counter claims filed     2  
AbCellera, Non-Infringement        
Loss Contingencies [Line Items]        
Counter claims filed     1  
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.22.1
Commitment and Contingencies (Product Warranty) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance, beginning of period $ 1,085 $ 1,271
Adjustments to existing warranties (245) (218)
Provision for new warranties 163 375
Settlement of pre-existing warranties (89) (160)
Balance, end of period $ 914 $ 1,268
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Numerator    
Net loss attributable to common stockholders, diluted $ (21,426) $ (15,435)
Net loss attributable to common stockholders, basic $ (21,426) $ (15,435)
Denominator    
Weighted-average shares used in calculating net loss per share, basic (in shares) 67,697,488 65,259,398
Weighted-average shares used in calculating net loss per share, diluted (in shares) 67,697,488 65,259,398
Net loss per share    
Net loss attributable to common stockholders per share, diluted (in dollars per share) $ (0.32) $ (0.24)
Net loss attributable to common stockholders per share, basic (in dollars per share) $ (0.32) $ (0.24)
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details) - shares
shares in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the calculation of net loss per share (in shares) 10,649,901 8,755,872
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the calculation of net loss per share (in shares) 7,020,591 8,399,147
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the calculation of net loss per share (in shares) 3,629,310 356,725
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.22.1
Segments (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
USD ($)
segment
Mar. 31, 2021
USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]    
Number of operating segments | segment 1  
Total revenue $ 20,206 $ 18,628
North America    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total revenue 13,715 7,362
Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total revenue 5,035 8,431
Europe    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total revenue $ 1,456 $ 2,835
XML 76 bli-20220331_htm.xml IDEA: XBRL DOCUMENT 0001689657 2022-01-01 2022-03-31 0001689657 2022-04-30 0001689657 2022-03-31 0001689657 2021-12-31 0001689657 us-gaap:ProductMember 2022-01-01 2022-03-31 0001689657 us-gaap:ProductMember 2021-01-01 2021-03-31 0001689657 us-gaap:ServiceMember 2022-01-01 2022-03-31 0001689657 us-gaap:ServiceMember 2021-01-01 2021-03-31 0001689657 2021-01-01 2021-03-31 0001689657 us-gaap:CommonStockMember 2021-12-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001689657 us-gaap:RetainedEarningsMember 2021-12-31 0001689657 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001689657 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001689657 us-gaap:CommonStockMember 2022-03-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001689657 us-gaap:RetainedEarningsMember 2022-03-31 0001689657 us-gaap:CommonStockMember 2020-12-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001689657 us-gaap:RetainedEarningsMember 2020-12-31 0001689657 2020-12-31 0001689657 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001689657 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001689657 us-gaap:CommonStockMember 2021-03-31 0001689657 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001689657 us-gaap:RetainedEarningsMember 2021-03-31 0001689657 2021-03-31 0001689657 bli:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerThreeMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001689657 bli:CustomerTwoMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001689657 bli:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001689657 bli:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001689657 bli:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001689657 bli:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001689657 us-gaap:SalesChannelDirectlyToConsumerMember 2022-01-01 2022-03-31 0001689657 us-gaap:SalesChannelDirectlyToConsumerMember 2021-01-01 2021-03-31 0001689657 us-gaap:SalesChannelThroughIntermediaryMember 2022-01-01 2022-03-31 0001689657 us-gaap:SalesChannelThroughIntermediaryMember 2021-01-01 2021-03-31 0001689657 bli:AntibodyTherapeuticsMember 2022-01-01 2022-03-31 0001689657 bli:AntibodyTherapeuticsMember 2021-01-01 2021-03-31 0001689657 bli:SyntheticBiologyMember 2022-01-01 2022-03-31 0001689657 bli:SyntheticBiologyMember 2021-01-01 2021-03-31 0001689657 bli:AgriculturalBiologyMember 2022-01-01 2022-03-31 0001689657 bli:AgriculturalBiologyMember 2021-01-01 2021-03-31 0001689657 bli:GeneTherapyMember 2022-01-01 2022-03-31 0001689657 bli:GeneTherapyMember 2021-01-01 2021-03-31 0001689657 bli:CellTherapyMember 2022-01-01 2022-03-31 0001689657 bli:CellTherapyMember 2021-01-01 2021-03-31 0001689657 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001689657 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0001689657 us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001689657 us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0001689657 2022-04-01 2022-03-31 0001689657 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001689657 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001689657 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001689657 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001689657 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001689657 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001689657 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-03-31 0001689657 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-03-31 0001689657 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001689657 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001689657 bli:EquipmentToolingAndMoldsMember 2022-03-31 0001689657 bli:EquipmentToolingAndMoldsMember 2021-12-31 0001689657 us-gaap:ComputerEquipmentMember 2022-03-31 0001689657 us-gaap:ComputerEquipmentMember 2021-12-31 0001689657 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001689657 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001689657 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001689657 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001689657 us-gaap:ConstructionInProgressMember 2022-03-31 0001689657 us-gaap:ConstructionInProgressMember 2021-12-31 0001689657 us-gaap:BuildingMember 2021-09-30 0001689657 bli:EWBLoanMember us-gaap:NotesPayableToBanksMember 2018-05-23 0001689657 bli:TermLoanMember us-gaap:NotesPayableToBanksMember 2021-06-30 0001689657 bli:TermLoanMember us-gaap:NotesPayableToBanksMember 2021-06-30 2021-06-30 0001689657 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-06-30 0001689657 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:PrimeRateMember 2021-06-30 2021-06-30 0001689657 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-03-31 0001689657 bli:TermLoanMember us-gaap:NotesPayableToBanksMember 2022-03-31 0001689657 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001689657 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001689657 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001689657 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001689657 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001689657 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001689657 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001689657 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0001689657 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-10 2022-03-10 0001689657 srt:ChiefExecutiveOfficerMember 2022-03-10 2022-03-10 0001689657 srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2022-03-10 2022-03-10 0001689657 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember 2022-03-10 2022-03-10 0001689657 srt:MinimumMember srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2022-03-10 0001689657 srt:MaximumMember srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2022-03-10 0001689657 srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2022-01-01 2022-03-31 0001689657 bli:AbCelleraAndUBCMember 2021-07-01 2021-07-01 0001689657 bli:AbCelleraUnfairCompetitionMember 2020-08-01 2020-08-31 0001689657 bli:AbCelleraNonInfringementMember 2020-08-01 2020-08-31 0001689657 2020-10-01 2020-10-31 0001689657 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001689657 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001689657 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001689657 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001689657 srt:NorthAmericaMember 2022-01-01 2022-03-31 0001689657 srt:NorthAmericaMember 2021-01-01 2021-03-31 0001689657 srt:AsiaPacificMember 2022-01-01 2022-03-31 0001689657 srt:AsiaPacificMember 2021-01-01 2021-03-31 0001689657 srt:EuropeMember 2022-01-01 2022-03-31 0001689657 srt:EuropeMember 2021-01-01 2021-03-31 shares iso4217:USD iso4217:USD shares pure bli:facility bli:patent bli:claim bli:segment 0001689657 --12-31 2022 Q1 false http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent 10-Q true 2022-03-31 false 001-39388 Berkeley Lights, Inc. DE 35-2415390 5858 Horton Street, Suite 320 Emeryville CA 94608 510 858-2855 Common stock, $0.00005 par value BLI NASDAQ Yes Yes Large Accelerated Filer false false false 67826564 164674000 178096000 17721000 25942000 15665000 14547000 10304000 11985000 208364000 230570000 270000 270000 29913000 27992000 25325000 26060000 1985000 2361000 265857000 287253000 8015000 8198000 9916000 12425000 9780000 12128000 27711000 32751000 19778000 19762000 1600000 2187000 23567000 24337000 72656000 79037000 0.00005 0.00005 300000000 300000000 67820115 67820115 67595535 67595535 4000 4000 478231000 471820000 -285034000 -263608000 193201000 208216000 265857000 287253000 9774000 13533000 10432000 5095000 20206000 18628000 2695000 3703000 3684000 2474000 6379000 6177000 13827000 12451000 17573000 13027000 11716000 8967000 5811000 5606000 35100000 27600000 -21273000 -15149000 224000 354000 34000 66000 57000 19000 -21406000 -15418000 20000 17000 -21426000 -21426000 -15435000 -15435000 -0.32 -0.32 -0.24 -0.24 67697488 67697488 65259398 65259398 67595535 4000 471820000 -263608000 208216000 81654 412000 412000 27580 115346 610000 610000 5389000 5389000 -21426000 -21426000 67820115 4000 478231000 -285034000 193201000 64486246 3000 436662000 -191884000 244781000 1778130 1000 6361000 6362000 5000 115360 2157000 2157000 4501000 4501000 -15435000 -15435000 66384736 4000 449681000 -207319000 242366000 -21426000 -15435000 1944000 1345000 5393000 4494000 735000 495000 -16000 -18000 195000 44000 28000 13000 -8221000 3493000 1317000 2744000 -2057000 1036000 298000 2690000 -2935000 3039000 -2552000 -429000 -726000 -361000 -10069000 -11360000 4375000 402000 -4375000 -402000 412000 6362000 610000 2157000 1022000 8519000 -13422000 -3243000 178366000 233678000 164944000 230435000 The Company and Basis of Presentation<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Berkeley Lights, Inc. (the “Company” or “Berkeley Lights”) is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights’ platform is a fully integrated, end-to-end solution, comprised of proprietary consumables, including the Company’s OptoSelect chips and reagent kits, advanced automation systems and advanced application and workflow software.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Berkeley Lights and its consolidated subsidiaries are hereinafter referred to as the “Company”. The Company’s headquarters are in Emeryville, California.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">Liquidity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company has experienced losses from its operations since its inception and has relied primarily on equity and debt financing to fund its operations to date. For the three months ended March 31, 2022, the Company had a consolidated net loss of $21.4 million and as of March 31, 2022 had an accumulated deficit of $285.0 million and unrestricted cash and cash equivalents of $164.7 million. Management expects to continue to incur significant expenses for the foreseeable future and to incur operating losses in the near term while the Company makes investments to support its anticipated growth. The Company believes that its cash and cash equivalents balance as of March 31, 2022 provides sufficient capital resources to continue its operations for at least 12 months from the issuance date of the accompanying consolidated financial statements.</span></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.</span></div> -21400000 -285000000 164700000 Summary of Significant Accounting Policies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission and have not materially changed during the three months ended March 31, 2022, with the exception of the Company’s accounting policy for stock-based compensation, as the Company granted awards with market conditions for the first time during the three months ended March 31 2022, as described further below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.</span></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.</span></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company maintains an incentive compensation plan under which stock options and restricted stock units (“RSU”) are granted to employees and non-employee consultants. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation expense is based on the grant date fair value of the award. The Company determines the fair value of RSUs based on the closing value of its stock price listed on the Nasdaq at the date of the grant. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company estimates the fair value of the majority of stock option awards on the grant date using the Black-Scholes option-pricing model. For option awards that include a goal tied to the Company share price (i.e. a market condition) the Company uses a Monte Carlo simulation to estimate the fair value. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock options and RSUs with only a service condition is recognized as compensation expense on a straight-line basis over the requisite service period in which the awards are expected to vest and forfeitures are recognized as they occur. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options and RSUs that include a service condition and a performance condition are considered expected to vest when the performance condition is probable of being met. Compensation expense associated with performance stock options and awards that are determined to be probable of achievement is recognized over the requisite service period on a tranche-by-tranche basis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For performance stock options and awards not initially assessed as probable of achievement, the Company records a cumulative adjustment to compensation expense in the period the Company changes its determination that a performance condition becomes probable of being achieved. The Company ceases recognition of compensation expense in any periods where the Company determines the attainment of a performance condition is no longer probable. If the performance goals are determined to be improbable, any previously recognized compensation expense is reversed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of stock option with a market condition is recognized over the requisite service period for each tranche of the award and is recognized regardless of whether (or to what extent) the market condition is ultimately achieved.</span></div> Significant Risks and Uncertainties Including Business and Credit Concentrations<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and trade receivables. The Company’s cash and cash equivalents are held by large, credit worthy financial institutions. The Company invests its excess cash in money market funds. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. Deposits in these banks may exceed the amounts of insurance provided on such deposits. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company controls credit risk through credit approvals and monitoring procedures. The Company performs periodic credit evaluations of its customers and generally does not require collateral. Accounts receivable are recorded net of an allowance for doubtful accounts. The allowance for doubtful accounts is based on management’s assessment of the collectability of specific customer accounts and the aging of the related invoices and represents the Company’s best estimate of expected credit losses in its existing trade accounts receivable. At each of March 31, 2022 and December 31, 2021, the Company had not recorded any material allowance for doubtful accounts. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Most of the Company’s customers are located in the United States and Asia Pacific. For the three months ended March 31, 2022, three customers accounted for 18%, 13% and 10% of revenue. For the three months ended March 31, 2021, two customers accounted for 11% and 10% of revenue. </span></div>As of March 31, 2022, four customers comprised 22%, 14%, 11% and 10% of accounts receivable. As of December 31, 2021, three customers accounted for 15%, 11% and 11% of accounts receivable. 0.18 0.13 0.10 0.11 0.10 0.22 0.14 0.11 0.10 0.15 0.11 0.11 Revenue From Contracts With Customers<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table depicts the disaggregation of revenue by type of customer or sales channel, market segment as defined by nature of workflows and activities of the end customer and timing of revenue recognition (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Type of Sales Channel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Direct sales channel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,486 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Distributor channel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Antibody therapeutics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Synthetic biology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agricultural biology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gene therapy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cell therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goods and services transferred at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goods and services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,370 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenues by market are determined by the revenue associated with workflows that the Company’s customers are utilizing, primarily on the Company’s Beacon platform, or by the nature of the workflows that the Company is developing under strategic partnerships and services agreements. Revenues by geographical markets are presented in Note 15 to these condensed consolidated financial statements. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A significant number of the Company’s product and service sales, as well as its feasibility study arrangements, are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14 exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 31, 2022, the aggregate amount of remaining performance obligations that are unsatisfied or partially unsatisfied related to customer contracts in excess of one year w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as $6.9 million, which is included in deferred revenue on the Company’s condensed consolidated balance sheets, of which approximately 35% is e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">xpected to be recognized as revenue in the next 12 months, with the remainder recognized afterwards. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.477%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17,721 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract assets, which are included in “Prepaid expenses and other current assets”</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,896 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract assets, long-term, which are included in “Other assets”</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue (current)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,780 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue (non-current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The contract liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of $11.4 million and $14.3 million as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of March 31, 2022 and December 31, 2021, respectively, consisted of deferred revenue related to extended warranty service agreements, strategic partnerships and services agreements and advanced automation systems arrangements. Revenue recorded during the three months ended March 31, 2022 i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ncluded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$4.6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of previously deferred revenue that was included in contract liabilities as of December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Sales-type Lease Arrangements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company also enters into sales-type lease arrangements with certain qualified customers. Revenue related to lease elements from sales-type leases is presented as product revenue and was nil and $1.7 million for the three months ended March 31, 2022 and 2021, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the future maturity of the Company’s fixed-term customer leases and reconciles the undiscounted cash flows from the amounts due from customers under such arrangements as of March 31, 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sales-Type<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: unearned income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total amounts due from customers, gross</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table depicts the disaggregation of revenue by type of customer or sales channel, market segment as defined by nature of workflows and activities of the end customer and timing of revenue recognition (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Type of Sales Channel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Direct sales channel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,486 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Distributor channel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,720 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Antibody therapeutics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Synthetic biology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agricultural biology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gene therapy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cell therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goods and services transferred at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goods and services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,370 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 15486000 10439000 4720000 8189000 20206000 18628000 14225000 15114000 2472000 1984000 1491000 0 1774000 1225000 244000 305000 20206000 18628000 9836000 13064000 10370000 5564000 20206000 18628000 6900000 0.35 P12M The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.477%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17,721 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract assets, which are included in “Prepaid expenses and other current assets”</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,896 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract assets, long-term, which are included in “Other assets”</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue (current)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,780 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue (non-current)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 17721000 25942000 1896000 1736000 571000 1070000 9780000 12128000 1600000 2187000 11400000 14300000 4600000 0 1700000 <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the future maturity of the Company’s fixed-term customer leases and reconciles the undiscounted cash flows from the amounts due from customers under such arrangements as of March 31, 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sales-Type<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: unearned income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total amounts due from customers, gross</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1655000 445000 853000 2953000 368000 2585000 Balance Sheet Accounts<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Inventory</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table shows the components of inventory (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,861 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,665 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,547 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table shows the components of prepaid expenses and other current assets (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,896 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vendor deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,944 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,304 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,985 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) Other includes primarily prepaid rent expenses, software licenses and prepaid VAT.</span></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table shows the components of accrued expenses and other current liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued payroll and employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwMTM5N2ZmNGExYjRmMzZhNGFhOGYyYjc1ZTI5NzEyL3NlYzo5MDEzOTdmZjRhMWI0ZjM2YTRhYThmMmI3NWUyOTcxMl80My9mcmFnOjllYmJhYjVmN2UxYzRiODdhYmU0MjBiODZmMjY0NmM5L3RhYmxlOjdjZDIyYTc4YjVlMDQ4NGRhZTkwNDU2ZjRiZDEyMDQ0L3RhYmxlcmFuZ2U6N2NkMjJhNzhiNWUwNDg0ZGFlOTA0NTZmNGJkMTIwNDRfMy0wLTEtMS0yNzA4NQ_4d8a80f9-6d14-4c89-b833-90d17ec8c275"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwMTM5N2ZmNGExYjRmMzZhNGFhOGYyYjc1ZTI5NzEyL3NlYzo5MDEzOTdmZjRhMWI0ZjM2YTRhYThmMmI3NWUyOTcxMl80My9mcmFnOjllYmJhYjVmN2UxYzRiODdhYmU0MjBiODZmMjY0NmM5L3RhYmxlOjdjZDIyYTc4YjVlMDQ4NGRhZTkwNDU2ZjRiZDEyMDQ0L3RhYmxlcmFuZ2U6N2NkMjJhNzhiNWUwNDg0ZGFlOTA0NTZmNGJkMTIwNDRfMy0wLTEtMS0yNzA4NQ_b7b51515-c3f2-4047-9e74-1b6b6ac9490f">Lease liability – short-term</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued product warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,085 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued legal expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,916 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,425 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div>(1) Other includes primarily accrued income taxes, sales taxes, accrued royalties and other miscellaneous accruals. <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table shows the components of inventory (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,861 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,804 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,665 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,547 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> 8861000 8296000 6804000 6251000 15665000 14547000 The following table shows the components of prepaid expenses and other current assets (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contract asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,896 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vendor deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,712 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,944 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,304 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,985 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) Other includes primarily prepaid rent expenses, software licenses and prepaid VAT.</span></div> 1896000 1736000 2712000 2802000 512000 561000 1640000 2944000 3544000 3942000 10304000 11985000 <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table shows the components of accrued expenses and other current liabilities (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued payroll and employee related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwMTM5N2ZmNGExYjRmMzZhNGFhOGYyYjc1ZTI5NzEyL3NlYzo5MDEzOTdmZjRhMWI0ZjM2YTRhYThmMmI3NWUyOTcxMl80My9mcmFnOjllYmJhYjVmN2UxYzRiODdhYmU0MjBiODZmMjY0NmM5L3RhYmxlOjdjZDIyYTc4YjVlMDQ4NGRhZTkwNDU2ZjRiZDEyMDQ0L3RhYmxlcmFuZ2U6N2NkMjJhNzhiNWUwNDg0ZGFlOTA0NTZmNGJkMTIwNDRfMy0wLTEtMS0yNzA4NQ_4d8a80f9-6d14-4c89-b833-90d17ec8c275"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwMTM5N2ZmNGExYjRmMzZhNGFhOGYyYjc1ZTI5NzEyL3NlYzo5MDEzOTdmZjRhMWI0ZjM2YTRhYThmMmI3NWUyOTcxMl80My9mcmFnOjllYmJhYjVmN2UxYzRiODdhYmU0MjBiODZmMjY0NmM5L3RhYmxlOjdjZDIyYTc4YjVlMDQ4NGRhZTkwNDU2ZjRiZDEyMDQ0L3RhYmxlcmFuZ2U6N2NkMjJhNzhiNWUwNDg0ZGFlOTA0NTZmNGJkMTIwNDRfMy0wLTEtMS0yNzA4NQ_b7b51515-c3f2-4047-9e74-1b6b6ac9490f">Lease liability – short-term</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued product warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,085 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued legal expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,916 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,425 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div>(1) Other includes primarily accrued income taxes, sales taxes, accrued royalties and other miscellaneous accruals. 4697000 6757000 2984000 2941000 914000 1085000 680000 504000 641000 1138000 9916000 12425000 Fair Value of Financial Instruments<div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying amounts of the Company’s cash equivalents, accounts receivable and accounts payable approximate fair value due to their relatively short maturities. The Company classifies its cash equivalents, which are comprised primarily of money market funds, within Level 1, as it uses quoted market prices in the determination of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values and fair values of the Company’s financial instruments not measured at fair value were as follows (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,778 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,295 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,762 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company estimated the fair value of its long-term debt using a market-based approach that considers an average cost of debt. The Company has incorporated its own credit risk for all liability fair value measurements. Such fair value measurements are considered Level 2 under the fair value hierarchy.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company did not have any transfers of financial assets measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 for any of the periods presented.</span></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 25141000 25141000 0 0 25141000 25141000 0 0 25138000 25138000 0 0 25138000 25138000 0 0 <div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values and fair values of the Company’s financial instruments not measured at fair value were as follows (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,778 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,295 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,762 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19778000 19295000 19762000 19298000 Property and Equipment, net<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net comprised the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equipment, tooling and molds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,972 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer software and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,955 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53,356 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49,790 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(23,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27,992 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total depreciation expense for the three months ended March 31, 2022 and 2021 was $1.9 million and $1.3 million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022 and 2021, losses on the impairment and disposal of property and equipment was not material.</span></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net comprised the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equipment, tooling and molds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37,050 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,972 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer software and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,955 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53,356 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49,790 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(23,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27,992 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> 37050000 33972000 2845000 3019000 1955000 1891000 10750000 6105000 756000 4803000 53356000 49790000 23443000 21798000 29913000 27992000 1900000 1300000 Leases<div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company leases office, manufacturing, distribution and laboratory facilities in Emeryville, California under multiple operating leases. During the third quarter of 2021, the Company extended the term for its leases related to the facilities in Emeryville and these leases will now expire in 2029. Also, during the third quarter of 2021, the Company entered into a seven year lease of space for office and laboratory operations in Lexington, Massachusetts, which commenced on July 1, 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company also leases two facilities in Shanghai, China for office and laboratory facilities under operating lease agreements that were entered into in July 2020. These leases expire at various dates, the latest of which is August 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future payments associated with the Company’s operating lease liabilities as of March 31, 2022 is as follows (in thousands): </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Operating leases</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Undiscounted lease payments for the year ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,621 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,108 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: implied interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: tenant improvement allowances receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Present value of operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,551 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: current portion (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total long-term operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) Included in the balance sheet caption “Accrued expenses and other current liabilities.”</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rent expense for the three months ended March 31, 2022 and 2021 was $1.1 million and $0.8 million, respectively. Under the terms of the lease agreements, the Company is also responsible for certain variable lease payments that are not included in the measurement of the lease liability. Variable lease payments for operating leases were $0.8 million and $0.5 million for the three months ended March 31, 2022 and 2021, respectively, including non-lease components such as common area maintenance fees. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets obtained for new operating lease liabilities </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following summarizes additional information related to operating leases:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.51</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>The Company also enters into leasing transactions in which the Company is the lessor, which to date have been classified as sales-type leases. See Note 4 of these condensed consolidated financial statements for the related lease disclosures. P7Y 2 <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future payments associated with the Company’s operating lease liabilities as of March 31, 2022 is as follows (in thousands): </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Operating leases</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Undiscounted lease payments for the year ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,276 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,621 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,108 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: implied interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: tenant improvement allowances receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Present value of operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,551 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: current portion (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total long-term operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div>(1) Included in the balance sheet caption “Accrued expenses and other current liabilities.” 3148000 4276000 4355000 4486000 4621000 12222000 33108000 5131000 1426000 26551000 2984000 23567000 1100000 800000 800000 500000 <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets obtained for new operating lease liabilities </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following summarizes additional information related to operating leases:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.51</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0 0 1098000 691000 P7Y3M7D P7Y6M3D 0.0467 0.0467 Notes Payable<div style="margin-top:6pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On May 23, 2018, the Company entered into a Loan and Security Agreement with East West Bank (“EWB”) providing it the ability to borrow up to $20.0 million. The loan facility was fully drawn as of May 23, 2018.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On June 30, 2021, the Company entered into an Amended and Restated Loan and Security Agreement (the “Agreement”) with EWB. Pursuant to the Agreement, EWB provided a $20.0 million term loan (the “Term Loan”) which was used to refinance the term loan outstanding under the Loan and Security Agreement dated May 23, 2018. The Term Loan matures in </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">48 months and bears a fixed interest rate of 4.17%. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Term Loan has an initial interest-only period of 24 months, which can be extended to up to 36 months based on the achievement of certain liquidity measures, and can be pre-paid without penalty at any time. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Agreement grants EWB a security interest in and liens on all assets of the Company, excluding intellectual property, which is subject to a double negative pledge. In addition, certain other terms of the original agreements as previously in effect were amended by the Agreement, including certain financial covenants. The Amended and Restated Loan and Security Agreement was accounted for as a debt modification and the Company capitalized incremental debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, the Agreement also provided the Company with a new $10.0 million revolving credit (the “Revolving Line”), which bears interest on the outstanding daily balance thereof of 0.70% above the Prime Rate (as defined in the Agreement). No amounts were outstanding under the Revolving Line as of March 31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Agreement contains certain financial and non-financial covenants. As of March 31, 2022, the Company was in compliance with the terms and covenants of the Agreement. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following is a schedule of payments due on notes payable as of March 31, 2022 (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ending December 31:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total payments due</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,870 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest payments, loan discounts and financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current portion, less loan discounts and financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,778 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table>Total interest cost incurred for the three months ended March 31, 2022 and 2021 was $0.2 million and $0.4 million, respectively. 20000000 20000000 P48M 0.0417 P24M P36M 10000000 0.0070 0 The following is a schedule of payments due on notes payable as of March 31, 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ending December 31:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">637 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total payments due</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,870 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest payments, loan discounts and financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current portion, less loan discounts and financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,778 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table> 637000 6617000 10406000 4210000 21870000 2092000 0 19778000 200000 400000 Stock Compensation Plans<div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation related to the Company's stock-based awards was recorded as an expense and allocated as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,393 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,494 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation capitalized in inventory was not material as of March 31, 2022 and December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On March 10, 2022, the Company granted the newly appointed Chief Executive Officer of the Company 1,017,177 RSUs, 339,059 stock options and 678,118 performance-based stock options (“PSOs”). The RSUs and stock options vest quarterly over 3 years and the stock options have a 10 year term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The PSOs have a 7-year performance period, a 10-year term and vest based upon certain market conditions and a continued service-based requirement. Market condition-related vesting is triggered based on the Company’s stock price reaching certain goals that range from two to 20 times the Company share price on the date of grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Although no awards will vest until a market condition is satisfied, as of March 31, 2022 the Company began recording stock-based compensation expense for each vesting tranche based on the estimated achievement date of the specified stock price target. The valuation and probability of achievement for each tranche is determined using a Monte Carlo simulation. The same Monte Carlo simulation is used as the basis for determining the expected achievement date. As the probability of achievement is factored in as part of the Monte Carlo simulation, the expense for these tranches will be recognized concurrently over each tranche’s estimated achievement date even if some or all of the options never vest. If the related market condition for a tranche is achieved earlier than </span></div>expected, all unamortized expense for such tranche will be recognized immediately. As of March 31, 2022, none of the PSOs had vested. <div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation related to the Company's stock-based awards was recorded as an expense and allocated as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,393 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,494 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 51000 42000 1581000 1061000 2211000 1372000 1550000 2019000 5393000 4494000 1017177 339059 678118 P3Y P3Y P10Y P7Y P10Y 2 20 0 Income TaxesThe Company’s provision for income taxes was $20 thousand and $17 thousand, respectively, for the three months ended March 31, 2022 and 2021. For the three months ended March 31, 2022 and 2021, income from operations before taxes consisted of amounts related to U.S. operations and the Company’s foreign operations. The Company maintains a full valuation allowance on its deferred tax assets, and intends to do so until there is sufficient evidence to support the reversal of all or some portion of these allowances. 20000 17000 Statements of Cash Flows<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The supplemental cash flow information consists of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inventory transferred to property and equipment (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in accounts payable and accrued liabilities related to purchases of property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) The non-cash transfer of inventory to property and equipment principally relates to Beacons that were transferred to the Company’s BioFoundry operations in the first and second quarter of 2021. As a result of the growth of the Company’s BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in the Company’s BioFoundry operations will be categorized as “Purchase of property and equipment.”</span></div> <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The supplemental cash flow information consists of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inventory transferred to property and equipment (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in accounts payable and accrued liabilities related to purchases of property and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) The non-cash transfer of inventory to property and equipment principally relates to Beacons that were transferred to the Company’s BioFoundry operations in the first and second quarter of 2021. As a result of the growth of the Company’s BioFoundry operations, including growth in the number of Beacons used to fulfill strategic partnerships and services agreements, beginning in the third quarter of 2021, Beacons that at inception are planned to be used in the Company’s BioFoundry operations will be categorized as “Purchase of property and equipment.”</span></div> 137000 337000 0 2813000 -482000 751000 Commitments and Contingencies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. The Company records a liability in its financial statements for these matters when a loss is known and considered probable and the amount can be reasonably estimated. The Company does not recognize gain contingencies until they are realized. Legal costs incurred relating to loss contingencies are expensed as incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">AbCellera Biologics Litigation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In July 2020, AbCellera Biologics Inc. (“AbCellera”) filed a complaint in the United States District Court for the District of Delaware, alleging that the Company infringed and continues to infringe, directly and indirectly, the following patents exclusively licensed by AbCellera by making, using, offering for sale, selling and/or importing the Company’s Beacon and Culture Station instruments and the OptoSelect chips, and sale of the Opto Plasma B Discovery Workflow: U.S. Patent Nos. 10,107,812, 10,274,494, 10,466,241, 10,578,618, 10,697,962, 10,087,408, 10,421,936 and 10,704,018 (“AbCellera I”).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2020, AbCellera filed a second complaint in the United States District Court for the District of Delaware, making the same allegations with regard to U.S. Patent Nos. 10,718,768, 10,738,270, 10,746,737, and 10,753,933 (“AbCellera II”). In September 2020, AbCellera filed amended complaints in each of AbCellera I and AbCellera II adding The University of British Columbia (“UBC”) as a named plaintiff. Also in September 2020, AbCellera and UBC filed a third complaint in the United States District Court for the District of Delaware, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">making the same allegations with regard to U.S. Patent Nos. 10,775,376, 10,775,377, and 10,775,378 (“AbCellera III”). AbCellera and UBC are seeking, among other things, judgment of infringement, a permanent injunction and damages (including lost profits, a reasonable royalty, reasonable costs and attorney’s fees and treble damages for willful infringement). In addition to procedural motions, the Company has filed an answer and counterclaims in response to each of the AbCellera I, AbCellera II and AbCellera III lawsuits. The Company’s counterclaims in each lawsuit include counts for declaratory judgment of non-infringement of the asserted patents, for declaratory judgment of invalidity of the asserted patents and for declaratory judgment of unenforceability of the asserted patents due to inequitable conduct. The Company filed a motion to transfer the AbCellera I, AbCellera II and AbCellera III lawsuits to the United States District Court for the Northern District of California, which was granted and where the lawsuits have been consolidated and are now pending (the “consolidated lawsuit”). On May 6, 2021, and pursuant to Court Order, AbCellera and UBC reduced, without prejudice, the asserted patents in the consolidated lawsuit to the following: US Patent Nos. 10,087,408, 10,421,936, 10,738,270, 10,697,962, 10,753,933, 10,775,376 and 10,775,378. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On July 1, 2021, the court granted the Company’s motion to amend its answer and counterclaims to add federal and state unfair competition counterclaims against AbCellera Biologics; on July 22, 2021, the Company filed its amended answer and counterclaims. Also on July 1, 2021 the court issued a Case Management Order that, among other things, requires AbCellera and UBC to reduce the number of asserted patents to no more than two, and the total asserted patent claims to no more than four per patent prior to the trial.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Also in July 2021, the Company filed petitions for Inter Partes Review (“IPR”) with the United States Patent &amp; Trademark Office (“USPTO”), challenging the validity of various asserted claims of U.S. Patent No. 10,087,408 and all asserted claims of U.S. Patent No. 10,421,936, then filed a motion in the district court to stay the consolidated lawsuit pending the outcome of the IPR proceedings. In August 2021, the Company filed a third petition for IPR with the USPTO, challenging the validity of all asserted claims of U.S. Patent No. 10,739,270. Also in August 2021, the court granted the Company’s motion to stay the consolidated AbCellera I, AbCellera II, and AbCellera III lawsuits pending the outcome of the IPR proceedings.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In January 2022, the Patent Trial and Appeal Board (“PTAB”) of the USPTO issued a decision instituting IPR on U.S. Patent No. 10,087,408 and a decision denying IPR on U.S. Patent No. 10,421,936. In February 2022, the PTAB issued a decision denying IPR on U.S. Patent No. 10,739,270.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2020, the Company filed a complaint in the United States District Court for the Northern District of California against AbCellera and Lineage BioSciences, Inc., an entity previously acquired by AbCellera (“AbCellera IV”). The complaint included two counts of unfair competition and one count of a declaratory judgment of non-infringement of U.S. Patent No. 10,058,839. The Company was seeking, among other things, damages and a judgment of non-infringement. In October 2020, the Company filed an amended complaint asserting the same three counts and AbCellera and Lineage filed a motion to dismiss the amended complaint, which was granted, without prejudice, in part. In light of the Company’s amended answer and counterclaims in the consolidated lawsuits, which were amended to include its federal and state unfair competition claims as discussed above, in July 2021 the Company filed a notice of dismissal without prejudice in the AbCellera IV lawsuit, resulting in its termination.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company believes that the patent assertions by AbCellera and UBC are without merit and intends to defend itself vigorously. The Company also intends to proceed with its claims and counterclaims against AbCellera and UBC. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in these lawsuits could subject the Company to significant liabilities, require it to seek licenses from or pay royalties to AbCellera and/or UBC, or prevent it from manufacturing, selling or using certain of its products, any of which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Securities Class Action</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In December 2021, Victor J. Ng filed a securities class action on behalf of all purchasers of Berkeley Lights common stock between July 17, 2020 and September 14, 2021, inclusive, alleging that the Company and certain of the Company’s current and former senior executives had violated §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder (the “Securities Class Action”). The Company believes that the assertions in the Securities Class Action are without merit and intends to defend itself vigorously. Outcomes in litigation can be uncertain and it is possible a court may disagree with the Company’s positions. An adverse determination in the Securities Class Action could subject the Company to significant liabilities, which could have a material adverse effect on the Company’s business, financial condition, results of operations and prospects. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derivative Action</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In March 2022, Trung Nguyen filed a shareholder derivative complaint on behalf of nominal defendant Berkeley Lights, Inc., alleging that certain of the Company’s current and former directors and certain of the Company’s current and former senior executives breached their fiduciary duties to the Company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The complaint also alleged that certain of the Company’s current and former directors and former senior executives used material, non-public information to improperly profit from the sale of Company stock, and that certain of the Company’s current and former senior executives owe the Company contribution for violations of sections 10(b) and 21D of the Securities Exchange Act of 1934. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is not currently involved in any other claims or legal actions, nor is management aware of any potential claims or legal actions, for which the ultimate disposition could have a material adverse effect on the Company’s financial position, results of operations, or liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">No provision has been made for litigation because the Company believes that it is not probable that a liability had been incurred as of March 31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company provides a 13-month assurance-type warranty, generally beginning on the shipment date, on its platforms and chip consumables. The table below represents the activity in the product warranty accrual included in accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,085 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,271 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustments to existing warranties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Provision for new warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Settlement of pre-existing warranties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2 4 2 1 3 0 P13M The table below represents the activity in the product warranty accrual included in accrued expenses and other current liabilities on the condensed consolidated balance sheets (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,085 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,271 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustments to existing warranties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Provision for new warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Settlement of pre-existing warranties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 1085000 1271000 -245000 -218000 163000 375000 89000 160000 914000 1268000 Net Loss Attributable to Common Stockholders Per Share<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards. Awards granted with performance conditions are excluded from the shares used to compute diluted earnings per share until the performance conditions associated with the awards are met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per common share (in thousands, except share and per share data):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15,435)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average shares used to compute net income per share, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67,697,488</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65,259,398</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since the Company was in a loss position for all periods presented, basic net loss per share attributable to common stockholders is the same as diluted net loss per share attributable to common stockholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented as they had an anti-dilutive effect:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,020,591 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,399,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,629,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">356,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,649,901 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,755,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> The following table sets forth the computation of basic and diluted earnings per common share (in thousands, except share and per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15,435)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average shares used to compute net income per share, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67,697,488</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65,259,398</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> -21426000 -21426000 -15435000 -15435000 67697488 67697488 65259398 65259398 -0.32 -0.32 -0.24 -0.24 The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented as they had an anti-dilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,020,591 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,399,147 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,629,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">356,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,649,901 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,755,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 7020591000 8399147000 3629310000 356725000 10649901000 8755872000 Segments<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company has one business activity and there are no segment managers who are held accountable for operations. Accordingly, the Company has one operating segment. The Company’s principal operations and decision-making functions are located in the United States.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table provides the Company’s revenues by geographical market based on the location where the services were provided or to which product was shipped (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,362 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Asia Pacific (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,035 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,431 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,456 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) Asia Pacific includes Australia.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 31, 2022 and December 31, 2021, substantially all of the Company’s long-lived assets were located in the United States</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div> 1 <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table provides the Company’s revenues by geographical market based on the location where the services were provided or to which product was shipped (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.996%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,362 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Asia Pacific (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,035 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,431 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,456 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,628 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) Asia Pacific includes Australia.</span></div> 13715000 7362000 5035000 8431000 1456000 2835000 20206000 18628000 EXCEL 77 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 78 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 79 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 80 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 117 229 1 false 57 0 false 8 false false R1.htm 0001001 - Document - Cover Sheet http://berkeleylights.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets Sheet http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 2101101 - Disclosure - The Company and Basis of Presentation Sheet http://berkeleylights.com/role/TheCompanyandBasisofPresentation The Company and Basis of Presentation Notes 7 false false R8.htm 2104102 - Disclosure - Summary of Significant Accounting Policies Sheet http://berkeleylights.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2105103 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations Sheet http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrations Significant Risks and Uncertainties Including Business and Credit Concentrations Notes 9 false false R10.htm 2107104 - Disclosure - Revenue From Contracts With Customers Sheet http://berkeleylights.com/role/RevenueFromContractsWithCustomers Revenue From Contracts With Customers Notes 10 false false R11.htm 2113105 - Disclosure - Balance Sheet Accounts Sheet http://berkeleylights.com/role/BalanceSheetAccounts Balance Sheet Accounts Notes 11 false false R12.htm 2118106 - Disclosure - Fair Value of Financial Instruments Sheet http://berkeleylights.com/role/FairValueofFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 2122107 - Disclosure - Property and Equipment, net Sheet http://berkeleylights.com/role/PropertyandEquipmentnet Property and Equipment, net Notes 13 false false R14.htm 2126108 - Disclosure - Leases Sheet http://berkeleylights.com/role/Leases Leases Notes 14 false false R15.htm 2132109 - Disclosure - Notes Payable Notes http://berkeleylights.com/role/NotesPayable Notes Payable Notes 15 false false R16.htm 2136110 - Disclosure - Stock Compensation Plans Sheet http://berkeleylights.com/role/StockCompensationPlans Stock Compensation Plans Notes 16 false false R17.htm 2140111 - Disclosure - Income Taxes Sheet http://berkeleylights.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2142112 - Disclosure - Statements of Cash Flows Sheet http://berkeleylights.com/role/StatementsofCashFlows Statements of Cash Flows Notes 18 false false R19.htm 2145113 - Disclosure - Commitment and Contingencies Sheet http://berkeleylights.com/role/CommitmentandContingencies Commitment and Contingencies Notes 19 false false R20.htm 2149114 - Disclosure - Net Loss Attributable to Common Stockholders Per Share Sheet http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShare Net Loss Attributable to Common Stockholders Per Share Notes 20 false false R21.htm 2153115 - Disclosure - Segments Sheet http://berkeleylights.com/role/Segments Segments Notes 21 false false R22.htm 2202201 - Disclosure - The Company and Basis of Presentation (Policies) Sheet http://berkeleylights.com/role/TheCompanyandBasisofPresentationPolicies The Company and Basis of Presentation (Policies) Policies http://berkeleylights.com/role/SummaryofSignificantAccountingPolicies 22 false false R23.htm 2308301 - Disclosure - Revenue From Contracts With Customers (Tables) Sheet http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables Revenue From Contracts With Customers (Tables) Tables http://berkeleylights.com/role/RevenueFromContractsWithCustomers 23 false false R24.htm 2314302 - Disclosure - Balance Sheet Accounts (Tables) Sheet http://berkeleylights.com/role/BalanceSheetAccountsTables Balance Sheet Accounts (Tables) Tables http://berkeleylights.com/role/BalanceSheetAccounts 24 false false R25.htm 2319303 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://berkeleylights.com/role/FairValueofFinancialInstruments 25 false false R26.htm 2323304 - Disclosure - Property and Equipment, net (Tables) Sheet http://berkeleylights.com/role/PropertyandEquipmentnetTables Property and Equipment, net (Tables) Tables http://berkeleylights.com/role/PropertyandEquipmentnet 26 false false R27.htm 2327305 - Disclosure - Leases (Table) Sheet http://berkeleylights.com/role/LeasesTable Leases (Table) Tables http://berkeleylights.com/role/Leases 27 false false R28.htm 2333306 - Disclosure - Notes Payable (Tables) Notes http://berkeleylights.com/role/NotesPayableTables Notes Payable (Tables) Tables http://berkeleylights.com/role/NotesPayable 28 false false R29.htm 2337307 - Disclosure - Stock Compensation Plans (Tables) Sheet http://berkeleylights.com/role/StockCompensationPlansTables Stock Compensation Plans (Tables) Tables http://berkeleylights.com/role/StockCompensationPlans 29 false false R30.htm 2343308 - Disclosure - Statements of Cash Flows (Tables) Sheet http://berkeleylights.com/role/StatementsofCashFlowsTables Statements of Cash Flows (Tables) Tables http://berkeleylights.com/role/StatementsofCashFlows 30 false false R31.htm 2346309 - Disclosure - Commitment and Contingencies (Tables) Sheet http://berkeleylights.com/role/CommitmentandContingenciesTables Commitment and Contingencies (Tables) Tables http://berkeleylights.com/role/CommitmentandContingencies 31 false false R32.htm 2350310 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Tables) Sheet http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables Net Loss Attributable to Common Stockholders Per Share (Tables) Tables http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShare 32 false false R33.htm 2354311 - Disclosure - Segments (Tables) Sheet http://berkeleylights.com/role/SegmentsTables Segments (Tables) Tables http://berkeleylights.com/role/Segments 33 false false R34.htm 2403401 - Disclosure - The Company and Basis of Presentation (Details) Sheet http://berkeleylights.com/role/TheCompanyandBasisofPresentationDetails The Company and Basis of Presentation (Details) Details http://berkeleylights.com/role/TheCompanyandBasisofPresentationPolicies 34 false false R35.htm 2406402 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations (Details) Sheet http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails Significant Risks and Uncertainties Including Business and Credit Concentrations (Details) Details http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrations 35 false false R36.htm 2409403 - Disclosure - Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details) Sheet http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details) Details http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables 36 false false R37.htm 2410404 - Disclosure - Revenue from Contracts with Customer (Narrative) (Details) Sheet http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails Revenue from Contracts with Customer (Narrative) (Details) Details 37 false false R38.htm 2411405 - Disclosure - Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details) Sheet http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details) Details http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables 38 false false R39.htm 2412406 - Disclosure - Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details) Sheet http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details) Details 39 false false R40.htm 2415407 - Disclosure - Balance Sheet Accounts (Inventory) (Details) Sheet http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails Balance Sheet Accounts (Inventory) (Details) Details http://berkeleylights.com/role/BalanceSheetAccountsTables 40 false false R41.htm 2416408 - Disclosure - Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details) Sheet http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details) Details http://berkeleylights.com/role/BalanceSheetAccountsTables 41 false false R42.htm 2417409 - Disclosure - Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details) Sheet http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details) Details http://berkeleylights.com/role/BalanceSheetAccountsTables 42 false false R43.htm 2420410 - Disclosure - Fair Value of Financial Instruments (Assets and Liabilities) (Details) Sheet http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails Fair Value of Financial Instruments (Assets and Liabilities) (Details) Details http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables 43 false false R44.htm 2421411 - Disclosure - Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details) Sheet http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details) Details http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables 44 false false R45.htm 2424412 - Disclosure - Property and Equipment, net (Schedule of Property and Equipment) (Details) Sheet http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails Property and Equipment, net (Schedule of Property and Equipment) (Details) Details http://berkeleylights.com/role/PropertyandEquipmentnetTables 45 false false R46.htm 2425413 - Disclosure - Property and Equipment, net (Narrative) (Details) Sheet http://berkeleylights.com/role/PropertyandEquipmentnetNarrativeDetails Property and Equipment, net (Narrative) (Details) Details http://berkeleylights.com/role/PropertyandEquipmentnetTables 46 false false R47.htm 2428414 - Disclosure - Leases (Narrative) (Details) Sheet http://berkeleylights.com/role/LeasesNarrativeDetails Leases (Narrative) (Details) Details http://berkeleylights.com/role/LeasesTable 47 false false R48.htm 2429415 - Disclosure - Leases (Maturity Schedule of Operating Lease Liabilities) (Details) Sheet http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails Leases (Maturity Schedule of Operating Lease Liabilities) (Details) Details http://berkeleylights.com/role/LeasesTable 48 false false R49.htm 2430416 - Disclosure - Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details) Sheet http://berkeleylights.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details) Details http://berkeleylights.com/role/LeasesTable 49 false false R50.htm 2431417 - Disclosure - Leases (Schedule of Additional Information Related to Operating Leases) (Details) Sheet http://berkeleylights.com/role/LeasesScheduleofAdditionalInformationRelatedtoOperatingLeasesDetails Leases (Schedule of Additional Information Related to Operating Leases) (Details) Details http://berkeleylights.com/role/LeasesTable 50 false false R51.htm 2434418 - Disclosure - Notes Payable (Narrative) (Details) Notes http://berkeleylights.com/role/NotesPayableNarrativeDetails Notes Payable (Narrative) (Details) Details http://berkeleylights.com/role/NotesPayableTables 51 false false R52.htm 2435419 - Disclosure - Notes Payable (Schedule of Payment Due on Notes Payable) (Details) Notes http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails Notes Payable (Schedule of Payment Due on Notes Payable) (Details) Details http://berkeleylights.com/role/NotesPayableTables 52 false false R53.htm 2438420 - Disclosure - Stock Compensation Plans (Stock-Based Compensation) (Details) Sheet http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails Stock Compensation Plans (Stock-Based Compensation) (Details) Details http://berkeleylights.com/role/StockCompensationPlansTables 53 false false R54.htm 2439421 - Disclosure - Stock Compensation Plans (Narrative) (Details) Sheet http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails Stock Compensation Plans (Narrative) (Details) Details http://berkeleylights.com/role/StockCompensationPlansTables 54 false false R55.htm 2441422 - Disclosure - Income Taxes (Details) Sheet http://berkeleylights.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://berkeleylights.com/role/IncomeTaxes 55 false false R56.htm 2444423 - Disclosure - Statements of Cash Flows (Details) Sheet http://berkeleylights.com/role/StatementsofCashFlowsDetails Statements of Cash Flows (Details) Details http://berkeleylights.com/role/StatementsofCashFlowsTables 56 false false R57.htm 2447424 - Disclosure - Commitment and Contingencies (Narrative) (Details) Sheet http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails Commitment and Contingencies (Narrative) (Details) Details http://berkeleylights.com/role/CommitmentandContingenciesTables 57 false false R58.htm 2448425 - Disclosure - Commitment and Contingencies (Product Warranty) (Details) Sheet http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails Commitment and Contingencies (Product Warranty) (Details) Details http://berkeleylights.com/role/CommitmentandContingenciesTables 58 false false R59.htm 2451426 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) Sheet http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) Details http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables 59 false false R60.htm 2452427 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details) Sheet http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details) Details http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables 60 false false R61.htm 2455428 - Disclosure - Segments (Details) Sheet http://berkeleylights.com/role/SegmentsDetails Segments (Details) Details http://berkeleylights.com/role/SegmentsTables 61 false false All Reports Book All Reports bli-20220331.htm bli-20220331.xsd bli-20220331_cal.xml bli-20220331_def.xml bli-20220331_lab.xml bli-20220331_pre.xml ex-102transitionandseparat.htm ex-103employmentagreements.htm ex-104changeinctrlseveranc.htm ex-311blix20220331x10q.htm ex-312blix20220331x10q.htm ex-321blix20220331x10q.htm ex-322blix20220331x10q.htm bli-20220331_g1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bli-20220331.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 117, "dts": { "calculationLink": { "local": [ "bli-20220331_cal.xml" ] }, "definitionLink": { "local": [ "bli-20220331_def.xml" ] }, "inline": { "local": [ "bli-20220331.htm" ] }, "labelLink": { "local": [ "bli-20220331_lab.xml" ] }, "presentationLink": { "local": [ "bli-20220331_pre.xml" ] }, "schema": { "local": [ "bli-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 392, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 2, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 7 }, "keyCustom": 14, "keyStandard": 215, "memberCustom": 15, "memberStandard": 40, "nsprefix": "bli", "nsuri": "http://berkeleylights.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://berkeleylights.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107104 - Disclosure - Revenue From Contracts With Customers", "role": "http://berkeleylights.com/role/RevenueFromContractsWithCustomers", "shortName": "Revenue From Contracts With Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113105 - Disclosure - Balance Sheet Accounts", "role": "http://berkeleylights.com/role/BalanceSheetAccounts", "shortName": "Balance Sheet Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118106 - Disclosure - Fair Value of Financial Instruments", "role": "http://berkeleylights.com/role/FairValueofFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122107 - Disclosure - Property and Equipment, net", "role": "http://berkeleylights.com/role/PropertyandEquipmentnet", "shortName": "Property and Equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126108 - Disclosure - Leases", "role": "http://berkeleylights.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2132109 - Disclosure - Notes Payable", "role": "http://berkeleylights.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2136110 - Disclosure - Stock Compensation Plans", "role": "http://berkeleylights.com/role/StockCompensationPlans", "shortName": "Stock Compensation Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2140111 - Disclosure - Income Taxes", "role": "http://berkeleylights.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2142112 - Disclosure - Statements of Cash Flows", "role": "http://berkeleylights.com/role/StatementsofCashFlows", "shortName": "Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2145113 - Disclosure - Commitment and Contingencies", "role": "http://berkeleylights.com/role/CommitmentandContingencies", "shortName": "Commitment and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149114 - Disclosure - Net Loss Attributable to Common Stockholders Per Share", "role": "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShare", "shortName": "Net Loss Attributable to Common Stockholders Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2153115 - Disclosure - Segments", "role": "http://berkeleylights.com/role/Segments", "shortName": "Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - The Company and Basis of Presentation (Policies)", "role": "http://berkeleylights.com/role/TheCompanyandBasisofPresentationPolicies", "shortName": "The Company and Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Revenue From Contracts With Customers (Tables)", "role": "http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables", "shortName": "Revenue From Contracts With Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314302 - Disclosure - Balance Sheet Accounts (Tables)", "role": "http://berkeleylights.com/role/BalanceSheetAccountsTables", "shortName": "Balance Sheet Accounts (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319303 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2323304 - Disclosure - Property and Equipment, net (Tables)", "role": "http://berkeleylights.com/role/PropertyandEquipmentnetTables", "shortName": "Property and Equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327305 - Disclosure - Leases (Table)", "role": "http://berkeleylights.com/role/LeasesTable", "shortName": "Leases (Table)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2333306 - Disclosure - Notes Payable (Tables)", "role": "http://berkeleylights.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2337307 - Disclosure - Stock Compensation Plans (Tables)", "role": "http://berkeleylights.com/role/StockCompensationPlansTables", "shortName": "Stock Compensation Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2343308 - Disclosure - Statements of Cash Flows (Tables)", "role": "http://berkeleylights.com/role/StatementsofCashFlowsTables", "shortName": "Statements of Cash Flows (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2346309 - Disclosure - Commitment and Contingencies (Tables)", "role": "http://berkeleylights.com/role/CommitmentandContingenciesTables", "shortName": "Commitment and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350310 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Tables)", "role": "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables", "shortName": "Net Loss Attributable to Common Stockholders Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2354311 - Disclosure - Segments (Tables)", "role": "http://berkeleylights.com/role/SegmentsTables", "shortName": "Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - The Company and Basis of Presentation (Details)", "role": "http://berkeleylights.com/role/TheCompanyandBasisofPresentationDetails", "shortName": "The Company and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ib4eecc290b914576885b8014b8903b58_D20220101-20220331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations (Details)", "role": "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails", "shortName": "Significant Risks and Uncertainties Including Business and Credit Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ib4eecc290b914576885b8014b8903b58_D20220101-20220331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details)", "role": "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails", "shortName": "Revenue From Contracts With Customers (Schedule of Disaggregation of Revenue) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i354cff3ec239471b9ea35bc0d72499b8_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Revenue from Contracts with Customer (Narrative) (Details)", "role": "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails", "shortName": "Revenue from Contracts with Customer (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details)", "role": "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails", "shortName": "Revenue From Contracts With Customers (Schedule of Receivables, Contract Assets and Deferred Revenue) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details)", "role": "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails", "shortName": "Revenue From Contracts With Customers - Sale-type Lease Arrangement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "role": "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415407 - Disclosure - Balance Sheet Accounts (Inventory) (Details)", "role": "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails", "shortName": "Balance Sheet Accounts (Inventory) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416408 - Disclosure - Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details)", "role": "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails", "shortName": "Balance Sheet Accounts (Prepaid Expenses and Other Current Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepositsAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details)", "role": "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails", "shortName": "Balance Sheet Accounts (Accrued Expenses and Other Current Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Fair Value of Financial Instruments (Assets and Liabilities) (Details)", "role": "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails", "shortName": "Fair Value of Financial Instruments (Assets and Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i9de818763c07428b99d9133530b5e66f_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details)", "role": "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails", "shortName": "Fair Value of Financial Instruments (Schedule of Financial Instruments Not Measured at Fair Value) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i9de818763c07428b99d9133530b5e66f_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424412 - Disclosure - Property and Equipment, net (Schedule of Property and Equipment) (Details)", "role": "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails", "shortName": "Property and Equipment, net (Schedule of Property and Equipment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - Property and Equipment, net (Narrative) (Details)", "role": "http://berkeleylights.com/role/PropertyandEquipmentnetNarrativeDetails", "shortName": "Property and Equipment, net (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bli:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428414 - Disclosure - Leases (Narrative) (Details)", "role": "http://berkeleylights.com/role/LeasesNarrativeDetails", "shortName": "Leases (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bli:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "facility", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429415 - Disclosure - Leases (Maturity Schedule of Operating Lease Liabilities) (Details)", "role": "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails", "shortName": "Leases (Maturity Schedule of Operating Lease Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430416 - Disclosure - Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)", "role": "http://berkeleylights.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails", "shortName": "Leases (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ie551dde08eb0486da9bfd98f718fbffa_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ie551dde08eb0486da9bfd98f718fbffa_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431417 - Disclosure - Leases (Schedule of Additional Information Related to Operating Leases) (Details)", "role": "http://berkeleylights.com/role/LeasesScheduleofAdditionalInformationRelatedtoOperatingLeasesDetails", "shortName": "Leases (Schedule of Additional Information Related to Operating Leases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i52644c3afc774c9983b7d7f9433787d7_I20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434418 - Disclosure - Notes Payable (Narrative) (Details)", "role": "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "shortName": "Notes Payable (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i675fb610c2da4591b116a1871f796bec_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435419 - Disclosure - Notes Payable (Schedule of Payment Due on Notes Payable) (Details)", "role": "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails", "shortName": "Notes Payable (Schedule of Payment Due on Notes Payable) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i675fb610c2da4591b116a1871f796bec_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438420 - Disclosure - Stock Compensation Plans (Stock-Based Compensation) (Details)", "role": "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails", "shortName": "Stock Compensation Plans (Stock-Based Compensation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ie24ee8f62de746e39b1f37926662aec5_D20220310-20220310", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439421 - Disclosure - Stock Compensation Plans (Narrative) (Details)", "role": "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails", "shortName": "Stock Compensation Plans (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "ie24ee8f62de746e39b1f37926662aec5_D20220310-20220310", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441422 - Disclosure - Income Taxes (Details)", "role": "http://berkeleylights.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444423 - Disclosure - Statements of Cash Flows (Details)", "role": "http://berkeleylights.com/role/StatementsofCashFlowsDetails", "shortName": "Statements of Cash Flows (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i3a67aaded7f245e1ada2f064fc1be99a_D20201001-20201031", "decimals": "INF", "first": true, "lang": "en-US", "name": "bli:LossContingencyAmendedComplaintNumberOfClaims", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447424 - Disclosure - Commitment and Contingencies (Narrative) (Details)", "role": "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails", "shortName": "Commitment and Contingencies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "i3a67aaded7f245e1ada2f064fc1be99a_D20201001-20201031", "decimals": "INF", "first": true, "lang": "en-US", "name": "bli:LossContingencyAmendedComplaintNumberOfClaims", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "if717254ad809447195f5171851e2c605_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448425 - Disclosure - Commitment and Contingencies (Product Warranty) (Details)", "role": "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails", "shortName": "Commitment and Contingencies (Product Warranty) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "if717254ad809447195f5171851e2c605_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451426 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details)", "role": "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails", "shortName": "Net Loss Attributable to Common Stockholders Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452427 - Disclosure - Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details)", "role": "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails", "shortName": "Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455428 - Disclosure - Segments (Details)", "role": "http://berkeleylights.com/role/SegmentsDetails", "shortName": "Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - The Company and Basis of Presentation", "role": "http://berkeleylights.com/role/TheCompanyandBasisofPresentation", "shortName": "The Company and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://berkeleylights.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105103 - Disclosure - Significant Risks and Uncertainties Including Business and Credit Concentrations", "role": "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrations", "shortName": "Significant Risks and Uncertainties Including Business and Credit Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bli-20220331.htm", "contextRef": "iaaa1f80e61bc423c94bb25ebe22414c6_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 57, "tag": { "bli_AbCelleraAndUBCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AbCellera And UBC", "label": "AbCellera And UBC [Member]", "terseLabel": "AbCellera And UBC" } } }, "localname": "AbCelleraAndUBCMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "bli_AbCelleraNonInfringementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AbCellera, Non-Infringement", "label": "AbCellera, Non-Infringement [Member]", "terseLabel": "AbCellera, Non-Infringement" } } }, "localname": "AbCelleraNonInfringementMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "bli_AbCelleraUnfairCompetitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AbCellera, Unfair Competition", "label": "AbCellera, Unfair Competition [Member]", "terseLabel": "AbCellera, Unfair Competition" } } }, "localname": "AbCelleraUnfairCompetitionMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "bli_AgriculturalBiologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agricultural Biology", "label": "Agricultural Biology [Member]", "terseLabel": "Agricultural biology" } } }, "localname": "AgriculturalBiologyMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bli_AntibodyTherapeuticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Antibody Therapeutics", "label": "Antibody Therapeutics [Member]", "terseLabel": "Antibody therapeutics" } } }, "localname": "AntibodyTherapeuticsMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bli_CellTherapyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cell Therapy", "label": "Cell Therapy [Member]", "terseLabel": "Cell therapy" } } }, "localname": "CellTherapyMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bli_CustomerFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Four", "label": "Customer Four [Member]", "terseLabel": "Customer Four" } } }, "localname": "CustomerFourMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "bli_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One", "label": "Customer One [Member]", "terseLabel": "Customer One" } } }, "localname": "CustomerOneMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "bli_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three", "label": "Customer Three [Member]", "terseLabel": "Customer Three" } } }, "localname": "CustomerThreeMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "bli_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two", "label": "Customer Two [Member]", "terseLabel": "Customer Two" } } }, "localname": "CustomerTwoMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "bli_DebtInstrumentInterestOnlyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Interest-Only Period", "label": "Debt Instrument, Interest-Only Period", "terseLabel": "Interest-only period" } } }, "localname": "DebtInstrumentInterestOnlyPeriod", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "durationItemType" }, "bli_DebtInstrumentInterestOnlyPeriodWithExtension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Interest-Only Period With Extension", "label": "Debt Instrument, Interest-Only Period With Extension", "terseLabel": "Interest-only period with extensions" } } }, "localname": "DebtInstrumentInterestOnlyPeriodWithExtension", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "durationItemType" }, "bli_EWBLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EWB Loan", "label": "EWB Loan [Member]", "terseLabel": "EWB Loan" } } }, "localname": "EWBLoanMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "bli_EarningsPerShareNumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share, Numerator", "label": "Earnings Per Share, Numerator [Abstract]", "terseLabel": "Numerator" } } }, "localname": "EarningsPerShareNumeratorAbstract", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "bli_EquipmentToolingAndMoldsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment, Tooling And Molds", "label": "Equipment, Tooling And Molds [Member]", "terseLabel": "Equipment, tooling and molds" } } }, "localname": "EquipmentToolingAndMoldsMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "bli_GeneTherapyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gene Therapy", "label": "Gene Therapy [Member]", "terseLabel": "Gene therapy" } } }, "localname": "GeneTherapyMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bli_IncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Operating Assets And Liabilities", "label": "Increase (Decrease) In Operating Assets And Liabilities [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAndLiabilitiesAbstract", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "bli_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease Liability, Payments Due After Year Four", "label": "Lessee, Operating Lease Liability, Payments Due After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "bli_LesseeOperatingLeaseTenantImprovementAllowance": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Tenant Improvement Allowance", "label": "Lessee, Operating Lease, Tenant Improvement Allowance", "negatedTerseLabel": "Less: tenant improvement allowances receivable" } } }, "localname": "LesseeOperatingLeaseTenantImprovementAllowance", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "bli_LongTermDebtInterestPayableLoanDiscountsAndFinancingCost": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails_1": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term Debt, Interest Payable, Loan Discounts and Financing Cost", "label": "Long-term Debt, Interest Payable, Loan Discounts and Financing Cost", "negatedTerseLabel": "Interest payments, loan discounts and financing costs" } } }, "localname": "LongTermDebtInterestPayableLoanDiscountsAndFinancingCost", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "bli_LossContingencyAmendedComplaintNumberOfClaims": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Amended Complaint, Number Of Claims", "label": "Loss Contingency, Amended Complaint, Number Of Claims", "terseLabel": "Number of counts in amended complaint" } } }, "localname": "LossContingencyAmendedComplaintNumberOfClaims", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "bli_LossContingencyCaseManagementOrderMaximumAssertedPatentClaimsPerPatentNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Case Management Order, Maximum Asserted Patent Claims Per Patent, Number", "label": "Loss Contingency, Case Management Order, Maximum Asserted Patent Claims Per Patent, Number", "terseLabel": "Case management order, maximum asserted patent claims per patent" } } }, "localname": "LossContingencyCaseManagementOrderMaximumAssertedPatentClaimsPerPatentNumber", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "bli_LossContingencyCaseManagementOrderMaximumPatentsAllegedlyInfringedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Case Management Order, Maximum Patents Allegedly Infringed, Number", "label": "Loss Contingency, Case Management Order, Maximum Patents Allegedly Infringed, Number", "terseLabel": "Case management order, maximum number of patents allegedly infringed" } } }, "localname": "LossContingencyCaseManagementOrderMaximumPatentsAllegedlyInfringedNumber", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "bli_LossContingencyCounterClaimsFiledNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Counter Claims Filed, Number", "label": "Loss Contingency, Counter Claims Filed, Number", "terseLabel": "Counter claims filed" } } }, "localname": "LossContingencyCounterClaimsFiledNumber", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "bli_NoncashIncomeExpenseRelatedToDebtAndNoteReceivableAgreements": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash Income (Expense) Related to Debt and Note Receivable Agreements", "label": "Noncash Income (Expense) Related to Debt and Note Receivable Agreements", "negatedTerseLabel": "Non-cash interest and other expense related to debt and note receivable agreements" } } }, "localname": "NoncashIncomeExpenseRelatedToDebtAndNoteReceivableAgreements", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "bli_NoncashIncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfFixedAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash Increase (Decrease) In Accounts Payable And Accrued Liabilities Related to Purchase Of Fixed Assets", "label": "Noncash Increase (Decrease) In Accounts Payable And Accrued Liabilities Related to Purchase Of Fixed Assets", "terseLabel": "Change in accounts payable and accrued liabilities related to purchases of property and equipment" } } }, "localname": "NoncashIncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfFixedAssets", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "bli_NumberOfFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Facilities", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfFacilities", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "integerItemType" }, "bli_ProductWarrantyDuration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Warranty, Duration", "label": "Product Warranty, Duration", "terseLabel": "Product warranty, term" } } }, "localname": "ProductWarrantyDuration", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "bli_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockPriceMultiplierOfDateOfGrantSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Price Multiplier Of Date Of Grant Share Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Price Multiplier Of Date Of Grant Share Price", "terseLabel": "Stock price goal multiplier of share price on date of grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockPriceMultiplierOfDateOfGrantSharePrice", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "pureItemType" }, "bli_SyntheticBiologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Synthetic Biology", "label": "Synthetic Biology [Member]", "terseLabel": "Synthetic biology" } } }, "localname": "SyntheticBiologyMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bli_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://berkeleylights.com/20220331", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://berkeleylights.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r162", "r273", "r278", "r435" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r219", "r251", "r293", "r294", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r432", "r436", "r459", "r460" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r219", "r251", "r293", "r294", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r432", "r436", "r459", "r460" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r162", "r273", "r278", "r435" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r157", "r273", "r276", "r404", "r431", "r433" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r157", "r273", "r276", "r404", "r431", "r433" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r219", "r251", "r284", "r293", "r294", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r432", "r436", "r459", "r460" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r219", "r251", "r284", "r293", "r294", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r432", "r436", "r459", "r460" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r158", "r159", "r273", "r277", "r434", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r158", "r159", "r273", "r277", "r434", "r443", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r164", "r388" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r12", "r40" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r23", "r165", "r166" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r11", "r12", "r44" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal expenses" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r178" ], "calculation": { "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r313", "r391" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r95", "r96", "r97", "r310", "r311", "r312", "r337" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r295", "r297", "r315", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r297", "r307", "r314" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from the calculation of net loss per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r90", "r143", "r147", "r153", "r168", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r332", "r334", "r354", "r389", "r391", "r406", "r421" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r9", "r52", "r90", "r168", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r332", "r334", "r354", "r389", "r391" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r340" ], "calculation": { "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r298", "r308" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/TheCompanyandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r36", "r83" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/TheCompanyandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Money market funds" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r77", "r83", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r77", "r355" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Statements of Cash Flows" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlows" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r48", "r186", "r410", "r425" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r183", "r184", "r185", "r193", "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r95", "r96", "r337" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r252" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r391" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00005 par value. Authorized 300,000,000 shares at March 31, 2022 and December 31, 2021; issued and outstanding 67,820,115 and 67,595,535 shares at March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r55", "r57", "r58", "r66", "r413", "r427" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Net loss and comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer software and equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r131", "r132", "r162", "r351", "r352", "r445" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r131", "r132", "r162", "r351", "r352", "r442", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r131", "r132", "r162", "r351", "r352", "r442", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Significant Risks and Uncertainties Including Business and Credit Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r131", "r132", "r162", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r129", "r131", "r132", "r133", "r351", "r353", "r445" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r131", "r132", "r162", "r351", "r352", "r445" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in process" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent": { "auth_ref": [ "r170", "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, Allowance for Credit Loss, Noncurrent", "terseLabel": "Contract assets, long-term, which are included in \u201cOther assets\u201d" } } }, "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of receivables, contract assets and deferred revenue from contracts with customers" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r258", "r260", "r274" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract assets, which are included in \u201cPrepaid expenses and other current assets\u201d", "verboseLabel": "Contract asset" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r258", "r259", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": { "auth_ref": [ "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.", "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized", "terseLabel": "Contract liability , revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r258", "r259", "r274" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue (current)" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r258", "r259", "r274" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred revenue, net of current portion", "verboseLabel": "Deferred revenue (non-current)" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofReceivablesContractAssetsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerSalesChannelAxis": { "auth_ref": [ "r273", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by sales channel for delivery of good or service in contract with customer.", "label": "Contract with Customer, Sales Channel [Axis]", "terseLabel": "Type of Sales Channel" } } }, "localname": "ContractWithCustomerSalesChannelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerSalesChannelDomain": { "auth_ref": [ "r273", "r282" ], "lang": { "en-us": { "role": { "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.", "label": "Contract with Customer, Sales Channel [Domain]", "terseLabel": "Contract with Customer, Sales Channel [Domain]" } } }, "localname": "ContractWithCustomerSalesChannelDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r70", "r404" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Total cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Cost of sales:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r130", "r162" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r88", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r233", "r240", "r241", "r243", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r89", "r93", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r229", "r230", "r231", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r246", "r247", "r248", "r249", "r366", "r407", "r408", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r20", "r244", "r408", "r420" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "totalLabel": "Total payments due" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r46", "r217" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r47", "r89", "r93", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r229", "r230", "r231", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r246", "r247", "r248", "r249", "r366" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r47", "r89", "r93", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r229", "r230", "r231", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r242", "r246", "r247", "r248", "r249", "r253", "r254", "r255", "r256", "r363", "r364", "r366", "r367", "r419" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Note payable, term (in years)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Schedule of prepaid expenses and other current assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCostsCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.", "label": "Deferred Costs, Current", "terseLabel": "Deferred costs" } } }, "localname": "DeferredCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Deposits Assets, Current", "terseLabel": "Vendor deposits" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r81", "r176" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://berkeleylights.com/role/PropertyandEquipmentnetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r273", "r276", "r277", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock Compensation Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r67", "r100", "r101", "r102", "r103", "r104", "r108", "r111", "r118", "r119", "r120", "r124", "r125", "r338", "r339", "r414", "r428" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss attributable to common stockholders per share, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net loss per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]", "terseLabel": "Denominator" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r67", "r100", "r101", "r102", "r103", "r104", "r111", "r118", "r119", "r120", "r124", "r125", "r338", "r339", "r414", "r428" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss attributable to common stockholders per share, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r121", "r122", "r123", "r126" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Attributable to Common Stockholders Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll and employee related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Options to purchase common stock", "verboseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails", "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r59", "r60", "r61", "r95", "r96", "r97", "r99", "r105", "r107", "r128", "r169", "r252", "r257", "r310", "r311", "r312", "r323", "r324", "r337", "r356", "r357", "r358", "r359", "r360", "r361", "r437", "r438", "r439", "r470" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r231", "r246", "r247", "r348" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r340", "r341", "r342", "r345" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of financial assets measured at fair value" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails", "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r340", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r231", "r246", "r247", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r341", "r392", "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails", "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r231", "r246", "r247", "r340", "r346" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r231", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Measurement Basis [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value.", "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]", "terseLabel": "Schedule of financial instruments not measured at fair value" } } }, "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r231", "r285", "r286", "r291", "r292", "r341", "r392" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r231", "r246", "r247", "r285", "r286", "r291", "r292", "r341", "r393" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails", "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r231", "r246", "r247", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r341", "r394" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r231", "r246", "r247", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r392", "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsAssetsandLiabilitiesDetails", "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture, fixtures and other" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r71" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r69", "r90", "r143", "r146", "r149", "r152", "r155", "r168", "r205", "r206", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r354" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r81", "r175" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of Long-Lived Assets to be Disposed of", "terseLabel": "Loss on disposal and impairment of property and equipment" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r64", "r143", "r146", "r149", "r152", "r155", "r405", "r411", "r417", "r429" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r180", "r182" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r91", "r320", "r321", "r322", "r325", "r327", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r92", "r106", "r107", "r142", "r319", "r326", "r328", "r430" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Trade accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r80", "r402" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r80", "r376" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaid expenses, other current assets and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r62", "r141", "r362", "r365", "r416" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r72", "r237", "r245", "r248", "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest cost" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeDepositsWithFinancialInstitutions": { "auth_ref": [ "r415", "r467", "r468" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.", "label": "Interest Income, Deposits with Financial Institutions", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeDepositsWithFinancialInstitutions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r76", "r78", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r29", "r172" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r50", "r391" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails", "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r30", "r172" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r171" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Provision for excess and obsolete inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of supplemental cash flow information related to operating leases and additional information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of operating lease liabilities maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "Remainder of 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r381" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: implied interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43", "r90", "r148", "r168", "r205", "r206", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r333", "r334", "r335", "r354", "r389", "r390" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r90", "r168", "r354", "r391", "r409", "r423" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45", "r90", "r168", "r205", "r206", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r333", "r334", "r335", "r354", "r389", "r390", "r391" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r20", "r408", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Amounts outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails_1": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "negatedTerseLabel": "Current portion, less loan discounts and financing costs" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term debt, including current maturities" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r93", "r203", "r235" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r93", "r203", "r235" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r93", "r203", "r235" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r93" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "Remainder of 2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails_1": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Notes payable" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r47" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "Notes payable" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r47", "r204" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r195", "r196" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r186" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Loss contingency accrual" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r77" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r77" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r77", "r79", "r82" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r54", "r56", "r61", "r65", "r82", "r90", "r98", "r100", "r101", "r102", "r103", "r106", "r107", "r116", "r143", "r146", "r149", "r152", "r155", "r168", "r205", "r206", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r339", "r354", "r412", "r426" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss attributable to common stockholders, basic and diluted", "totalLabel": "Net loss and comprehensive loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/TheCompanyandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r100", "r101", "r102", "r103", "r108", "r109", "r117", "r120", "r143", "r146", "r149", "r152", "r155" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net loss attributable to common stockholders, basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r110", "r112", "r113", "r114", "r115", "r117", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Net loss attributable to common stockholders, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableToBanksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a bank.", "label": "Notes Payable to Banks [Member]", "terseLabel": "Notes Payable" } } }, "localname": "NotesPayableToBanksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails", "http://berkeleylights.com/role/NotesPayableScheduleofPaymentDueonNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r143", "r146", "r149", "r152", "r155" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Rent expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r369" ], "calculation": { "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Present value of operating lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r369" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 }, "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedTerseLabel": "Less: current portion", "terseLabel": "Lease liability \u2013 short-term" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating lease, current [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r369" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Total long-term operating lease liabilities", "verboseLabel": "Lease liability, long-term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/LeasesMaturityScheduleofOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r372", "r376" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r368" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r81" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r379", "r382" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesScheduleofAdditionalInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r378", "r382" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesScheduleofAdditionalInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "The Company and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/TheCompanyandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11", "r12", "r13", "r44" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r51", "r391" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r73" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r74" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "PSO" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r7", "r34", "r35" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails", "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r6", "r8", "r173", "r174" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsPrepaidExpensesandOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r75" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r75", "r309" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r44", "r194", "r197" ], "calculation": { "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "terseLabel": "Accrued product warranty" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r38", "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails", "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r181", "r447", "r448", "r449" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r37", "r177" ], "calculation": { "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Gross, Period Increase (Decrease)", "terseLabel": "Inventory transferred to property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r16", "r179", "r391", "r418", "r424" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r15", "r179" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r15", "r177" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails", "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r318", "r403", "r461" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r10", "r17", "r85", "r444" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units", "verboseLabel": "RSU" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails", "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r257", "r313", "r391", "r422", "r440", "r441" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/TheCompanyandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r95", "r96", "r97", "r99", "r105", "r107", "r169", "r310", "r311", "r312", "r323", "r324", "r337", "r437", "r439" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r139", "r140", "r145", "r150", "r151", "r157", "r158", "r162", "r272", "r273", "r404" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Net revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails", "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r131", "r162" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SignificantRisksandUncertaintiesIncludingBusinessandCreditConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r262", "r263", "r264", "r265", "r266", "r267", "r270", "r271", "r275", "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue From Contracts With Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Summary of revenue by geographic areas" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Remaining performance obligation, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Remaining performance obligation, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r377", "r382" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesChannelDirectlyToConsumerMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred directly to consumer.", "label": "Sales Channel, Directly to Consumer [Member]", "terseLabel": "Direct sales channel" } } }, "localname": "SalesChannelDirectlyToConsumerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesChannelThroughIntermediaryMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred through intermediary.", "label": "Sales Channel, Through Intermediary [Member]", "terseLabel": "Distributor channel" } } }, "localname": "SalesChannelThroughIntermediaryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": { "auth_ref": [ "r385", "r387" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails_1": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable", "terseLabel": "Total amounts due from customers, gross" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]", "terseLabel": "Schedule of sales-type lease maturity" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": { "auth_ref": [ "r385" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received", "totalLabel": "Total undiscounted cash flows" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r385" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One", "terseLabel": "2023" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear": { "auth_ref": [ "r385" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Remainder of Fiscal Year", "terseLabel": "Remainder of 2022" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r385" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails": { "order": 3.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two", "terseLabel": "2024" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount": { "auth_ref": [ "r385" ], "calculation": { "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails_1": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted lease receivable in excess of discounted receivable for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount", "terseLabel": "Less: unearned income" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersSaletypeLeaseArrangementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseLeaseIncome": { "auth_ref": [ "r127", "r384", "r386" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.", "label": "Sales-type Lease, Lease Income", "terseLabel": "Lease income" } } }, "localname": "SalesTypeLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenuefromContractswithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of cash flow, supplemental disclosures" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StatementsofCashFlowsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r47", "r93", "r246", "r248", "r253", "r254", "r255", "r256", "r363", "r364", "r367", "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of payments due on notes payable" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of basic and diluted earnings per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r297", "r306", "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r297", "r306", "r314" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock-based compensation" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r14", "r31", "r32", "r33" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccountsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of product warranty liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r38", "r179" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/PropertyandEquipmentnetScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r63", "r161" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r298", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r135", "r137", "r138", "r143", "r144", "r149", "r153", "r154", "r155", "r156", "r157", "r161", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/Segments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r80" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "RSUs granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r296", "r301" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r298", "r302" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/TheCompanyandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Shares vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/StockCompensationPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r87", "r94" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r201" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r198" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlement of pre-existing warranties" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r200" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the standard product warranty accrual from changes in estimates attributable to preexisting product warranties. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "terseLabel": "Adjustments to existing warranties" } } }, "localname": "StandardProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Provision for new warranties" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CommitmentandContingenciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r49", "r59", "r60", "r61", "r95", "r96", "r97", "r99", "r105", "r107", "r128", "r169", "r252", "r257", "r310", "r311", "r312", "r323", "r324", "r337", "r356", "r357", "r358", "r359", "r360", "r361", "r437", "r438", "r439", "r470" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r95", "r96", "r97", "r128", "r404" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited", "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r21", "r22", "r252", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r21", "r22", "r252", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Vesting of restricted stock units (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r252", "r257", "r303" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r21", "r22", "r252", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r49", "r252", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r26", "r27", "r90", "r167", "r168", "r354", "r391" ], "calculation": { "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets", "http://berkeleylights.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Accounts" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/BalanceSheetAccounts" ], "xbrltype": "textBlockItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r273", "r281" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]", "terseLabel": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r273", "r281" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]", "terseLabel": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]", "terseLabel": "Goods and services transferred at a point in time" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Goods and services transferred over time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/RevenueFromContractsWithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableLeasePayment": { "auth_ref": [ "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability.", "label": "Variable Lease, Payment", "terseLabel": "Variable lease payments" } } }, "localname": "VariableLeasePayment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/NotesPayableNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r110", "r120" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares used in calculating net loss per share, diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r108", "r120" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares used in calculating net loss per share, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://berkeleylights.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited", "http://berkeleylights.com/role/NetLossAttributabletoCommonStockholdersPerShareScheduleofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r331": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498357-110258" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r383": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r462": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r463": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r464": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r465": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r466": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r467": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r468": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r469": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r86": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "http://asc.fasb.org/topic&trid=2134446" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" } }, "version": "2.1" } ZIP 83 0001689657-22-000019-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001689657-22-000019-xbrl.zip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

  •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